: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.

Irritable Bowel Syndrome, January 2022
Free Subscription

Abstracts
Retrieve all available abstracts of the following 937 articles:
HTML format

Single Articles

JI L, Zhao X, Zhang Y, Zhao P, et al
Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial.
Medicine (Baltimore). 2022;101:e28895.
Abstract

RUSSO F, Riezzo G, Linsalata M, Orlando A, et al
Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study.
Front Nutr. 2022;9:797192.
Abstract

REJ A, Sanders DS, Shaw CC, Buckle R, et al
Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet and the Gluten-Free Diet.
Clin Gastroenterol Hepatol. 2022 Feb 28. pii: S1542-3565(22)00202.
Abstract

NOBLE H, Hasan SS, Whorwell PJ, Vasant DH, et al
The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID-19 pandemic.
Neurogastroenterol Motil. 2022 Mar 3:e14347. doi: 10.1111/nmo.14347.
Abstract

LEE JY, Kim N, Yoon H, Shin CM, et al
A Randomized, Double-Blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Functional Dyspepsia and Constipation-type Irritable Bowel Syndrome Overlap: A Pilot Study.
J Neurogastroenterol Motil. 2022 Mar 2. pii: jnm20236. doi: 10.5056/jnm20236.
Abstract

STROZYK A, Horvath A, Szajewska H
FODMAP dietary restrictions in the management of children with functional abdominal pain disorders: A systematic review.
Neurogastroenterol Motil. 2022 Mar 1:e14345. doi: 10.1111/nmo.14345.
Abstract

BAO C, Wu L, Shi Y, Shi Z, et al
Long-term effect of moxibustion on irritable bowel syndrome with diarrhea: a randomized clinical trial.
Therap Adv Gastroenterol. 2022;15:17562848221075131.
Abstract

EL-HAGGAR SM, Hegazy SK, Abd-Elsalam SM, Elkaeed EB, et al
A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial.
J Inflamm Res. 2022;15:1159-1172.
Abstract

GARCIA-RODRIGUEZ F, Raygoza-Cortez K, Moreno-Hernandez L, Garcia-Perez R, et al
Outcomes of transitional care programs on adolescent chronic inflammatory systemic diseases: systematic review and meta-analyses.
Pediatr Rheumatol Online J. 2022;20:15.
Abstract

KALUZNA M, Kompf P, Wachowiak-Ochmanska K, Moczko J, et al
Are patients with polycystic ovary syndrome more prone to irritable bowel syndrome?
Endocr Connect. 2022 Mar 1. pii: EC-21-0309. doi: 10.1530/EC-21-0309.
Abstract

BAVANI NG, Hajhashemy Z, Saneei P, Keshteli AH, et al
The relationship between meal regularity with Irritable Bowel Syndrome (IBS) in adults.
Eur J Clin Nutr. 2022 Mar 10. pii: 10.1038/s41430-022-01108.
Abstract

VERGNOLLE N
Abdominal pain in irritable bowel syndrome.
Nat Rev Gastroenterol Hepatol. 2022 Mar 10. pii: 10.1038/s41575-022-00599.
Abstract

YACHHA SK, Sarma MS, Mohan N, Wadhwa N, et al
Indian Academy of Pediatrics Consensus Guidelines for Probiotic Use in Childhood Diarrhea.
Indian Pediatr. 2022 Mar 10. pii: S097475591600411.
Abstract

YANG PL, Matthews SW, Burr RL, Cain KC, et al
Cognitive Behavioral Therapy-Based Comprehensive Self-Management Program Improves Presenteeism in Persons with Irritable Bowel Syndrome: A Secondary Data Analysis.
Int J Environ Res Public Health. 2022;19.
Abstract

MENDOZA-MARTINEZ VM, Zavala-Solares MR, Espinosa-Flores AJ, Leon-Barrera KL, et al
Is a Non-Caloric Sweetener-Free Diet Good to Treat Functional Gastrointestinal Disorder Symptoms? A Randomized Controlled Trial.
Nutrients. 2022;14.
Abstract

ELWING JE, Atassi H, Rogers BD, Sayuk GS, et al
Emerging therapies in the management of Irritable Bowel Syndrome (IBS).
Expert Opin Emerg Drugs. 2022 Mar 10. doi: 10.1080/14728214.2022.2052043.
Abstract

BAYER SB, Frampton CM, Gearry RB, Barbara G, et al
Habitual Green Kiwifruit Consumption is Associated with a Reduction in Upper Gastrointestinal Symptoms - A Systematic Scoping Review.
Adv Nutr. 2022 Mar 10. pii: 6546207. doi: 10.1093.
Abstract

SCHWILLE-KIUNTKE J, Ittermann T, Schmidt CO, Grabe HJ, et al
Quality of life and sleep in individuals with irritable bowel syndrome according to different diagnostic criteria and inflammatory bowel diseases: A comparison using data from a population-based survey.
Z Gastroenterol. 2022;60:299-309.
Abstract

CAPOZZA M, Laforgia N, Rizzo V, Salvatore S, et al
Probiotics and Functional Gastrointestinal Disorders in Pediatric Age: A Narrative Review.
Front Pediatr. 2022;10:805466.
Abstract

MARTIN A, Struble S, Prado A, Robinson J, et al
A Case of Portal Vein Thrombosis in a Patient With Methylenetetrahydrofolate Reductase A1298C Polymorphism.
Cureus. 2022;14:e21743.
Abstract

CHEN M, Ruan G, Chen L, Ying S, et al
Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome.
Front Endocrinol (Lausanne). 2022;13:817100.
Abstract

NUNEZ F P, Quera R, Bay C, Thomson P, et al
Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases.
Gastroenterol Hepatol. 2022;45:223-230.
Abstract

WU H, Zhan K, Rao K, Zheng H, et al
Comparison of five diarrhea-predominant irritable bowel syndrome (IBS-D) rat models in the brain-gut-microbiota axis.
Biomed Pharmacother. 2022;149:112811.
Abstract

EL-SALHY M, Mazzawi T, Hausken T, Hatlebakk JG, et al
Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation.
Neurogastroenterol Motil. 2022 Mar 18:e14353. doi: 10.1111/nmo.14353.
Abstract

SHEN J, Zhang B, Chen J, Cheng J, et al
SAHA Alleviates Diarrhea-Predominant Irritable Bowel Syndrome Through Regulation of the p-STAT3/SERT/5-HT Signaling Pathway.
J Inflamm Res. 2022;15:1745-1756.
Abstract

AGUILERA-LIZARRAGA J, Hussein H, Boeckxstaens GE
Immune activation in irritable bowel syndrome: what is the evidence?
Nat Rev Immunol. 2022 Mar 16. pii: 10.1038/s41577-022-00700.
Abstract

WU J, Lv L, Wang C
Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
Front Cell Infect Microbiol. 2022;12:827395.
Abstract

ESTUDILLO-GUERRA MA, Mesia-Toledo I, Schneider JC, Morales-Quezada L, et al
The Use of Conditioning Open-Label Placebo in Opioid Dose Reduction: A Case Report and Literature Review.
Front Pain Res (Lausanne). 2021;2:697475.
Abstract

BOONMA P, Shapiro JM, Hollister EB, Badu S, et al
Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome.
Front Pain Res (Lausanne). 2021;2:691689.
Abstract

WILLITS AB, Grossi V, Glidden NC, Hyams JS, et al
Identification of a Pain-Specific Gene Expression Profile for Pediatric Recurrent Abdominal Pain.
Front Pain Res (Lausanne). 2021;2:759634.
Abstract

KOECHLIN H, Kharko A, Probst T, Pradela J, et al
Placebo Responses and Their Clinical Implications in Fibromyalgia: A Meta-Analysis Using SSRI and SNRI Trials.
Front Pain Res (Lausanne). 2021;2:750523.
Abstract

WEAVER KR, Griffioen MA, Klinedinst NJ, Galik E, et al
Quantitative Sensory Testing Across Chronic Pain Conditions and Use in Special Populations.
Front Pain Res (Lausanne). 2022;2:779068.
Abstract

WANG RS, Lembo AJ, Kaptchuk TJ, Cheng V, et al
Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome.
Front Pain Res (Lausanne). 2022;2:775386.
Abstract

DE PALMA G, Bercik P
Long-term personalized low FODMAP diet in IBS.
Neurogastroenterol Motil. 2022 Mar 16:e14356. doi: 10.1111/nmo.14356.
Abstract

JONES MP, Shah A, Walker MM, Koloski NA, et al
Overlap of heartburn, functional dyspepsia, and irritable bowel syndrome in a population sample: Prevalence, temporal stability, and associated comorbidities.
Neurogastroenterol Motil. 2022 Mar 16:e14349. doi: 10.1111/nmo.14349.
Abstract

SANTUCCI NR, King C, El-Chammas KI, Wongteerasut A, et al
Effect of percutaneous electrical nerve field stimulation on mechanosensitivity, sleep, and psychological comorbidities in adolescents with functional abdominal pain disorders.
Neurogastroenterol Motil. 2022 Mar 16:e14358. doi: 10.1111/nmo.14358.
Abstract

FREUER D, Linseisen J, Meisinger C
Asthma and the risk of gastrointestinal disorders: a Mendelian randomization study.
BMC Med. 2022;20:82.
Abstract

SO D, Yao CK, Gibson PR, Muir JG, et al
Evaluating tolerability of resistant starch 2, alone and in combination with minimally fermented fibre for patients with irritable bowel syndrome: a pilot randomised controlled cross-over trial.
J Nutr Sci. 2022;11:e15.
Abstract

O'DRISCOLL S, Piggott C, Benton SC
Evaluation of a faecal calprotectin method using the OC-SENSOR PLEDIA.
Clin Chem Lab Med. 2022 Mar 14. pii: cclm-2022-0126. doi: 10.1515/cclm-2022-0126
Abstract

ALQAHTANI NH, Mahfouz MEM
The Prevalence and Risk Factors of Irritable Bowel Syndrome in Saudi Arabia in 2019.
Int J Prev Med. 2022;13:13.
Abstract

QIN D, Tao QF, Huang SL, Chen M, et al
Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysis.
Front Pharmacol. 2022;13:757969.
Abstract

KATSUMI Y, Kodo K, Goto S
Case Report: COVID-19 Pandemic Exacerbates Eating Disorder by Social and Intrafamilial Isolation.
Front Pediatr. 2022;10:819214.
Abstract

KAUL I, Staggs VS, Bagherian A, Ali A, et al
Pediatric Rome IV diagnosis agreement is greater than agreement on diagnostic testing.
Neurogastroenterol Motil. 2022 Mar 13:e14355. doi: 10.1111/nmo.14355.
Abstract

HOJSAK I, Benninga MA, Hauser B, Kansu A, et al
Benefits of dietary fibre for children in health and disease.
Arch Dis Child. 2022 Mar 11. pii: archdischild-2021-323571.
Abstract

USAI-SATTA P, Lai M, Oppia F
Lactose Malabsorption and Presumed Related Disorders: A Review of Current Evidence.
Nutrients. 2022;14.
Abstract

GIACOSA A, Riva A, Petrangolini G, Allegrini P, et al
Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with Irritable Bowel Syndrome and Small Bowel Dysbiosis.
Nutrients. 2022;14.
Abstract

SIMOES CD, Maganinho M, Sousa AS
FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence.
Eur J Nutr. 2022;61:1187-1198.
Abstract

AWAD A, Madla CM, McCoubrey LE, Ferraro F, et al
Clinical translation of advanced colonic drug delivery technologies.
Adv Drug Deliv Rev. 2022;181:114076.
Abstract

MELGAARD D, Sorensen J, Riis J, Ovesen TS, et al
Efficacy of FODMAP Elimination and Subsequent Blinded Placebo-Controlled Provocations in a Randomised Controlled Study in Patients with Ulcerative Colitis in Remission and Symptoms of Irritable Bowel Syndrome: A Feasibility Study.
Nutrients. 2022;14.
Abstract

CURCI F, Corbo F, Clodoveo ML, Salvagno L, et al
Polyphenols from Olive-Mill Wastewater and Biological Activity: Focus on Irritable Bowel Syndrome.
Nutrients. 2022;14.
Abstract

SURYAWANSHI SS
Gastrointestinal Health of People Working From Home Due to the COVID-19 Pandemic: Online, Cross-sectional Survey.
Altern Ther Health Med. 2022 Mar 24. pii: AT7140.
Abstract

AGUILERA-LIZARRAGA J, Hussein H, Boeckxstaens GE
Publisher Correction: Immune activation in irritable bowel syndrome: what is the evidence?
Nat Rev Immunol. 2022 Mar 23. pii: 10.1038/s41577-022-00713.
Abstract

SAADATI S, Sadeghi A, Mohaghegh-Shalmani H, Rostami-Nejad M, et al
Effects of a gluten challenge in patients with irritable bowel syndrome: a randomized single-blind controlled clinical trial.
Sci Rep. 2022;12:4960.
Abstract

BABAR AN, Hassan MK, Ullah F, Ullah A, et al
Role of Lactobacillus plantarum 299v versus Placebo in symptomatic improvement of irritable bowel syndrome patients.
J Pak Med Assoc. 2022;72:404-408.
Abstract

SABATE JM, Iglicki F
Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome.
World J Gastroenterol. 2022;28:732-744.
Abstract

LI R, Chen S, Gu X, An S, et al
Role of the nuclear receptor subfamily 4a in mast cells in the development of irritable bowel syndrome.
Comput Struct Biotechnol J. 2022;20:1198-1207.
Abstract

CHEN YM, Li Y, Wang X, Wang ZL, et al
Effect of Bacillus subtilis, Enterococcus faecium, and Enterococcus faecalis supernatants on serotonin transporter expression in cells and tissues.
World J Gastroenterol. 2022;28:532-546.
Abstract

CAETANO AC, Costa D, Silva-Mendes S, Correia-Pinto J, et al
Constipation: Prevalence in the Portuguese community using Rome IV-Associated factors, toilet behaviours and healthcare seeking.
United European Gastroenterol J. 2022 Mar 22. doi: 10.1002/ueg2.12221.
Abstract

HASLER WL, Grabauskas G, Singh P, Owyang C, et al
Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome.
Neurogastroenterol Motil. 2022 Mar 21:e14339. doi: 10.1111/nmo.14339.
Abstract

LIANG SB, Han M, Cheng HJ, Zhang QY, et al
Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
Trials. 2022;23:226.
Abstract

GAO Y, Mei C, Chen P, Chen X, et al
The contribution of neuro-immune crosstalk to pain in the peripheral nervous system and the spinal cord.
Int Immunopharmacol. 2022;107:108700.
Abstract

IBRAHIM M, Ahmeid M
Metformin effects on zonulin level in polycystic ovarian women.
ADMET DMPK. 2022;9:49-55.
Abstract

WU X, Wang J, Ye Z, Wang J, et al
Risk of Colorectal Cancer in Patients With Irritable Bowel Syndrome: A Meta-Analysis of Population-Based Observational Studies.
Front Med (Lausanne). 2022;9:819122.
Abstract

COLOMIER E, Melchior C, Algera JP, Hreinsson JP, et al
Global prevalence and burden of meal-related abdominal pain.
BMC Med. 2022;20:71.
Abstract

CHA RR, Kim JH, Koo HS, Jung KW, et al
Self-reported Non-celiac Gluten Sensitivity in the Korean Population: Demographic and Clinical Characteristics.
J Neurogastroenterol Motil. 2022;28:283-290.
Abstract

LI Y, Liu N, Ge Y, Yang Y, et al
Tryptophan and the innate intestinal immunity: Crosstalk between metabolites, host innate immune cells and microbiota.
Eur J Immunol. 2022 Apr 1. doi: 10.1002/eji.202149401.
Abstract

PIRIYAKITPHAIBOON V, Sirinam S, Noipayak P, Sirivichayakul C, et al
Risk Factors for Recurrent Abdominal Pain in Children with Nonorganic Acute Abdominal Pain.
Pediatr Gastroenterol Hepatol Nutr. 2022;25:129-137.
Abstract

FOWLER S, Hoedt EC, Talley NJ, Keely S, et al
Circadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions.
Front Neurosci. 2022;16:825246.
Abstract

XIE CR, Tang B, Shi YZ, Peng WY, et al
Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis.
Front Pharmacol. 2022;13:853011.
Abstract

HANEVIK K, Saghaug C, Aaland M, Morch K, et al
No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection.
JGH Open. 2022;6:185-188.
Abstract

VAN THIEL IAM, Stavrou AA, de Jong A, Theelen B, et al
Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome.
Sci Rep. 2022;12:5391.
Abstract

KENDLER KS, Rosmalen JGM, Ohlsson H, Sundquist J, et al
A distinctive profile of family genetic risk scores in a Swedish national sample of cases of fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome compared to rheumatoid arthritis and major depression.
Psychol Med. 2022 Mar 31:1-8. doi: 10.1017/S0033291722000526.
Abstract

BURNS GL, Talley NJ, Keely S
Immune responses in the irritable bowel syndromes: time to consider the small intestine.
BMC Med. 2022;20:115.
Abstract

ZHANG HY, Zhang Y, Zhang Y, Jiang ZP, et al
ROS-responsive thioketal-linked alginate/chitosan carriers for irritable bowel syndrome with diarrhea therapy.
Int J Biol Macromol. 2022 Mar 26. pii: S0141-8130(22)00588.
Abstract

JASON LA, Cotler J, Islam MF, Furst J, et al
Predictors for Developing Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Following Infectious Mononucleosis.
J Rehabil Ther. 2022;4:1-5.
Abstract

TIAN YQ, Li JH, Li YC, Xu YC, et al
Overexpression of GRK6 alleviates chronic visceral hypersensitivity through downregulation of P2Y6 receptors in anterior cingulate cortex of rats with prenatal maternal stress.
CNS Neurosci Ther. 2022 Mar 29. doi: 10.1111/cns.13827.
Abstract

SIAJUNBORIBOON S, Tanpowpong P, Empremsilapa S, Lertudomphonwanit C, et al
Prevalence of functional abdominal pain disorders and functional constipation in adolescents.
J Paediatr Child Health. 2022 Mar 29. doi: 10.1111/jpc.15950.
Abstract

JOSE S, Devi SS, Sajeev A, Girisa S, et al
Repurposing FDA Approved Drugs as FXR Agonists: A Structure Based in silico Pharmacological Study.
Biosci Rep. 2022 Mar 29. pii: 231090. doi: 10.1042/BSR20212791.
Abstract

BASPINAR MM, Basat O
Frequency and severity of irritable bowel syndrome in cigarette smokers, Turkey 2019.
Tob Induc Dis. 2022;20:27.
Abstract

JOUKAR F, Yeganeh S, Shafaghi A, Mahjoob A, et al
The seroprevalence of celiac disease in patients with symptoms of irritable bowel syndrome: A cross-sectional study in north of Iran.
Hum Antibodies. 2022 Mar 16. pii: HAB211516. doi: 10.3233/HAB-211516.
Abstract

LI DJ, Chen MH, Bai YM, Tsai SJ, et al
Risk of Pain Disorders in Offspring of Parents with Substance Use Disorders.
Psychiatry Clin Neurosci. 2022 Mar 27. doi: 10.1111/pcn.13357.
Abstract

DI NARDO G, Cremon C, Staiano A, Stanghellini V, et al
Role of inflammation in pediatric irritable bowel syndrome.
Neurogastroenterol Motil. 2022 Mar 27:e14365. doi: 10.1111/nmo.14365.
Abstract

BALLOU S, Hassan R, Nee J, Iturrino J, et al
Are they side effects? Extra-intestinal symptoms reported during clinical trials of IBS may be more severe at baseline.
Clin Gastroenterol Hepatol. 2022 Mar 23. pii: S1542-3565(22)00293.
Abstract

SCUDERI SA, Casili G, Lanza M, Ardizzone A, et al
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model.
Int J Mol Sci. 2022;23.
Abstract

KAMPHUIS JBJ, Reber LL, Eutamene H, Theodorou V, et al
Increased fermentable carbohydrate intake alters colonic mucus barrier function through glycation processes and increased mast cell counts.
FASEB J. 2022;36:e22297.
Abstract

RABAGO R, Bonilla A, Escamilla-Diego E, Higuera de la Tijera MF, et al
Pictograms are more effective than verbal descriptors in Spanish for bloating and distension.
Neurogastroenterol Motil. 2022 Apr 8:e14364. doi: 10.1111/nmo.14364.
Abstract

KUMBHARE SV, Francis-Lyon PA, Kachru D, Uday T, et al
Digital Therapeutics Care Utilizing Genetic and Gut Microbiome Signals for the Management of Functional Gastrointestinal Disorders: Results From a Preliminary Retrospective Study.
Front Microbiol. 2022;13:826916.
Abstract

UNALAN-ALTINTOP T, Vahabov C, Ergunay K, Kurt O, et al
Investigation of Dientamoeba fragilis and Blastocystis in patients from Turkey with ulcerative colitis and irritable bowel syndrome: any relation with genotypes?
Acta Trop. 2022 Apr 4:106451. doi: 10.1016/j.actatropica.2022.106451.
Abstract

GU Y, Li L, Yang M, Liu T, et al
Bile acid-gut microbiota crosstalk in irritable bowel syndrome.
Crit Rev Microbiol. 2022 Apr 7:1-20. doi: 10.1080/1040841X.2022.2058353.
Abstract

WENG ZJ, Hu SX, Zhang F, Zhang ZY, et al
Spinal cord astrocyte P2X7Rs mediate the inhibitory effect of electroacupuncture on visceral hypersensitivity of rat with irritable bowel syndrome.
Purinergic Signal. 2022 Apr 7. pii: 10.1007/s11302-021-09830.
Abstract

BIESIEKIERSKI JR, Tuck CJ
Low FODMAP diet beyond IBS: Evidence for use in other conditions.
Curr Opin Pharmacol. 2022;64:102208.
Abstract

KHAN EH, Ahamed F, Karim MR, Roy P, et al
Psychiatric Morbidity in Irritable Bowel Syndrome.
Mymensingh Med J. 2022;31:458-465.
Abstract

KLINGE MW, Krogh K, Mark EB, Drewes AM, et al
Colonic volume in patients with functional constipation or irritable bowel syndrome determined by magnetic resonance imaging.
Neurogastroenterol Motil. 2022 Apr 5:e14374. doi: 10.1111/nmo.14374.
Abstract

LEWANDOWSKI K, Kaniewska M, Karlowicz K, Rosolowski M, et al
The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome.
Prz Gastroenterol. 2022;17:28-34.
Abstract

HUANG HL, Xu HM, Liu YD, Shou DW, et al
First Application of Fecal Microbiota Transplantation in Adult Asperger Syndrome With Digestive Symptoms-A Case Report.
Front Psychiatry. 2022;13:695481.
Abstract

TAO E, Zhu Z, Hu C, Long G, et al
Potential Roles of Enterochromaffin Cells in Early Life Stress-Induced Irritable Bowel Syndrome.
Front Cell Neurosci. 2022;16:837166.
Abstract

SCHNEDL WJ, Meier-Allard N, Schenk M, Lackner S, et al
Helicobacter pylori infection and lactose intolerance increase expiratory hydrogen.
EXCLI J. 2022;21:426-435.
Abstract

HUANG WL, Chang SS, Liao SC
The psychological features of distinct somatic syndromes: A cluster analysis according to population-based somatic symptom profiles in Taiwan.
J Formos Med Assoc. 2022 Mar 30. pii: S0929-6646(22)00111.
Abstract

DEBRAS C, Chazelas E, Srour B, Julia C, et al
Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Cancer Risk in the Prospective NutriNet-Sante Cohort.
J Nutr. 2022;152:1059-1069.
Abstract

HUANG R, Wu F, Zhou Q, Wei W, et al
Lactobacillus and intestinal diseases: Mechanisms of action and clinical applications.
Microbiol Res. 2022;260:127019.
Abstract

GIN GT
Female Pelvic Conditions: Chronic Pelvic Pain.
FP Essent. 2022;515:11-19.
Abstract

ISSRANI R, Reddy J, Dabah THE, Prabhu N, et al
Role of Oral Microbiota in Carcinogenesis: A Short Review.
J Cancer Prev. 2022;27:16-21.
Abstract

GALICA AN, Galica R, Dumitrascu DL
Diet, fibers, and probiotics for irritable bowel syndrome.
J Med Life. 2022;15:174-179.
Abstract

BAGAGIOLO D, Rosa D, Borrelli F
Efficacy and safety of osteopathic manipulative treatment: an overview of systematic reviews.
BMJ Open. 2022;12:e053468.
Abstract

WAN YP, Ng SM
Hypnotherapy for persons with Irritable Bowel Syndrome: A three-arm randomized controlled trial.
Am J Clin Hypn. 2022 Apr 12:1-26. doi: 10.1080/00029157.2022.2051424.
Abstract

BALLOU S, Haas JW, Iturrino J, Nee J, et al
Psychological Predictors of Response to Open-label versus Double-blind Placebo in a Randomized Controlled Trial in Irritable Bowel Syndrome.
Psychosom Med. 2022 Apr 12. pii: 00006842-990000000-00009.
Abstract

COWAN LM, Strege PR, Rusinova R, Andersen OS, et al
Capsaicin as an amphipathic modulator of NaV1.5 mechanosensitivity.
Channels (Austin). 2022;16:9-26.
Abstract

LOUWIES T, Greenwood-Van Meerveld B
Chronic stress increases DNA methylation of the GR promoter in the central nucleus of the amygdala of female rats.
Neurogastroenterol Motil. 2022 Apr 11:e14377. doi: 10.1111/nmo.14377.
Abstract

GHAFFARI P, Shoaie S, Nielsen LK
Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions.
J Transl Med. 2022;20:173.
Abstract

KIM J, Lee S, Rhew K
Association between Gastrointestinal Diseases and Migraine.
Int J Environ Res Public Health. 2022;19.
Abstract

RYDELL N, Ekoff H, Hellstrom PM, Moverare R, et al
Measurement of Serum IgG Anti-Integrin alphavbeta6 Autoantibodies Is a Promising Tool in the Diagnosis of Ulcerative Colitis.
J Clin Med. 2022;11.
Abstract

ACCARIE A, Toth J, Wauters L, Farre R, et al
Estrogens Play a Critical Role in Stress-Related Gastrointestinal Dysfunction in a Spontaneous Model of Disorders of Gut-Brain Interaction.
Cells. 2022;11.
Abstract

LIU Y, Chen M
Insights into the underlying mechanisms and clinical management of microscopic colitis in relation to other gastrointestinal disorders.
Gastroenterol Rep (Oxf). 2022;10:goac011.
Abstract

REJ A, Buckle RL, Shaw CC, Trott N, et al
National survey evaluating the provision of gastroenterology dietetic services in England.
Frontline Gastroenterol. 2020;12:380-384.
Abstract

VOLLERT J, Wang R, Regis S, Yetman H, et al
Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome.
Front Psychiatry. 2022;13:842030.
Abstract

OTANI K, Watanabe T, Takahashi K, Ominami M, et al
A questionnaire-based survey on the etiopathogenesis of chronic constipation during a medical check-up in Japan.
J Clin Biochem Nutr. 2022;70:205-211.
Abstract

SWIER RM, Siebrasse A, Coscia E, Peery AF, et al
Diet in Benign Colonic Disorders: A Narrative Review.
Clin Ther. 2022 Apr 7. pii: S0149-2918(22)00114.
Abstract

GOTA CE
Fibromyalgia: Recognition and Management in the Primary Care Office.
Rheum Dis Clin North Am. 2022;48:467-478.
Abstract

TANG R, Peng X, Zhou X, Zheng Z, et al
Mechanism of the Treatment of Irritable Bowel Syndrome with Sini Powder and Tong Xie Yao Fang Decoction Based on Network Pharmacology.
Evid Based Complement Alternat Med. 2022;2022:3598856.
Abstract

MISERY L, Bataille A, Talagas M, Le Gall-Ianotto C, et al
Sensitive Skin Syndrome: A Low-Noise Small-Fiber Neuropathy Related to Environmental Factors?
Front Pain Res (Lausanne). 2022;3:853491.
Abstract

TOGHA M, Karimitafti MJ, Ghorbani Z, Farham F, et al
Characteristics and comorbidities of headache in patients over 50 years of age: a cross-sectional study.
BMC Geriatr. 2022;22:313.
Abstract

ZHOU C, Cheng X, Liu C, Li P, et al
Interpersonal coordination enhances brain-to-brain synchronization and influences responsibility attribution and reward allocation in social cooperation.
Neuroimage. 2022;252:119028.
Abstract

YAO F, Wu X, Zhao H, Gan C, et al
Efficacy of psychological interventions for irritable bowel syndrome: A protocol for systematic review and meta-analysis.
Medicine (Baltimore). 2022;101:e29033.
Abstract

SALAMIN F, Gobin N, Cereda JM, Bonnaud G, et al
[Irritable bowel syndrome : physiopathology and complementary management].
Rev Med Suisse. 2022;18:763-768.
Abstract

JIAN J, Nie MT, Xiang B, Qian H, et al
Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids.
Front Pharmacol. 2022;13:841132.
Abstract

MUJAGIC Z, Kasapi M, Jonkers DM, Garcia-Perez I, et al
Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome.
Gut Microbes. 2022;14:2063016.
Abstract

DUFFY C, Pridgen WL, Whitley RJ
Gastric herpes simplex virus type 1 infection is associated with functional gastrointestinal disorders in the presence and absence of comorbid fibromyalgia: a pilot case-control study.
Infection. 2022 Apr 21. pii: 10.1007/s15010-022-01823.
Abstract

A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial [Retraction].
J Inflamm Res. 2022;15:2381-2382.
Abstract

GAN Y, Huang SL, Luo MQ, Chen M, et al
Acupuncture in addition to usual care for patients with irritable bowel syndrome: a component network meta-analysis.
Acupunct Med. 2022 Apr 18:9645284221085280. doi: 10.1177/09645284221085280.
Abstract

G S A
Biopharmaceutical applications of alpha-galactosidases.
Biotechnol Appl Biochem. 2022 Apr 18. doi: 10.1002/bab.2349.
Abstract

CHEN T, Chen S, Zheng X, Zhu Y, et al
The pathological involvement of spinal cord EphB2 in visceral sensitization in male rats.
Stress. 2022;25:166-178.
Abstract

ZHANG T, Zhang C, Zhang J, Sun F, et al
Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
Front Cell Infect Microbiol. 2022;12:859967.
Abstract

CORDEIRO SANTOS ML, da Silva Junior RT, de Brito BB, Franca da Silva FA, et al
Non-pharmacological management of pediatric functional abdominal pain disorders: Current evidence and future perspectives.
World J Clin Pediatr. 2022;11:105-119.
Abstract

SINGHA M, Trejo Paredes C, Alang N, Wu U, et al
Dangerous dog licks! - A rare case of epidural abscess secondary to Capnocytophaga.
IDCases. 2022;28:e01483.
Abstract

MAMIEVA Z, Poluektova E, Svistushkin V, Sobolev V, et al
Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
World J Gastroenterol. 2022;28:1204-1219.
Abstract

BUBAN T, Sipeki N, Varvolgyi C, Papp M, et al
A vastagbel-diverticulosis veszelyei es kezelese.
Orv Hetil. 2022;163:614-623.
Abstract

CHIU YC, Chang WP, Tang GJ, Lan TY, et al
Chronic obstructive pulmonary disease is associated with a higher risk of functional gastrointestinal disorders.
Respir Med. 2022;197:106833.
Abstract

HOLROYD CB
Interbrain synchrony: on wavy ground.
Trends Neurosci. 2022;45:346-357.
Abstract

IRIBARREN C, Nordlander S, Sundin J, Isaksson S, et al
Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids.
Neurogastroenterol Motil. 2022 Apr 29:e14390. doi: 10.1111/nmo.14390.
Abstract

NILHOLM C, Manoharan L, Roth B, D'Amato M, et al
A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA level
United European Gastroenterol J. 2022 Apr 28. doi: 10.1002/ueg2.12227.
Abstract

EDWINSON AL, Yang L, Peters S, Hanning N, et al
Gut microbial beta-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome.
Nat Microbiol. 2022 Apr 28. pii: 10.1038/s41564-022-01103.
Abstract

LAI Y, Liang X, Fan H, Liu Y, et al
Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: a randomized controlled trial.
Complement Ther Med. 2022 Apr 25:102839. doi: 10.1016/j.ctim.2022.102839.
Abstract

COOK TM, Mansuy-Aubert V
Communication between the gut microbiota and peripheral nervous system in health and chronic disease.
Gut Microbes. 2022;14:2068365.
Abstract

TRIESCHMANN K, Chang L, Park S, Naliboff B, et al
The visceral sensitivity index: A novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease.
Neurogastroenterol Motil. 2022 Apr 27:e14384. doi: 10.1111/nmo.14384.
Abstract

SANDERS AE, Weatherspoon ED, Ehrmann BM, Soma PS, et al
Ratio of omega-6/omega-3 polyunsaturated fatty acids associated with somatic and depressive symptoms in people with painful temporomandibular disorder and irritable bowel syndrome.
J Pain. 2022 Apr 24. pii: S1526-5900(22)00304.
Abstract

WILHELM-ROMERO K, Quiros-Fallas MI, Vega-Baudrit JR, Guillen-Giron T, et al
Evaluation of Piperine as Natural Coformer for Eutectics Preparation of Drugs Used in the Treatment of Cardiovascular Diseases.
AAPS PharmSciTech. 2022;23:127.
Abstract

BIELECKA U, Schier K, Hardt J
Own body experience and parents' attitudes perceived retrospectively in patients with irritable bowel syndrome.
Psychiatr Pol. 2021;55:1405-1420.
Abstract

NAITOU K, Iwashita H, Ueda HH, Shiraishi M, et al
Intrathecally administered substance P activated the spinal defecation center and enhanced colorectal motility in anesthetized rats.
Am J Physiol Gastrointest Liver Physiol. 2022.
Abstract

PERUHOVA M, Mihova A, Altankova I, Velikova T, et al
Specific Immunoglobulin E and G to Common Food Antigens and Increased Serum Zonulin in IBS Patients: A Single-Center Bulgarian Study.
Antibodies (Basel). 2022;11.
Abstract

PARVEEN S, Imran Afridi H, Gul Kazi T, Talpur FN, et al
Impacts of Smoking and Stomach Disorders on Essential Elements in Biological Samples of Cement and Glass Industrial Workers.
Biol Trace Elem Res. 2022 Apr 23. pii: 10.1007/s12011-022-03238.
Abstract

REXWINKEL R, Vlieger AM, Saps M, Tabbers MM, et al
A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified.
Eur J Pediatr. 2022 Apr 23. pii: 10.1007/s00431-022-04459.
Abstract

YUK JS, Kim JM
Uterine fibroids increase the risk of thyroid goiter and thyroid nodules.
Sci Rep. 2022;12:6620.
Abstract

BALMUS IM, Copolovici D, Copolovici L, Ciobica A, et al
Biomolecules from Plant Wastes Potentially Relevant in the Management of Irritable Bowel Syndrome and Co-Occurring Symptomatology.
Molecules. 2022;27.
Abstract

RUSSO F, Riezzo G, Orlando A, Linsalata M, et al
A Comparison of the Low-FODMAPs Diet and a Tritordeum-Based Diet on the Gastrointestinal Symptom Profile of Patients Suffering from Irritable Bowel Syndrome-Diarrhea Variant (IBS-D): A Randomized Controlled Trial.
Nutrients. 2022;14.
Abstract

KASTI A, Petsis K, Lambrinou S, Katsas K, et al
A Combination of Mediterranean and Low-FODMAP Diets for Managing IBS Symptoms? Ask Your Gut!
Microorganisms. 2022;10.
Abstract

ROMBOLA L, Straface M, Scuteri D, Sakurada T, et al
Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues.
Pharmaceutics. 2022;14.
Abstract

LEE DY, Kang HE
Pharmacokinetics of DA-6886, A New 5-HT4 Receptor Agonist, in Rats.
Pharmaceutics. 2022;14.
Abstract

BARBOI OB, Chirila I, Ciortescu I, Anton C, et al
Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with Constipation-Randomized Case-Control Study.
J Clin Med. 2022;11.
Abstract

STEPAN MD, Cioboata R, Vintilescu SB, Vasile CM, et al
Pediatric Functional Abdominal Pain Disorders following COVID-19.
Life (Basel). 2022;12.
Abstract

LIU L, Zhang W, Zhao W, Guo S, et al
Linaclotide for treating patients with irritable bowel syndrome with predominant constipation: a multicentre study of real-world data in China.
Therap Adv Gastroenterol. 2022;15:17562848221092596.
Abstract

LIN L, Wang T, Lu Y, Chen P, et al
Mucosal healing and quality of life in therapeutic goals of ulcerative colitis: occurrence and related factors of functional bowel disorder-like symptoms.
Therap Adv Gastroenterol. 2022;15:17562848221092597.
Abstract

HUANG H, Lu L, Chen Y, Zeng Y, et al
The efficacy of vitamin D supplementation for irritable bowel syndrome: a systematic review with meta-analysis.
Nutr J. 2022;21:24.
Abstract

CAMILLERI M, Magnus Y, Carlson P, Wang XJ, et al
Differential mRNA Expression in Ileal and Colonic Biopsies in Irritable Bowel Syndrome with Diarrhea or Constipation.
Am J Physiol Gastrointest Liver Physiol. 2022.
Abstract

LIU D, Ruan M, Tong C, Huang R, et al
Effect of Shugan Jianpi Recipe Combined with Cross Moxibustion on Biochemical Examination Indexes and Total Score of TCM Symptoms in Patients with Spleen-Stomach Damp-Heat Diarrhea Irritable Bowel Syndrome.
Comput Math Methods Med. 2022;2022:8286146.
Abstract

Findings from a survey about hidradenitis suppurativa in the Netherlands.
Br J Dermatol. 2022;186:e200-e219.
Abstract

GONCALVES S, Nunes-Costa D, Cardoso SM, Empadinhas N, et al
Enzyme Promiscuity in Serotonin Biosynthesis, From Bacteria to Plants and Humans.
Front Microbiol. 2022;13:873555.
Abstract

LI M, Wang C, Guo Q, Xu C, et al
More Positive or More Negative? Metagenomic Analysis Reveals Roles of Virome in Human Disease-Related Gut Microbiome.
Front Cell Infect Microbiol. 2022;12:846063.
Abstract

YANG W, Yang X, Cai X, Zhou Z, et al
The Prevalence of Irritable Bowel Syndrome Among Chinese University Students: A Systematic Review and Meta-Analysis.
Front Public Health. 2022;10:864721.
Abstract

SHUKLA R, Pahal S, Gupta A, Choudhary P, et al
Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer's and Parkinson's diseases as druggable targets through Withania somnifera bioactives: an in silico study.
J Biomol Struct Dyn. 2022 May 1:1-19. doi: 10.1080/07391102.2022.2068072.
Abstract

ISMAIL MH, Molan AL, Abbas SK
Serological levels of cytokines in irritable bowel syndrome (IBS) patients and non-IBS subjects with and without Blastocystis spp. infection.
Ann Parasitol. 2022;68:77-85.
Abstract

BACKRYD E
[Navigating between opiophobia and opiocentrism in today's healthcare].
Lakartidningen. 2022;119.
Abstract

MOBEEN A, Moazzam SW
Jawarish Shahi: A special dosage form of herbal formulations for functional gastrointestinal disorders in Unani medicine- A comprehensive review.
J Ethnopharmacol. 2022;293:115319.
Abstract

WEI LJ, Hou Q, Yao NN, Liang Y, et al
[Construction of a nomogram model for predicting 2-year survival rate of small cell lung cancer based on more comprehensive variables].
Zhonghua Yi Xue Za Zhi. 2022;102:1283-1289.
Abstract

XIAO D, Zhang Y, Chen W, Xuan J, et al
Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China.
Adv Ther. 2022 Apr 30. pii: 10.1007/s12325-022-02161.
Abstract

RESTREPO-PINEDA S, Sanchez-Puig N, Perez NO, Garcia-Hernandez E, et al
The pre-induction temperature affects recombinant HuGM-CSF aggregation in thermoinducible Escherichia coli.
Appl Microbiol Biotechnol. 2022;106:2883-2902.
Abstract

HAUSER W, Andresen V
[Functional gastrointestinal disorders].
Dtsch Med Wochenschr. 2022;147:595-604.
Abstract

COFFMAN CN, Varga MG, Alcock J, Carrol-Portillo A, et al
Norepinephrine induces growth of Desulfovibrio vulgaris in an iron dependent manner.
Anaerobe. 2022 May 6:102582. doi: 10.1016/j.anaerobe.2022.102582.
Abstract

BLACK CJ, Houghton LA, Ford AC
Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.
Neurogastroenterol Motil. 2022 May 9:e14391. doi: 10.1111/nmo.14391.
Abstract

JI S, Zhang Q
Momordica charantia polysaccharides alleviate diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and barrier via NF-kappaB pathway.
Allergol Immunopathol (Madr). 2022;50:62-70.
Abstract

NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model.
Neuropeptides. 2022;94:102248.
Abstract

RAY K
Regulating protease homeostasis in irritable bowel syndrome.
Nat Rev Gastroenterol Hepatol. 2022 May 6. pii: 10.1038/s41575-022-00629.
Abstract

JI NN, Meng QX, Wang Y, Zhou ZM, et al
Microglia-derived TNF-alpha inhibiting GABAergic neurons in the anterior lateral bed nucleus of the stria terminalis precipitates visceral hypersensitivity induced by colorectal distension in rats.
Neurobiol Stress. 2022;18:100449.
Abstract

WURTZ F, Zahler L, Blackwell SE, Margraf J, et al
Scrambled but valid? The scrambled sentences task as a measure of interpretation biases in psychopathology: A systematic review and meta-analysis.
Clin Psychol Rev. 2022;93:102133.
Abstract

OHLSSON B
Functional bowel symptoms in the general population (Review).
Mol Med Rep. 2022;26.
Abstract

ALSMADI MM, Al-Daoud NM, Obaidat RM, Abu-Farsakh NA, et al
Enhancing Atorvastatin In Vivo Oral Bioavailability in the Presence of Inflammatory Bowel Disease and Irritable Bowel Syndrome Using Supercritical Fluid Technology Guided by wbPBPK Modeling in Rat and Human.
AAPS PharmSciTech. 2022;23:148.
Abstract

CHANG WY, Yang YT, She MP, Tu CH, et al
5-HT7 receptor-dependent intestinal neurite outgrowth contributes to visceral hypersensitivity in irritable bowel syndrome.
Lab Invest. 2022 May 18. pii: 10.1038/s41374-022-00800.
Abstract

UHLENBUSCH N, Manthey C, Nestoriuc Y, Andresen V, et al
[Psychosocial Support for People with Ulcerative Colitis and Irritable Bowel Syndrome: A Feasibility Study on Need, Focus and Viability].
Psychother Psychosom Med Psychol. 2022 May 18. doi: 10.1055/a-1785-5496.
Abstract

LUO M, Liu Q, Xiao L, Xiong LS, et al
Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation.
J Health Popul Nutr. 2022;41:21.
Abstract

PRIYA S, Burns MB, Ward T, Mars RAT, et al
Identification of shared and disease-specific host gene-microbiome associations across human diseases using multi-omic integration.
Nat Microbiol. 2022 May 16. pii: 10.1038/s41564-022-01121.
Abstract

RIJNAARTS I, de Roos NM, Wang T, Zoetendal EG, et al
A high-fibre personalised dietary advice given via a web tool reduces constipation complaints in adults.
J Nutr Sci. 2022;11:e31.
Abstract

YU Z, Liu LY, Lai YY, Tian ZL, et al
Altered Resting Brain Functions in Patients With Irritable Bowel Syndrome: A Systematic Review.
Front Hum Neurosci. 2022;16:851586.
Abstract

DE GRAAF MCG, Spooren CEGM, Hendrix EMB, Hesselink MAM, et al
Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients.
Nutrients. 2022;14.
Abstract

FERNANDEZ-BANARES F
Carbohydrate Maldigestion and Intolerance.
Nutrients. 2022;14.
Abstract

PLAIDUM S, Patcharatrakul T, Promjampa W, Gonlachanvit S, et al
The Effect of Fermentable, Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Meals on Transient Lower Esophageal Relaxations (TLESR) in Gastroesophageal Reflux Disease (GERD) Patients with Overlapping Irritable Bowel Syndrome (IBS
Nutrients. 2022;14.
Abstract

ZAWISTOWSKA-ROJEK A, Tyski S
How to Improve Health with Biological Agents-Narrative Review.
Nutrients. 2022;14.
Abstract

ROTH B, Myllyvainio J, D'Amato M, Larsson E, et al
A Starch- and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin: A Randomized Controlled Study.
Nutrients. 2022;14.
Abstract

MAHMOOD A, Iqbal J
Purinergic receptors modulators: An emerging pharmacological tool for disease management.
Med Res Rev. 2022 May 13. doi: 10.1002/med.21888.
Abstract

JEONG B, Sung TS, Jeon D, Park KJ, et al
Inhibition of TRPC4 channel activity in colonic myocytes by tricyclic antidepressants disrupts colonic motility causing constipation.
J Cell Mol Med. 2022 May 12. doi: 10.1111/jcmm.17348.
Abstract

FRANCIS-MALAVE AM, Gonzalez SM, Pichardo C, Wilson TD, et al
Sex differences in pain-related behaviors and clinical progression of disease in mouse models of colonic pain.
Pain. 2022 May 13. pii: 00006396-990000000-00090.
Abstract

MIRZAIE Z, Bastani A, Haji-Aghamohammadi AA, Rashidi Nooshabadi M, et al
Effects of Ellagic Acid on Oxidative Stress Index, Inflammatory Markers and Quality of Life in Patients With Irritable Bowel Syndrome: Randomized Double-blind Clinical Trial.
Clin Nutr Res. 2022;11:98-109.
Abstract

CEULEMANS M, Jacobs I, Wauters L, Vanuytsel T, et al
Immune Activation in Functional Dyspepsia: Bystander Becoming the Suspect.
Front Neurosci. 2022;16:831761.
Abstract

INCZEFI O, Bacsur P, Resal T, Keresztes C, et al
The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease.
Front Nutr. 2022;9:718710.
Abstract

BIN Y, Kang L, Lili Y
Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: a systematic review and meta-analysis.
Nutr Hosp. 2022 May 12. doi: 10.20960/nh.04044.
Abstract

LALOUNI M, Olen O, Bjureberg J, Bonnert M, et al
Validation of child-adapted short scales for measuring gastrointestinal-specific avoidance and anxiety.
Acta Paediatr. 2022 May 11. doi: 10.1111/apa.16403.
Abstract

D'SILVA A, Marshall DA, Vallance J, Nasser Y, et al
Meditation and yoga for irritable bowel syndrome: study protocol for a randomised clinical trial (MY-IBS study).
BMJ Open. 2022;12:e059604.
Abstract

LING X, Peng S, Zhong J, Guo L, et al
Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome.
Front Pharmacol. 2022;13:778032.
Abstract

OH JH, Jang YS, Kang D, Kim HS, et al
Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Gut Liver. 2022 May 25. pii: gnl210478. doi: 10.5009/gnl210478.
Abstract

JAFARI S, Sajedi B, Jameshorani M, Salarpour F, et al
Comparison of fluoxetine and duloxetine hydrochloride therapeutic effects on patients with constipation-predominant irritable bowel syndrome.
Gastroenterol Hepatol Bed Bench. 2022;15:45-52.
Abstract

WUESTENBERGHS F, Baron M, Melchior C, Desprez C, et al
Overlaps with bladder pain syndrome and irritable bowel syndrome are associated with higher symptom burden and reduced quality of life in functional dyspepsia.
Neurogastroenterol Motil. 2022 May 24:e14414. doi: 10.1111/nmo.14414.
Abstract

SATISH KUMAR L, Pugalenthi LS, Ahmad M, Reddy S, et al
Probiotics in Irritable Bowel Syndrome: A Review of Their Therapeutic Role.
Cureus. 2022;14:e24240.
Abstract

SHAH A, Talley NJ, Holtmann G
Current and Future Approaches for Diagnosing Small Intestinal Dysbiosis in Patients With Symptoms of Functional Dyspepsia.
Front Neurosci. 2022;16:830356.
Abstract

GUAN L, Shi X, Tang Y, Yan Y, et al
Contribution of Amygdala Histone Acetylation in Early Life Stress-Induced Visceral Hypersensitivity and Emotional Comorbidity.
Front Neurosci. 2022;16:843396.
Abstract

GONZALEZ-DELGADO P, Muriel J, Jimenez T, Cameo JI, et al
Food protein-induced enterocolitis syndrome in adulthood: clinical characteristics, prognosis and risk factors.
J Allergy Clin Immunol Pract. 2022 May 19. pii: S2213-2198(22)00492.
Abstract

GALLAS S, Knaz H, Methnani J, Maatallah Kanzali M, et al
Prevalence and risk factors of functional gastrointestinal disorders in early period medical students: a pilot study in Tunisia.
Libyan J Med. 2022;17:2082029.
Abstract

PFANZAGL B, Pfragner R, Jensen-Jarolim E
Histamine via histamine H1 receptor enhances the muscarinic receptor-induced calcium response to acetylcholine in an enterochromaffin cell model.
Clin Exp Pharmacol Physiol. 2022 Jun 2. doi: 10.1111/1440-1681.13682.
Abstract

TANG Y, Chen L, Liu B, Sun P, et al
Spinal P2X4 Receptors Involved in Visceral Hypersensitivity of Neonatal Maternal Separation Rats.
Purinergic Signal. 2022 Jun 1. pii: 10.1007/s11302-022-09868.
Abstract

JUNG KW, Myung SJ
An Asian perspective on irritable bowel syndrome.
Intest Res. 2022 May 31. pii: ir.2021.00136. doi: 10.5217/ir.2021.00136.
Abstract

LIMA PA, Berg BB, Castor MGME
Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies.
Intest Res. 2022 May 31. pii: ir.2021.00160. doi: 10.5217/ir.2021.00160.
Abstract

KUTSCHKE J, Harris JR, Bengtson MB
The relationships between IBS and perceptions of physical and mental health-a Norwegian twin study.
BMC Gastroenterol. 2022;22:266.
Abstract

LATENSTEIN CSS, de Reuver PR
Tailoring diagnosis and treatment in symptomatic gallstone disease.
Br J Surg. 2022 May 31. pii: 6595861. doi: 10.1093.
Abstract

CHEN J, Zhang Y, Barandouzi ZA, Lee J, et al
The effect of self-management online modules plus nurse-led support on pain and quality of life among young adults with irritable bowel syndrome: A randomized controlled trial.
Int J Nurs Stud. 2022;132:104278.
Abstract

LABUS JS, Wang C, Mayer EA, Gupta A, et al
Sex-specific brain microstructural reorganization in irritable bowel syndrome.
Pain. 2022 May 25. pii: 00006396-990000000-00108.
Abstract

MANNING LP, Tuck CJ, Biesiekierski JR
The lived experience of irritable bowel syndrome: A focus on dietary management.
Aust J Gen Pract. 2022;51:395-400.
Abstract

MAGDY R, Eid RA, Hassan M, Abdelghaffar M, et al
The potential impact of nutritional intake on symptoms severity in patients with comorbid migraine and irritable bowel syndrome.
BMC Neurol. 2022;22:199.
Abstract

COCKRUM R, Tu F
Hysterectomy for Chronic Pelvic Pain.
Obstet Gynecol Clin North Am. 2022;49:257-271.
Abstract

BAUMANN-DURCHSCHEIN F, Furst S, Hammer HF
Practical application of breath tests in disorders of gut-brain interaction.
Curr Opin Pharmacol. 2022;65:102244.
Abstract

YASUDA R, Kamada K, Murakami T, Inoue R, et al
Astaxanthin attenuated the stress-induced intestinal motility disorder via altering the gut microbiota.
Int J Vitam Nutr Res. 2022 May 30. doi: 10.1024/0300-9831/a000756.
Abstract

OH H, Ehrenpreis ED, Tu FF, Dillane KE, et al
Menstrual Cycle Variation in MRI-Based Quantification of Intraluminal Gas in Women With and Without Dysmenorrhea.
Front Pain Res (Lausanne). 2022;3:720141.
Abstract

JI M, Huang H, Lan X
Correlation between Intestinal Microflora in Irritable Bowel Syndrome and Severity.
Dis Markers. 2022;2022:1031844.
Abstract

YE Y, Liu Y, Cheng K, Wu Z, et al
Effects of Intestinal Flora on Irritable Bowel Syndrome and Therapeutic Significance of Polysaccharides.
Front Nutr. 2022;9:810453.
Abstract

ARESKOUG SANDBERG E, Duberg A, Lorenzon Fagerberg U, Morelius E, et al
Saliva Cortisol in Girls With Functional Abdominal Pain Disorders: A Randomized Controlled Dance and Yoga Intervention.
Front Pediatr. 2022;10:836406.
Abstract

WANG X, Gao S, Yun S, Zhang M, et al
Microencapsulating Alginate-Based Polymers for Probiotics Delivery Systems and Their Application.
Pharmaceuticals (Basel). 2022;15.
Abstract

PENG Z, Yi J, Liu X
A Low-FODMAP Diet Provides Benefits for Functional Gastrointestinal Symptoms but Not for Improving Stool Consistency and Mucosal Inflammation in IBD: A Systematic Review and Meta-Analysis.
Nutrients. 2022;14.
Abstract

SCHNEDL WJ, Meier-Allard N, Michaelis S, Lackner S, et al
Serum Diamine Oxidase Values, Indicating Histamine Intolerance, Influence Lactose Tolerance Breath Test Results.
Nutrients. 2022;14.
Abstract

JUNG K, Kim A, Lee JH, Cho D, et al
Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1(TM)) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.
Nutrients. 2022;14.
Abstract

MISHIMA T, Fujioka S, Kawazoe M, Inoue K, et al
Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine.
J Pers Med. 2022;12.
Abstract

NEGUSSIE AB, Dell AC, Davis BA, Geibel JP, et al
Colonic Fluid and Electrolyte Transport 2022: An Update.
Cells. 2022;11.
Abstract

SALVO-ROMERO E, Rodino-Janeiro BK, Albert-Bayo M, Lobo B, et al
Eosinophils in the Gastrointestinal Tract: Key Contributors to Neuro-Immune Crosstalk and Potential Implications in Disorders of Brain-Gut Interaction.
Cells. 2022;11.
Abstract

OKAZAKI Y, Yoshida S, Kashima S, Miyamori D, et al
Increased prescriptions for irritable bowel syndrome after the 2018 Japan Floods: a longitudinal analysis based on the Japanese National Database of Health Insurance Claims and Specific Health Checkups.
BMC Gastroenterol. 2022;22:263.
Abstract

UPADHYAY A, Sundaria N, Dhiman R, Prajapati VK, et al
Complex Inclusion Bodies and Defective Proteome Hubs in Neurodegenerative Disease: New Clues, New Challenges.
Neuroscientist. 2022;28:271-282.
Abstract

EMRE E, Tazegul G, Akin M
Rome IV Criteria-Defined Irritable Bowel Syndrome in Atopic Patients and the Effect of Anxiety and Depression: A Case-Control Study.
Turk J Gastroenterol. 2022;33:397-405.
Abstract

BU Z, Ye X, Huang B, Liu R, et al
Bifidobacteria Was Decreased in Adult Patients With Irritable Bowel Syndrome Based on PCR and Bacterial Culture: A Systematic Review and Meta-Analysis.
Turk J Gastroenterol. 2022;33:368-376.
Abstract

CHENG L, Luo QQ, Chen SL
Expression of TRP Channels in Colonic Mucosa of IBS-D Patients and Its Correlation with the Severity of the Disease.
Gastroenterol Res Pract. 2022;2022:7294775.
Abstract

RAY J, LaBundy J
Lower Gastrointestinal Tract Disorders: Clinical Updates in Women's Health Care Primary and Preventive Care Review.
Obstet Gynecol. 2022;139:1201.
Abstract

BAKER JR, Curtin BF, Moshiree B, Rao SSC, et al
Organizing and Developing a GI Motility Lab in Community Practice: Challenges and Rewards.
Curr Gastroenterol Rep. 2022 Jun 8. pii: 10.1007/s11894-022-00838.
Abstract

DECRAECKER L, Boeckxstaens G, Denadai-Souza A
Inhibition of Serine Proteases as a Novel Therapeutic Strategy for Abdominal Pain in IBS.
Front Physiol. 2022;13:880422.
Abstract

JUN H, Ko SJ, Kim K, Kim J, et al
An Overview of Systematic Reviews of Herbal Medicine for Irritable Bowel Syndrome.
Front Pharmacol. 2022;13:894122.
Abstract

RURGO S, Vaino V, Andreozzi M, Pagliaro M, et al
Predictors of abdominal pain severity in patients with constipation-prevalent irritable bowel syndrome.
J Basic Clin Physiol Pharmacol. 2022 Jun 6. pii: jbcpp-2022-0081.
Abstract

SVENSSON A, Garcia-Etxebarria K, Akesson A, Borgfeldt C, et al
Applicability of polygenic risk scores in endometriosis clinical presentation.
BMC Womens Health. 2022;22:208.
Abstract

Tenapanor (Ibsrela) for irritable bowel syndrome with constipation.
Med Lett Drugs Ther. 2022;64:91-94.
Abstract

MOCCI E, Goto T, Chen J, Ament S, et al
Early and Late Transcriptional Changes in Blood, Neural, and Colon Tissues in Rat Models of Stress-Induced and Comorbid Pain Hypersensitivity Reveal Regulatory Roles in Neurological Disease.
Front Pain Res (Lausanne). 2022;3:886042.
Abstract

HUANG ST, Chen BB, Song ZJ, Tang HL, et al
Unraveling the role of Epac1-SOCS3 signaling in the development of neonatal-CRD-induced visceral hypersensitivity in rats.
CNS Neurosci Ther. 2022 Jun 15. doi: 10.1111/cns.13880.
Abstract

MIRYAN M, Soleimani D, Alavinejad P, Abbaspour M, et al
Effects of propolis supplementation on irritable bowel syndrome with constipation (IBS-C) and mixed (IBS-M) stool pattern: A randomized, double-blind clinical trial.
Food Sci Nutr. 2022;10:1899-1907.
Abstract

LOWE B, Nestoriuc Y, Andresen V, Vettorazzi E, et al
Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT).
BMJ Open. 2022;12:e059529.
Abstract

YEPEZ D, Grandes XA, Talanki Manjunatha R, Habib S, et al
Fibromyalgia and Depression: A Literature Review of Their Shared Aspects.
Cureus. 2022;14:e24909.
Abstract

SAVARINO E, Zingone F, Barberio B, Marasco G, et al
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility.
United European Gastroenterol J. 2022 Jun 13. doi: 10.1002/ueg2.12259.
Abstract

CIPCIC PALJETAK H, Baresic A, Panek M, Peric M, et al
Gut microbiota in mucosa and feces of newly diagnosed, treatment-naive adult inflammatory bowel disease and irritable bowel syndrome patients.
Gut Microbes. 2022;14:2083419.
Abstract

CIRIZA DE LOS RIOS C, Aparicio Cabezudo M, Zatarain Valles A, Rey E, et al
Practical approach to irritable bowel syndrome-diarrhea beyond low-FODMAP diet.
Rev Esp Enferm Dig. 2022;114.
Abstract

SALANSKI P, Kowalczyk M, Bardowski JK, Szczepankowska AK, et al
Health-Promoting Nature of Lactococcus lactis IBB109 and Lactococcus lactis IBB417 Strains Exhibiting Proliferation Inhibition and Stimulation of Interleukin-18 Expression in Colorectal Cancer Cells.
Front Microbiol. 2022;13:822912.
Abstract

LEE W, Wong JK, Ilhan E, Raj SR, et al
Iatrogenic Arteriovenous Fistula: A Rare Complication of Pacemaker Implantation.
JACC Case Rep. 2022;4:402-405.
Abstract

GU Y, Wang C, Qin X, Zhou B, et al
Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota.
Pharmacol Res. 2022;181:106291.
Abstract

COONEY J, Poullis A
Post-COVID-19 irritable bowel syndrome.
Neurogastroenterol Motil. 2022 Jun 11:e14420. doi: 10.1111/nmo.14420.
Abstract

KIM H, Oh Y, Chang SJ
Internet-Delivered Cognitive Behavioral Therapy in Patients With Irritable Bowel Syndrome: Systematic Review and Meta-Analysis.
J Med Internet Res. 2022;24:e35260.
Abstract

KARPE AV, Liu JW, Shah A, Koloski N, et al
Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome (IBS).
Metabolomics. 2022;18:38.
Abstract

CHEN J, Zhang Y, Barandouzi ZA, Xu W, et al
Somatosensory Profiles Differentiate Pain and Psychophysiological Symptoms Among Young Adults With Irritable Bowel Syndrome: A Cluster Analysis.
Clin J Pain. 2022;38:492-501.
Abstract

STRISCIUGLIO C, Cenni S, Serra MR, Dolce P, et al
Diet and Pediatric Functional Gastrointestinal Disorders in Mediterranean Countries.
Nutrients. 2022;14.
Abstract

SPECKMANN B, Kleinbolting J, Borner F, Jordan PM, et al
Synbiotic Compositions of Bacillus megaterium and Polyunsaturated Fatty Acid Salt Enable Self-Sufficient Production of Specialized Pro-Resolving Mediators.
Nutrients. 2022;14.
Abstract

EDER P, Kowalski P, Mastalerz-Migas A, Skrzydlo-Radomanska B, et al
Self-Medication with Drotaverine among Patients with Common Abdominal Symptoms and Treatment Efficacy from the Perspectives of Patients and General Practitioners-An Observational, Retrospective, Cross-Sectional Study Using Real-World Data.
J Clin Med. 2022;11.
Abstract

MARASCO G, Cremon C, Barbaro MR, Falangone F, et al
Pathophysiology and Clinical Management of Bile Acid Diarrhea.
J Clin Med. 2022;11.
Abstract

WEN L, Tang L, Zhang M, Wang C, et al
Gallic Acid Alleviates Visceral Pain and Depression via Inhibition of P2X7 Receptor.
Int J Mol Sci. 2022;23.
Abstract

LOPEZ-GOMEZ L, Anton J, Lopez-Tofino Y, Pomana B, et al
Effects of Commercial Probiotics on Colonic Sensitivity after Acute Mucosal Irritation.
Int J Environ Res Public Health. 2022;19.
Abstract

LAYUNTA E, Forcen R, Grasa L
TLR2 and TLR4 Modulate Mouse Ileal Motility by the Interaction with Muscarinic and Nicotinic Receptors.
Cells. 2022;11.
Abstract

HABUS M, Mykolenko S, Ivekovic S, Pastor K, et al
Bioprocessing of Wheat and Amaranth Bran for the Reduction of Fructan Levels and Application in 3D-Printed Snacks.
Foods. 2022;11.
Abstract

MAN REK, Fenwick EK, Khadka J, Wu Z, et al
Psychometric Evaluation of Glaucoma Quality of Life Item Banks (GlauCAT) and Initial Assessment Using Computerized Adaptive Testing.
Transl Vis Sci Technol. 2022;11:9.
Abstract

KOIZUMI K, Hamaguchi T, Tayama J, Fukudo S, et al
A Method of Generating a Classifier that Determines the Presence or Absence of IBS Symptoms by Supervised Learning from the Frequency Analysis of Electroencephalogram Data.
Front Biosci (Landmark Ed). 2022;27:187.
Abstract

MITTAL A, Gupta S, Afridi F, Dimitrey A, et al
Do Socio-Demographics Play a Role in the Prevalence of Red Flags and Pursuant Colonoscopies in Patients With Irritable Bowel Syndrome?
Cureus. 2022;14:e25137.
Abstract

GRENDA A, Grenda T, Domaradzki P, Kwiatek K, et al
Enterococci-Involvement in Pathogenesis and Therapeutic Potential in Cancer Treatment: A Mini-Review.
Pathogens. 2022;11.
Abstract

SHANG X, E FF, Guo KL, Li YF, et al
Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.
Nutrients. 2022;14.
Abstract

ALEXANDRU BA, Rat LA, Moldovan AF, Mihancea P, et al
An Open-Label Trial Study of Quality-of-Life Assessment in Irritable Bowel Syndrome and Their Treatment.
Medicina (Kaunas). 2022;58.
Abstract

KUMEI S, Ishioh M, Murakami Y, Ando K, et al
A patient with familial Mediterranean fever mimicking diarrhea-dominant irritable bowel syndrome who successfully responded to treatment with colchicine: a case report.
J Med Case Rep. 2022;16:247.
Abstract

ROBBERTZ AS, Cohen LL, Armistead LP, Reed B, et al
Pandemic-Related Social Disruption and Well-Being in Pediatric Gastrointestinal Diseases.
J Pediatr Psychol. 2022 Jun 22. pii: 6613068. doi: 10.1093.
Abstract

SO D, Loughman A, Staudacher HM
Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis.
Am J Clin Nutr. 2022 Jun 21. pii: 6612725. doi: 10.1093.
Abstract

LAROUTE V, Beaufrand C, Gomes P, Nouaille S, et al
Lactococcus lactis NCDO2118 exerts visceral antinociceptive properties in rat via GABA production in the gastro-intestinal tract.
Elife. 2022;11.
Abstract

MELCHIOR C, Algera J, Colomier E, Tornblom H, et al
Irritable bowel syndrome with food-related symptoms: Future directions in the clinical management.
United European Gastroenterol J. 2022 Jun 21. doi: 10.1002/ueg2.12265.
Abstract

WANG L, Song C, Wang Y, Hu L, et al
Symptoms Compatible with Rome IV Functional Bowel Disorder in Patients with Ankylosing Spondylitis.
Mod Rheumatol. 2022 Jun 21. pii: 6612220. doi: 10.1093.
Abstract

CHOO C, Mahurkar-Joshi S, Dong TS, Lenhart A, et al
Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome.
Am J Physiol Gastrointest Liver Physiol. 2022.
Abstract

ROMANAZZO S, Mansueto G, Cosci F
Anxiety in the Medically Ill: A Systematic Review of the Literature.
Front Psychiatry. 2022;13:873126.
Abstract

KIM HY, Park ES, Choi YS, Park SJ, et al
Kimchi improves irritable bowel syndrome: results of a randomized, double-blind placebo-controlled study.
Food Nutr Res. 2022;66.
Abstract

CEULEERS H, Hanning N, De Bruyn M, De Man JG, et al
The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult.
Front Pharmacol. 2022;13:765744.
Abstract

ZHAO HJ, Zhang XJ, Zhang NN, Yan B, et al
Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
Front Nutr. 2022;9:890357.
Abstract

WEI L, Singh R, Ghoshal UC
Enterochromaffin Cells-Gut Microbiota Crosstalk: Underpinning the Symptoms, Pathogenesis, and Pharmacotherapy in Disorders of Gut-Brain Interaction.
J Neurogastroenterol Motil. 2022 Jun 20. pii: jnm22008. doi: 10.5056/jnm22008.
Abstract

PETERS M, Mikeltadze I, Karro H, Saare M, et al
Endometriosis and irritable bowel syndrome: similarities and differences in the spectrum of comorbidities.
Hum Reprod. 2022 Jun 17. pii: 6609839. doi: 10.1093.
Abstract

ZHU SS, Wang JJ, Zou L, Chen JY, et al
[Anti-inflammation effect of moxibustion for rats with diarrhea-predominant irritable bowel syndrome based on multiple miRNAs regulating NF-kappaB signal pathway].
Zhongguo Zhen Jiu. 2022;42:654-62.
Abstract

MAHLER T, Hoffman I, Smets F, Vandenplas Y, et al
The Belgian consensus on irritable bowel syndrome: the paediatric gastroenterologist view.
Acta Gastroenterol Belg. 2022;85:384-386.
Abstract

KINDT S, Louis H, Deschepper H, Arts J, et al
Belgian consensus on irritable bowel syndrome.
Acta Gastroenterol Belg. 2022;85:360-382.
Abstract

VANUYTSEL T, Reenaers C
Essential reading from the editor's desk.
Acta Gastroenterol Belg. 2022;85:255-256.
Abstract

CID-RUZAFA J, Lacy BE, Schultze A, Duong M, et al
Linaclotide utilization and potential for off-label use and misuse in three European countries.
Therap Adv Gastroenterol. 2022;15:17562848221100946.
Abstract

SOLOV'EVA TF, Bakholdina SI, Khomenko VA, Sidorin EV, et al
Expression of membrane beta-barrel protein in E. coli at low temperatures: Structure of Yersinia pseudotuberculosis OmpF porin inclusion bodies.
Biochim Biophys Acta Biomembr. 2022;1864:183971.
Abstract

TARASCA MV, Naser D, Schaefer A, Soule TG, et al
Quenched hydrogen-deuterium amide exchange optimization for high-resolution structural analysis of cellular protein aggregates.
Anal Biochem. 2022;652:114675.
Abstract

RANGAN V, Nee J, Lembo AJ
Small Intestinal Bacterial Overgrowth Breath Testing in Gastroenterology: Clinical Utility and Pitfalls.
Clin Gastroenterol Hepatol. 2022;20:1450-1453.
Abstract

GROENENDIJK DW, Witteman BJ, Mulder BC
The Experiences of Female IBS Patients Concerning Physical Activity as Treatment Modality: A Qualitative Study.
Qual Health Res. 2022 Jun 30:10497323221110109. doi: 10.1177/10497323221110109.
Abstract

REZAZADEGAN M, Shahdadian F, Soheilipour M, Tarrahi MJ, et al
Zinc nutritional status, mood states and quality of life in diarrhea-predominant irritable bowel syndrome: a case-control study.
Sci Rep. 2022;12:11002.
Abstract

NUNAN D, Cai T, Gardener AD, Ordonez-Mena JM, et al
Physical activity for treatment of irritable bowel syndrome.
Cochrane Database Syst Rev. 2022;6:CD011497.
Abstract

ONGARO G, Ballou S, Kube T, Haas J, et al
Doctors Speak: A Qualitative Study of Physicians' Prescribing of Antidepressants in Functional Bowel Disorders.
Cult Med Psychiatry. 2022 Jun 28. pii: 10.1007/s11013-022-09795.
Abstract

QUIGLEY EMM
Gastrointestinal effects of diets low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols.
Curr Opin Clin Nutr Metab Care. 2022;25:260-264.
Abstract

PRICE SJ, Gibson N, Hamilton WT, Bostock J, et al
Diagnoses after newly recorded abdominal pain in primary care: observational cohort study.
Br J Gen Pract. 2022 Apr 20. pii: BJGP.2021.0709. doi: 10.3399/BJGP.2021.0709.
Abstract

HURYCH J, Vejmelka J, Hlinakova L, Kramna L, et al
Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors.
BMJ Open. 2022;12:e056594.
Abstract

WANG N, Liu X, Ye W, Shi Z, et al
Impact of shift work on irritable bowel syndrome and functional dyspepsia: A meta-analysis.
Medicine (Baltimore). 2022;101:e29211.
Abstract

BOGGS KB, Edmonds K, Cifuentes-Munoz N, El Najjar F, et al
Human Metapneumovirus Phosphoprotein Independently Drives Phase Separation and Recruits Nucleoprotein to Liquid-Like Bodies.
mBio. 2022;13:e0109922.
Abstract

MAZZOLA M, Bertoglio CL, Giani A, Zironda A, et al
Novel biodegradable internal stent as a mitigation strategy in high-risk pancreaticojejunostomy: technical notes and preliminary results.
Surg Today. 2022;52:1115-1119.
Abstract

AUSTHOF E, Bell ML, Riddle MS, Catalfamo C, et al
Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.
Epidemiol Infect. 2022 Jul 8:1-22. doi: 10.1017/S0950268822001200.
Abstract

NISHIYAMA J, Abe T, Imaizumi S, Yamane A, et al
Characteristics of outpatients with functional somatic syndromes at a university hospital's general medicine clinic.
J Gen Fam Med. 2022;23:268-274.
Abstract

BERENS S, Dong Y, Fritz N, Walstab J, et al
Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: A multicenter retrospective study.
World J Gastroenterol. 2022;28:2334-2349.
Abstract

JIANG X, Guo X, Zhou J, Ye S, et al
Acupuncture and Moxibustion in the Treatment of Adult Diarrhea Irritable Bowel Syndrome: A Network Meta-analysis.
Comput Math Methods Med. 2022;2022:9919839.
Abstract

CREED F
Risk Factors for Self-reported Irritable Bowel Syndrome With Prior Psychiatric Disorder: The Lifelines Cohort Study.
J Neurogastroenterol Motil. 2022;28:442-453.
Abstract

SULTAN N, Varney JE, Halmos EP, Biesiekierski JR, et al
How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice.
J Neurogastroenterol Motil. 2022;28:343-356.
Abstract

LEE HS
Irritable Bowel Syndrome or Psychiatric Disorders: Which Comes First?
J Neurogastroenterol Motil. 2022;28:335-336.
Abstract

OLYAIEE A, Sadeghi A, Yadegar A, Mirsamadi ES, et al
Gut Microbiota Shifting in Irritable Bowel Syndrome: The Mysterious Role of Blastocystis sp.
Front Med (Lausanne). 2022;9:890127.
Abstract

ZHENG X, Zhi MJ, Zhao LL, Chen L, et al
[Effect mechanism of blistering moxibustion on visceral hypersensitivity of irritable bowel syndrome in mice based on 5-HT signal pathway].
Zhongguo Zhen Jiu. 2022;42:773-8.
Abstract

DE BENEDITTIS G
Hypnobiome: A New, Potential Frontier of Hypnotherapy in the Treatment of Irritable Bowel Syndrome-A Narrative Review of the Literature.
Int J Clin Exp Hypn. 2022 Jul 6:1-14. doi: 10.1080/00207144.2022.2094269.
Abstract

NGUYEN M, Palm NW
Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries.
Semin Immunopathol. 2022 Jul 4. pii: 10.1007/s00281-022-00948.
Abstract

TORRICO TJ, Kaur S, Dayal M, Eagala P, et al
Lubiprostone for the Treatment of Clozapine-Induced Constipation: A Case Series.
Cureus. 2022;14:e25576.
Abstract

WANNER C, Kimonis V, Politei J, Warnock DG, et al
Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation study.
Mol Genet Metab Rep. 2022;31:100862.
Abstract

SAYUK GS, North CS, Pollio DE, Gott BM, et al
Episodic Memories Among Irritable Bowel Syndrome (IBS) Patients: An Important Aspect of the IBS Symptom Experience.
Front Pain Res (Lausanne). 2022;3:892313.
Abstract

SIMONS J, Shajee U, Palsson O, Simren M, et al
Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education.
United European Gastroenterol J. 2022 Jul 3. doi: 10.1002/ueg2.12271.
Abstract

GHAHRAMANI Z E, Grimm PD, Eary KJ, Swearengen MP, et al
Three-dimensional echo decorrelation monitoring of radiofrequency ablation in ex vivo bovine liver.
J Acoust Soc Am. 2022;151:3907.
Abstract

BARKER KH, Higham JP, Pattison LA, Taylor TS, et al
Sensitisation of colonic nociceptors by TNFalpha is dependent on TNFR1 expression and p38 MAPK activity.
J Physiol. 2022 Jul 1. doi: 10.1113/JP283170.
Abstract

ALHARBI W, Jahan S
Prevalence and Associated Risk Factors of Irritable Bowel Syndrome Among Female Secondary School students in Ar Rass City, Qassim Region.
Health Psychol Res. 2022;10:35482.
Abstract

DAS A, Razon AH, Ahmad T, Paul DK, et al
Prevalence of irritable bowel syndrome and its associated risk factors among university students of Bangladesh.
JGH Open. 2022;6:421-426.
Abstract

MELCHIOR C, Colomier E, Trindade IA, Khadija M, et al
Irritable bowel syndrome: Factors of importance for disease-specific quality of life.
United European Gastroenterol J. 2022 Jul 13. doi: 10.1002/ueg2.12277.
Abstract

VELASCO-BENITEZ CA, Collazos-Saa LI, Garcia-Perdomo HA
A SYSTEMATIC REVIEW AND META-ANALYSIS IN SCHOOLCHILDREN AND ADOLESCENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS ACCORDING TO ROME IV CRITERIA.
Arq Gastroenterol. 2022;59:304-313.
Abstract

MARTURANO M, Campagna G, Gaetani E, Natale F, et al
500 EFFECTS OF COVID-19 PANDEMICS ON SYMPTOMS AND QUALITY OF LIFE IN PATIENTS AFFECTED BY INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME (IC/PBS) AND IRRITABLE BOWEL SYNDROME (IBS).
Continence (Amst). 2022;2:1-2.
Abstract

ALSHAMMARI H, Al-Saeed E, Ahmed Z, Aslanpour Z, et al
Prevalence and Predictors of Potentially Inappropriate Medications Among Patients Aged >/=65 Years on Hospital Admissions in Kuwait.
Clin Interv Aging. 2022;17:1025-1036.
Abstract

SASEGBON A, Hasan SS, Whorwell PJ, Vasant DH, et al
Experience and clinical efficacy of gut-directed hypnotherapy in an Asian population with refractory irritable bowel syndrome.
JGH Open. 2022;6:447-453.
Abstract

PEERY AF, Keku TO, Galanko JA, Sandler RS, et al
Colonic Diverticulosis Is Not Associated With Painful Abdominal Symptoms in a US Population.
Gastro Hep Adv. 2022;1:659-665.
Abstract

JAIN M, Kumar GSS, Gowrishankar R, Srinivas M, et al
Defaecation disorders among information technology personnel: A cross-sectional study.
Natl Med J India. 2021;34:333-336.
Abstract

AHAMAD A, Tehreem B, Farooqi M, Maramara B, et al
Case report and literature review: double jeopardy - Exophiala dermatitidis and Mycobacterium canariasense central line-associated bloodstream infection in a patient.
Access Microbiol. 2022;4:000347.
Abstract

ALSUBAIE MA, Alkhalifah HA, Ali AH, Bahabri MA, et al
Adverse Childhood Experiences and Their Effect on Irritable Bowel Syndrome Among Saudi Arabian Adults.
Cureus. 2022;14:e25791.
Abstract

SHUTE A, Bihan DG, Lewis IA, Nasser Y, et al
Metabolomics: The Key to Unraveling the Role of the Microbiome in Visceral Pain Neurotransmission.
Front Neurosci. 2022;16:917197.
Abstract

TUCK CJ, Sultan N, Tonkovic M, Biesiekierski JR, et al
Orthorexia nervosa is a concern in gastroenterology: A scoping review.
Neurogastroenterol Motil. 2022 Jul 10:e14427. doi: 10.1111/nmo.14427.
Abstract

SUNDAS A, Sampath H, Lamtha SC, Soohinda G, et al
Psychosocial quality-of-life correlates in functional gastrointestinal disorders.
Rev Gastroenterol Mex (Engl Ed). 2022 Jul 6. pii: S2255-534X(22)00082.
Abstract

ISMAIL MH, Abbas SK, Molan AL
Prevalence and subtype diversity of Blastocystis sp. in an Iraqi population with and without irritable bowel syndrome (IBS).
Ann Parasitol. 2022;68:275-286.
Abstract

CECCHERINI C, Daniotti S, Bearzi C, Re I, et al
Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis.
Nutrients. 2022;14.
Abstract

ABUELAZM M, Muhammad S, Gamal M, Labieb F, et al
The Effect of Vitamin D Supplementation on the Severity of Symptoms and the Quality of Life in Irritable Bowel Syndrome Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Nutrients. 2022;14.
Abstract

BELLINI M, Tosetti C, Rettura F, Morganti R, et al
Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS.
J Clin Med. 2022;11.
Abstract

BANCIU DD, Cretoiu D, Cretoiu SM, Banciu A, et al
Telocytes' Role in Modulating Gut Motility Function and Development: Medical Hypotheses and Literature Review.
Int J Mol Sci. 2022;23.
Abstract

PARDO-CAMACHO C, Ganda Mall JP, Martinez C, Pigrau M, et al
Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations.
Cells. 2022;11.
Abstract

ALDERSON SL, Wright-Hughes A, Ford AC, Farrin A, et al
Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care.
Trials. 2022;23:552.
Abstract

LI Y, Peng S, Liang F, Liu S, et al
Effectiveness of acupuncture for irritable bowel syndrome: Protocol for a scoping review of systematic reviews and meta-analyses.
Medicine (Baltimore). 2022;101:e29218.
Abstract

EL SHARAWY SM, Amer IF, Elkadeem MZ
Irritable bowel syndrome in Egyptian medical students, prevalence and associated factors: a cross-sectional study.
Pan Afr Med J. 2022;41:311.
Abstract

GUO J, Chen L, Wang YH, Song YF, et al
Electroacupuncture Attenuates Post-Inflammatory IBS-Associated Visceral and Somatic Hypersensitivity and Correlates With the Regulatory Mechanism of Epac1-Piezo2 Axis.
Front Endocrinol (Lausanne). 2022;13:918652.
Abstract

CABALLERO N, Marin I, Riu F, Leal C, et al
Effect of intracolonic volume on gastric sensory-motor responses in constipation-predominant irritable bowel syndrome.
Neurogastroenterol Motil. 2022 Jul 21:e14433. doi: 10.1111/nmo.14433.
Abstract

JACOBS JW, Leadbetter MR, Bell N, Koo-McCoy S, et al
Discovery of Tenapanor: A First-in-Class Minimally Systemic Inhibitor of Intestinal Na(+)/H(+) Exchanger Isoform 3.
ACS Med Chem Lett. 2022;13:1043-1051.
Abstract

ADEWUYI EO, O'Brien EK, Nyholt DR, Porter T, et al
A large-scale genome-wide cross-trait analysis reveals shared genetic architecture between Alzheimer's disease and gastrointestinal tract disorders.
Commun Biol. 2022;5:691.
Abstract

GENTILE M, De Luca V, Patalano R, Laudisio D, et al
Proposal for innovative and integrated approaches to the unmet needs of irritable bowel syndrome patients. Preliminary Vigour report.
Ann Ital Chir. 2022;11.
Abstract

GNONI M, Beas R, Grewal R, Diaz-Pardave C, et al
Scurvy: an often misdiagnosed condition in the modern days?
Folia Med (Plovdiv). 2022;64:543-546.
Abstract

VAN DER GEEST AM, Schukking I, Brummer RJM, van de Burgwal LHM, et al
Comparing probiotic and drug interventions in irritable bowel syndrome: a meta-analysis of randomised controlled trials.
Benef Microbes. 2022 Jul 18:1-12. doi: 10.3920/BM2021.0123.
Abstract

VAN DER GEEST AM, Schukking I, Brummer RJM, Pieterse H, et al
Inadequate safety reporting in the publications of randomised clinical trials in irritable bowel syndrome: drug versus probiotic interventions.
Benef Microbes. 2022 Jul 18:1-10. doi: 10.3920/BM2021.0124.
Abstract

GU Q, Lei Y, Wu J, He T, et al
NUCB2/Nesfatin-1 Regulation of Chronic Visceral Hyperalgesia.
Appl Bionics Biomech. 2022;2022:4079533.
Abstract

LIU Y, Liao R, Qiang Z, Yang W, et al
Exogenous H2S promotes ion channel reconstruction to regulate colonic motility in rats with dinitrobenzene sulfonic acid-induced colitis.
Ann Transl Med. 2022;10:681.
Abstract

OKUMURA T, Nozu T, Ishioh M, Igarashi S, et al
Oxytocin acts centrally in the brain to improve leaky gut through the vagus nerve and a cannabinoid signaling in rats.
Physiol Behav. 2022;254:113914.
Abstract

WHELAN K, Staudacher H
Low FODMAP diet in irritable bowel syndrome: a review of recent clinical trials and meta-analyses.
Curr Opin Clin Nutr Metab Care. 2022 Jul 16. pii: 00075197-990000000-00017.
Abstract

HAMAZAKI M, Sawada T, Yamamura T, Maeda K, et al
Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan.
BMC Gastroenterol. 2022;22:342.
Abstract

STALLER K, Paz M, Rones R, Macklin EA, et al
Virtual Tai Chi program for patients with irritable bowel syndrome with constipation: Proof-of-concept feasibility trial.
Neurogastroenterol Motil. 2022 Jul 14:e14429. doi: 10.1111/nmo.14429.
Abstract

ZHANG T, Ma X, Tian W, Zhang J, et al
Global Research Trends in Irritable Bowel Syndrome: A Bibliometric and Visualized Study.
Front Med (Lausanne). 2022;9:922063.
Abstract

LI Y, Zhang T, Sun J, Liu N, et al
Fecal Microbiota Transplantation and Health Outcomes: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.
Front Cell Infect Microbiol. 2022;12:899845.
Abstract

SMITH SJ, Sichlau M, Sewall LE, Smith BH, et al
An online survey of pelvic congestion support group members regarding comorbid symptoms and syndromes.
Phlebology. 2022 Jul 13:2683555221112567. doi: 10.1177/02683555221112567.
Abstract

LI ZC, Yan J, Zhang S, Liang C, et al
Glioma survival prediction from whole-brain MRI without tumor segmentation using deep attention network: a multicenter study.
Eur Radiol. 2022;32:5719-5729.
Abstract

WU J, Li T, Mao G, Cha X, et al
The involvement of Pellino-1 downregulation in the modulation of visceral hypersensitivity via the TLR4/NF-kappaB pathway in the rat fastigial nucleus.
Neurosci Lett. 2022 Jul 25:136815. doi: 10.1016/j.neulet.2022.136815.
Abstract

XIAO D, Zhang Y, Chen W, Xuan J, et al
Correction to: Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China.
Adv Ther. 2022 Jul 28. pii: 10.1007/s12325-022-02236.
Abstract

DARWEISH E, Marzouk HM, Fayez YM, Eissa MS, et al
Advanced spectrophotometric resolution techniques for spectrally overlapping spasmolytic binary mixture along with Dichloroaniline as a toxic impurity: Application to content uniformity testing.
J AOAC Int. 2022 Jul 28. pii: 6651096. doi: 10.1093.
Abstract

LIU Y, Zhang S, Wu X, Li Q, et al
Instant messaging client gives the opportunity to recognize gut microbiota and dysbiosis-related disease: An investigation study on WeChat APP.
Digit Health. 2022;8:20552076221115018.
Abstract

DE PALMA G, Shimbori C, Reed DE, Yu Y, et al
Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signaling in mice.
Sci Transl Med. 2022;14:eabj1895.
Abstract

LEONI C, Giorgio V, Stella G, Onesimo R, et al
Prevalence of gastrointestinal disorders in individuals with RASopathies: May RAS/MAP/ERK pathway dysfunctions be a model of neuropathic pain and visceral hypersensitivity?
Am J Med Genet A. 2022 Jul 27. doi: 10.1002/ajmg.a.62917.
Abstract

WILS P, Caron B, D'Amico F, Danese S, et al
Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge.
J Clin Med. 2022;11.
Abstract

JIA W, Liang H, Wang L, Sun M, et al
Associations between Abnormal Eating Styles and Irritable Bowel Syndrome: A Cross-Sectional Study among Medical School Students.
Nutrients. 2022;14.
Abstract

ZIMMERMANN J, Longin FH, Schweinlin A, Basrai M, et al
No Difference in Tolerance between Wheat and Spelt Bread in Patients with Suspected Non-Celiac Wheat Sensitivity.
Nutrients. 2022;14.
Abstract

PENG S, Ling X, Rui W, Jin X, et al
LMWP (S3-3) from the Larvae of Musca domestica Alleviate D-IBS by Adjusting the Gut Microbiota.
Molecules. 2022;27.
Abstract

MAZZAWI T
Gut Microbiota Manipulation in Irritable Bowel Syndrome.
Microorganisms. 2022;10.
Abstract

BASSOTTI G
Irritable Bowel Syndrome: A Multifaceted World Still to Discover.
J Clin Med. 2022;11.
Abstract

CHOI HG, Kang HS, Lim H, Kim JH, et al
Changes in the Incidence Rates of Gastrointestinal Diseases Due to the COVID-19 Pandemic in South Korea: A Long-Term Perspective.
J Pers Med. 2022;12.
Abstract

BLASS I, Sahar T, Shraibman A, Ofer D, et al
Revisiting the Risk Factors for Endometriosis: A Machine Learning Approach.
J Pers Med. 2022;12.
Abstract

LASSMANN L, Pollis M, Zoltowska A, Manfredini D, et al
Gut Bless Your Pain-Roles of the Gut Microbiota, Sleep, and Melatonin in Chronic Orofacial Pain and Depression.
Biomedicines. 2022;10.
Abstract

WAN Y, Zhang B
The Impact of Zinc and Zinc Homeostasis on the Intestinal Mucosal Barrier and Intestinal Diseases.
Biomolecules. 2022;12.
Abstract

KUSHLINSKII NE, Gershtein ES, Zybina NN, Tsarapaev PV, et al
Blood Serum Zonulin in Colorectal Cancer, Autoimmune Bowel Diseases, and Irritable Bowel Syndrome.
Bull Exp Biol Med. 2022;173:376-379.
Abstract

ZHOU ZX, Ma HF, Yang YC, Chen JT, et al
[Effect of electroacupuncture on colonic motility and RhoA and ROCK protein expression in IBS-D rats].
Zhen Ci Yan Jiu. 2022;47:611-6.
Abstract

YU SJ, Lee HS, Gung HJ, Kim JS, et al
Efficacy of a Restrictive Diet in Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis.
Korean J Gastroenterol. 2022;80:6-16.
Abstract

DAS BB, Panda AK, Patra MP, Nayak K, et al
Study on the Role of Gastrointestinal Parasite in Irritable Bowel Syndrome Patients in a Tribal Region of India.
Cureus. 2022;14:e26091.
Abstract

ELSAYGH H, Alhafez I, Jaber M, Al-Rasheed M, et al
A Literature Review of Major Clinical Trials That Contributed to Treatment Protocols of Irritable Bowel Syndrome With Diarrhea.
Cureus. 2022;14:e26092.
Abstract

GONG Z, Yang Q, Wang Y, Weng X, et al
Pharmacokinetic Differences of Wuji Pill Components in Normal and Chronic Visceral Hypersensitivity Irritable Bowel Syndrome Rats Attributable to Changes in Tight Junction and Transporters.
Front Pharmacol. 2022;13:948678.
Abstract

MOSHIREE B, Heidelbaugh JJ, Sayuk GS
A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers.
Adv Ther. 2022 Jul 22. pii: 10.1007/s12325-022-02224.
Abstract

SUGAYA N, Tomita Y, Funaba M, Iida H, et al
Validity and reliability of the Japanese versions of cognitive and behavioral scales for irritable bowel syndrome.
Biopsychosoc Med. 2022;16:15.
Abstract

WHITE L
Like clockwork? (Re)imagining rhythms and routines when living with irritable bowel syndrome (IBS).
Sociol Health Illn. 2022 Aug 5. doi: 10.1111/1467-9566.13504.
Abstract

ROZENTAL A, Sorman K, Ojala O, Jangard S, et al
Mental health in individuals with self-reported psychiatric symptoms during the COVID-19 pandemic: Baseline data from a swedish longitudinal cohort study.
Front Psychiatry. 2022;13:933858.
Abstract

Lasting Effects of Helicobacter pylori Infection on the Microbial Communities of Patients with and without Small Intestinal Bacterial Overgrowth.
New Microbiol. 2022;45:193-198.
Abstract

ZHOU Y, Zhang F, Mao L, Feng T, et al
Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines.
Eur J Nutr. 2022 Aug 2. pii: 10.1007/s00394-022-02958.
Abstract

BAZHANOV S, Lan Y, Gonzales K, Winston JH, et al
Fetal corticosterone exposure leads to enhanced visceral hypersensitivity and is associated with down-regulation of placental 11-beta-steriod dehydrogenase 2.
Am J Physiol Gastrointest Liver Physiol. 2022.
Abstract

BROUNS F, Geisslitz S, Guzman C, Ikeda TM, et al
Do ancient wheats contain less gluten than modern bread wheat, in favour of better health?
Nutr Bull. 2022;47:157-167.
Abstract

DONG Z, Zhan T, Sun H, Wang J, et al
Astrocytic ERK/STAT1 signaling contributes to maintenance of stress-related visceral hypersensitivity in rats.
J Pain. 2022 Jul 29. pii: S1526-5900(22)00365.
Abstract

ZHANG G, Zhang T, Cao Z, Tao Z, et al
Effects and Mechanisms of Acupuncture on Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review.
Front Neurosci. 2022;16:918701.
Abstract

SHI JT, Zhang Y, She Y, Goyal H, et al
Diagnostic Utility of Non-invasive Tests for Inflammatory Bowel Disease: An Umbrella Review.
Front Med (Lausanne). 2022;9:920732.
Abstract

ENGEL F, Stadnitski T, Stroe-Kunold E, Berens S, et al
Temporal Relationships Between Abdominal Pain, Psychological Distress and Coping in Patients With IBS - A Time Series Approach.
Front Psychiatry. 2022;13:768134.
Abstract

HOU Z, Ding Q, Li Y, Zhao Z, et al
Intestinal epithelial beta Klotho is a critical protective factor in alcohol-induced intestinal barrier dysfunction and liver injury.
EBioMedicine. 2022;82:104181.
Abstract

SANDERS AE, Weatherspoon ED, Ehrmann BM, Soma PS, et al
Circulating polyunsaturated fatty acids, pressure pain thresholds, and nociplastic pain conditions.
Prostaglandins Leukot Essent Fatty Acids. 2022;184:102476.
Abstract

POLGAR A, Szalka B, Molnar T, Vassanyi I, et al
A mobilapplikacioval tamogatott alacsony-FODMAP-etrend a funkcionalis gastrointestinalis es a gyulladasos belbetegsegek kezeleseben.
Orv Hetil. 2022;163:1224-1230.
Abstract

EJTEHADI F, Anbardar MH, Imanieh MH, Niknam R, et al
Organic colonic lesions in patients with irritable bowel syndrome: A comparative study.
Rev Gastroenterol Mex (Engl Ed). 2022 Jul 26. pii: S2255-534X(22)00094.
Abstract

SHIMBORI C, De Palma G, Baerg L, Lu J, et al
Gut bacteria interact directly with colonic mast cells in a humanized mouse model of IBS.
Gut Microbes. 2022;14:2105095.
Abstract

MAHENDRA RAJ S, Ravindran S, Kaur M, Braganza MC, et al
Duodenal eosinophilia is associated with symptomatic erosive gastro-oesophageal reflux disease, presence of co-morbidities, and ethnicity but not undifferentiated functional dyspepsia: A retrospective Malaysian study.
Med J Malaysia. 2022;77:494-499.
Abstract

DOLNIK O, Becker S
Assembly and transport of filovirus nucleocapsids.
PLoS Pathog. 2022;18:e1010616.
Abstract

IZADPARAST F, Riahi-Zajani B, Yarmohammadi F, Hayes AW, et al
Protective effect of berberine against LPS-induced injury in the intestine: a review.
Cell Cycle. 2022 Jul 19:1-14. doi: 10.1080/15384101.2022.2100682.
Abstract

SANGALLI L, Miller CS
Low-dose naltrexone for treatment of burning mouth syndrome.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2022.
Abstract

KIM JH, Yi DY, Lee YM, Choi YJ, et al
Association between body mass index and fecal calprotectin levels in children and adolescents with irritable bowel syndrome.
Medicine (Baltimore). 2022;101:e29968.
Abstract

XU R, Liu X, Tian M, Chen D, et al
Atractylodes-I overcomes the oxidative stress-induced colonic mucosal epithelial cells dysfunction to prevent irritable bowel syndrome via modulating the miR-34a-5p-LDHA signaling pathway.
Curr Mol Med. 2022 Aug 11. pii: CMM-EPUB-125439.
Abstract

BISCHOFF SC, Barazzoni R, Busetto L, Campmans-Kuijpers M, et al
European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.
United European Gastroenterol J. 2022 Aug 12. doi: 10.1002/ueg2.12280.
Abstract

NABI MY, Nauhria S, Reel M, Londono S, et al
Endometriosis and irritable bowel syndrome: A systematic review and meta-analyses.
Front Med (Lausanne). 2022;9:914356.
Abstract

MATTILA J, Stenholm T, Loyttyniemi E, Koffert J, et al
Predictive Markers of Crohn's Disease in Small Bowel Capsule Endoscopy: A Retrospective Study of Small Bowel Capsule Endoscopy.
J Clin Med. 2022;11.
Abstract

KRISHNACHAITANYA SS, Liu M, Fujise K, Li Q, et al
MicroRNAs in Inflammatory Bowel Disease and Its Complications.
Int J Mol Sci. 2022;23.
Abstract

MEADE E, Garvey M
The Role of Neuro-Immune Interaction in Chronic Pain Conditions; Functional Somatic Syndrome, Neurogenic Inflammation, and Peripheral Neuropathy.
Int J Mol Sci. 2022;23.
Abstract

KOVACS DB, Szekely A, Hubai AG, Palsson O, et al
Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar.
BMJ Open Gastroenterol. 2022;9.
Abstract

NABAVI-RAD A, Sadeghi A, Asadzadeh Aghdaei H, Yadegar A, et al
The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management.
Gut Microbes. 2022;14:2108655.
Abstract

RYAN A, Healey M, Cheng C, Dior U, et al
Central sensitisation in pelvic pain: A cohort study.
Aust N Z J Obstet Gynaecol. 2022 Aug 11. doi: 10.1111/ajo.13596.
Abstract

ZHOU Q, Verne GN
Epigenetic modulation of visceral nociception.
Neurogastroenterol Motil. 2022 Aug 10:e14443. doi: 10.1111/nmo.14443.
Abstract

CAMILLERI M, Zhernakova A, Bozzarelli I, D'Amato M, et al
Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies.
Nat Rev Gastroenterol Hepatol. 2022 Aug 10. pii: 10.1038/s41575-022-00662.
Abstract

EFFENDI SSW, Ng IS
Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917.
Crit Rev Microbiol. 2022 Aug 10:1-17. doi: 10.1080/1040841X.2022.2109405.
Abstract

DEMIROREN K, Guney B, Bostanci M, Ekici D, et al
A Comparison Between Rome III and Rome IV Criteria in Children with Chronic Abdominal Pain: A Prospective Observational Cohort Study.
Turk J Gastroenterol. 2022 Aug 10. doi: 10.5152/tjg.2022.21893.
Abstract

CHAN WW, Grover M
The COVID-19 Pandemic and Postinfection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists.
Clin Gastroenterol Hepatol. 2022 Aug 6. pii: S1542-3565(22)00601.
Abstract

MA W, Drew DA, Staller K
The Gut Microbiome and Colonic Motility Disorders: A Practical Framework for the Gastroenterologist.
Curr Gastroenterol Rep. 2022 Aug 9. pii: 10.1007/s11894-022-00847.
Abstract

BOINPALLY R, McGeeney D, Kaczynski E, Weissman D, et al
An Open-Label Study to Evaluate the Effect of Eluxadoline on the Single-Dose Pharmacokinetics of Midazolam in Healthy Participants.
Clin Pharmacol Drug Dev. 2022 Aug 8. doi: 10.1002/cpdd.1150.
Abstract

BILAL M, Ashraf S, Zhao X
Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics.
Front Nutr. 2022;9:931458.
Abstract

ZHENG Z, Tang J, Hu Y, Zhang W, et al
Role of gut microbiota-derived signals in the regulation of gastrointestinal motility.
Front Med (Lausanne). 2022;9:961703.
Abstract

HUANG IH, Schol J, Khatun R, Carbone F, et al
Worldwide prevalence and burden of gastroparesis-like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.
United European Gastroenterol J. 2022 Aug 19. doi: 10.1002/ueg2.12289.
Abstract

HUSEIN DM, Rizk S, Hoter AU, Wanes D, et al
Severe pathogenic variants of intestinal sucrase-isomaltase interact avidly with the wild type enzyme and negatively impact its function and trafficking.
Biochim Biophys Acta Mol Basis Dis. 2022 Aug 16:166523.
Abstract

JADALLAH KA, Khatatbeh MM, Sarsak EW, Sweidan AN, et al
Irritable bowel syndrome and its associated factors among Jordanian medical students: A cross-sectional study.
Medicine (Baltimore). 2022;101:e30134.
Abstract

BILBAO A, Spanagel R
Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
BMC Med. 2022;20:259.
Abstract

YU C, Tovar S, Shi J, Padilla A, et al
SATISFACTION WITH TELEHEALTH AMONG PATIENTS WITH IRRITABLE BOWEL SYNDROME DURING COVID-19: CROSS-SECTIONAL SURVEY FINDINGS.
Clin Transl Gastroenterol. 2022 Aug 18. pii: 01720094-990000000-00079.
Abstract

MOUREY F, Decherf A, Jeanne JF, Clement-Ziza M, et al
Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation.
World J Gastroenterol. 2022;28:2509-2522.
Abstract

DONG LW, Ma ZC, Fu J, Huang BL, et al
Upregulated adenosine 2A receptor accelerates post-infectious irritable bowel syndrome by promoting CD4+ T cells' T helper 17 polarization.
World J Gastroenterol. 2022;28:2955-2967.
Abstract

CHURA-CHAMBI RM, Farah CS, Morganti L
Human growth hormone inclusion bodies present native-like secondary and tertiary structures which can be preserved by mild solubilization for refolding.
Microb Cell Fact. 2022;21:164.
Abstract

LACY BE, King J, Shortino D, Schaumburg C, et al
Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, double-blind, placebo-controlled phase 2 trial.
Neurogastroenterol Motil. 2022 Aug 16:e14448. doi: 10.1111/nmo.14448.
Abstract

ROACH K, Roberts J
A comprehensive summary of disease variants implicated in metal allergy.
J Toxicol Environ Health B Crit Rev. 2022.
Abstract

ADAM F, Jouet P, Sabate JM, Perrot S, et al
The thermal grill illusion of pain in chronic pain patients: a clinical marker of central sensitization?
Pain. 2022 Aug 15. pii: 00006396-990000000-00151.
Abstract

BISCHOFF SC, Barazzoni R, Busetto L, Campmans-Kuijpers M, et al
European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint ESPEN/UEG guideline.
Clin Nutr. 2022 Aug 11. pii: S0261-5614(22)00239.
Abstract

OHLSSON B
Extraintestinal manifestations in irritable bowel syndrome: A systematic review.
Therap Adv Gastroenterol. 2022;15:17562848221114558.
Abstract

SCHELL KR, Fernandes KE, Shanahan E, Wilson I, et al
The Potential of Honey as a Prebiotic Food to Re-engineer the Gut Microbiome Toward a Healthy State.
Front Nutr. 2022;9:957932.
Abstract

HE S, Lin Q, Huang J, Zheng L, et al
Effect and Mechanism of Flavored Tongxie Yaofang Decoction for Diarrheal Irritable Bowel Syndrome under Intestinal Microecology.
Evid Based Complement Alternat Med. 2022;2022:3904571.
Abstract

WANG J, Duan G, Zhan T, Dong Z, et al
Upregulation of Netrin-1 in the hippocampus mediates the formation of visceral hypersensitivity induced by maternal separation.
Front Mol Neurosci. 2022;15:908911.
Abstract

SHIN A, Xu H, Imperiale TF
The Prevalence, Humanistic Burden, and Healthcare Impact of Irritable Bowel Syndrome (IBS) Among United States Veterans.
Clin Gastroenterol Hepatol. 2022 Aug 11. pii: S1542-3565(22)00769.
Abstract

ZHONG P, Zhou J, Fan YT, Guo MF, et al
Co-existing polysaccharides affect the systemic exposure of major bioactive ingredients in Chang-Kang-Fang, a multi-herb prescription for treatment of irritable bowel syndrome.
J Ethnopharmacol. 2022;298:115601.
Abstract

FU Q, Song T, Ma X, Cui J, et al
Research progress on the relationship between intestinal microecology and intestinal bowel disease.
Animal Model Exp Med. 2022 Aug 12. doi: 10.1002/ame2.12262.
Abstract

BERTUCCIOLI A, Cardinali M, Di Pierro F, Zonzini GB, et al
Ketogenic and Low FODMAP Diet in Therapeutic Management of a Young Autistic Patient with Epilepsy and Dysmetabolism Poorly Responsive to Therapies: Clinical Response and Effects of Intestinal Microbiota.
Int J Mol Sci. 2022;23.
Abstract

MOHAMED OA, Samir S, Omar H, Hassan EA, et al
Lab-scale Preparation of Recombinant Human Insulin-like Growth Factor-1 in Escherichia coli and its Potential Safety on Normal Human Lung Cell Line.
Recent Pat Biotechnol. 2022;16:266-280.
Abstract

WEI X, Wen Y, Wei Y, Liang X, et al
External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: A systematic review and meta-analysis.
Front Med (Lausanne). 2022;9:940328.
Abstract

MROZ M, Czub M, Brytek-Matera A
Heart Rate Variability-An Index of the Efficacy of Complementary Therapies in Irritable Bowel Syndrome: A Systematic Review.
Nutrients. 2022;14.
Abstract

WIELGOSZ-GROCHOWSKA JP, Domanski N, Drywien ME
Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review.
Nutrients. 2022;14.
Abstract

WANG Z, Liu Y, Peng Y, Peng L, et al
Helicobacterpylori Infection-A Risk Factor for Irritable Bowel Syndrome? An Updated Systematic Review and Meta-Analysis.
Medicina (Kaunas). 2022;58.
Abstract

CHERRY RN, Blanchard SS, Chogle A, Santucci NR, et al
Herbal Approaches to Pediatric Functional Abdominal Pain.
Children (Basel). 2022;9.
Abstract

JOSHI V, Chhonker YS, Soni D, Cunningham KC, et al
A Selective and Sensitive LC-MS/MS Method for Quantitation of Indole in Mouse Serum and Tissues.
Metabolites. 2022;12.
Abstract

CHOUDHURY A, Tariq R, Jena A, Vesely EK, et al
Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis.
Therap Adv Gastroenterol. 2022;15:17562848221118403.
Abstract

CHEN HY, Liu J, Weng DZ, Yan L, et al
Ameliorative effect and mechanism of Si-Ni-San on chronic stress-induced diarrhea-irritable bowel syndrome in rats.
Front Pharmacol. 2022;13:940463.
Abstract

BARAZANJI N, Paul Hamilton J, Icenhour A, Simon RA, et al
Irritable bowel syndrome in women: Association between decreased insular subregion volumes and gastrointestinal symptoms.
Neuroimage Clin. 2022;35:103128.
Abstract

RIBEIRO M, Ferreira D, Siopa J, Rodriguez-Quijano M, et al
Natural Variation in the Content and Degree of Polymerization of Fructans in Wheat: Potential for Selection of Genotypes with Beneficial Health Composition.
J Agric Food Chem. 2022 Aug 24. doi: 10.1021/acs.jafc.2c03686.
Abstract

MICHAEL R, Bettina V, Eckehard L
Functional gastrointestinal disorders in children: Effectivity, safety, and tolerability of the herbal preparation STW-5 (Iberogast(R)) in general practice.
Complement Ther Med. 2022 Aug 20:102873. doi: 10.1016/j.ctim.2022.102873.
Abstract

NAZAREWSKA A, Lewandowski K, Kaniewska M, Rosolowski M, et al
Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2.
Pol Arch Intern Med. 2022 Aug 23. doi: 10.20452/pamw.16323.
Abstract

LI YC, Wang Q, Li MG, Hu SF, et al
A paraventricular hypothalamic nucleus input to ventral of lateral septal nucleus controls chronic visceral pain.
Pain. 2022 Aug 19. pii: 00006396-990000000-00158.
Abstract

YANG Y, Zhang S, Babygirija R, Shi B, et al
Intranasal administration of Neuropeptide Y significantly antagonized stress-induced colonic dysmotility via central GABAA receptors in male rats.
Am J Physiol Regul Integr Comp Physiol. 2022.
Abstract

VAN MALDEREN K, Hanning N, Lambrechts H, Haverhals T, et al
Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study.
Front Med (Lausanne). 2022;9:960000.
Abstract

WU S, Yuan C, Yang Z, Liu S, et al
Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study.
BMC Med. 2022;20:262.
Abstract

PATEL SM, Young MC
The Identification and Management of Small Intestinal Bacterial Overgrowth: A Functional Medicine Approach.
Phys Med Rehabil Clin N Am. 2022;33:587-603.
Abstract

PENG J, Lu Y, Chen L, Qiu K, et al
The prognostic value of machine learning techniques versus cox regression model for head and neck cancer.
Methods. 2022;205:123-132.
Abstract

NARVAEZ KR, Thompson T
Compounded Medications and Probiotics for Irritable Bowel Syndrome.
Int J Pharm Compd. 2022;26:378-384.
Abstract

AL-BILTAGI M, El Amrousy D, El Ashry H, Maher S, et al
Effects of adherence to the Mediterranean diet in children and adolescents with irritable bowel syndrome.
World J Clin Pediatr. 2022;11:330-340.
Abstract

PAN YY, Deng Y, Su S, Yin JH, et al
Structure Composition and Intracellular Transport of Clathrin-Mediated Intestinal Transmembrane Tight Junction Protein.
Inflammation. 2022 Sep 1. pii: 10.1007/s10753-022-01724.
Abstract

DING J, Zheng P, Sun YY, Wang XR, et al
[Analysis of Wumei Pills in treating chronic digestive system diseases with concept of "treating different diseases with same method" based on network pharmacology and molecular docking].
Zhongguo Zhong Yao Za Zhi. 2022;47:4164-4176.
Abstract

KUMAR A, Tanwar S, Gupta S, Chetiwal R, et al
Advanced metastatic pancreatic neuroendocrine tumor treated successfully with peptide receptor radionuclide therapy: a case report.
Explor Target Antitumor Ther. 2022;3:392-397.
Abstract

CHEN Y, Lian B, Li P, Yao S, et al
Studies on irritable bowel syndrome associated with anxiety or depression in the last 20 years: A bibliometric analysis.
Front Public Health. 2022;10:947097.
Abstract

CHOI YJ, Shin SH, Shin HS
Immunomodulatory Effects of Bifidobacterium spp. and Use of B. breve and B. longum on Acute Diarrhea in Children.
J Microbiol Biotechnol. 2022;32:1-9.
Abstract

DOROFEYEV A, Dorofeyeva A, Borysov A, Tolstanova G, et al
Gastrointestinal health: changes of intestinal mucosa and microbiota in patients with ulcerative colitis and irritable bowel syndrome from PM2.5-polluted regions of Ukraine.
Environ Sci Pollut Res Int. 2022 Aug 30. pii: 10.1007/s11356-022-22710.
Abstract

NOROUZI M, Pirestani M, Arefian E, Dalimi A, et al
Exosomes secreted by Blastocystis subtypes affect the expression of proinflammatory and anti-inflammatory cytokines (TNFalpha, IL-6, IL-10, IL-4).
Front Med (Lausanne). 2022;9:940332.
Abstract

ZENG J, Wang X, Pan F, Mao Z, et al
The relationship between Parkinson's disease and gastrointestinal diseases.
Front Aging Neurosci. 2022;14:955919.
Abstract

QI LY, Yang JW, Yan SY, She YF, et al
Effect of acupuncture for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized clinical trial.
Trials. 2022;23:711.
Abstract

TAN ZE, Tan YQ, Lin H, How CH, et al
Irritable bowel syndrome: an approach for primary care physicians.
Singapore Med J. 2022;63:367-370.
Abstract

MANIPIS K, Mulhern B, Haywood P, Viney R, et al
Estimating the willingness-to-pay to avoid the consequences of foodborne illnesses: a discrete choice experiment.
Eur J Health Econ. 2022 Sep 8. pii: 10.1007/s10198-022-01512.
Abstract

THOMAS A, Thomas A, Butler-Sanchez M
Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome.
Am J Lifestyle Med. 2021;16:608-621.
Abstract

ZHAN TT, Dong ZY, Yi LS, Zhang Y, et al
Tandospirone prevents stress-induced anxiety-like behavior and visceral hypersensitivity by suppressing theta oscillation enhancement via 5-HT1A receptors in the anterior cingulate cortex in rats.
Front Cell Neurosci. 2022;16:922750.
Abstract

BAO W, Qi L, Bao Y, Wang S, et al
Alleviating insomnia should decrease the risk of irritable bowel syndrome: Evidence from Mendelian randomization.
Front Pharmacol. 2022;13:900788.
Abstract

LIU Z, Zhu S, He M, Li M, et al
Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity.
Chin Med J (Engl). 2022 Aug 25. pii: 00029330-990000000-00145.
Abstract

XI M, Zhao P, Li F, Bao H, et al
MicroRNA-16 inhibits the TLR4/NF-kappaB pathway and maintains tight junction integrity in irritable bowel syndrome with diarrhea.
J Biol Chem. 2022 Sep 3:102461. doi: 10.1016/j.jbc.2022.102461.
Abstract

ALGERA JP, Tornblom H, Simren M
Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome.
Curr Opin Pharmacol. 2022;66:102284.
Abstract

CHU N, Chan JC, Chow E
A diet high in FODMAPs as a novel dietary strategy in diabetes?
Clin Nutr. 2022;41:2103-2112.
Abstract

ROSHIDI N, Arifin N
Disease Biomarkers of Giardiasis.
J Parasitol Res. 2022;2022:1932518.
Abstract

FRANKLIN F, Rajamanikam A, Raju CS, Gill JS, et al
Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients.
Parasit Vectors. 2022;15:313.
Abstract

HUSSEIN H, Boeckxstaens GE
Immune-mediated food reactions in irritable bowel syndrome.
Curr Opin Pharmacol. 2022;66:102285.
Abstract

YANG H, Hou C, Xiao W, Qiu Y, et al
The role of mechanosensitive ion channels in the gastrointestinal tract.
Front Physiol. 2022;13:904203.
Abstract

DE LAS MERCEDES VILLA ROSERO C, Mazin SC, Nogueira AA, Vargas-Costales JA, et al
Prevalence of chronic pelvic pain and primary dysmenorrhea in women of reproductive age in Ecuador.
BMC Womens Health. 2022;22:363.
Abstract

HUBBARD CRISTINACCE PL, Keaveney S, Aboagye EO, Hall MG, et al
Clinical translation of quantitative magnetic resonance imaging biomarkers - An overview and gap analysis of current practice.
Phys Med. 2022;101:165-182.
Abstract

FARSI F, Zonooz SR, Ebrahimi Z, Jebraili H, et al
The Incidence of Post-infectious Irritable Bowel Syndrome, Anxiety, and Depression in Iranian Patients with Coronavirus Disease 2019 Pandemic: A Cross-Sectional Study.
Turk J Gastroenterol. 2022 Sep 13. doi: 10.5152/tjg.2022.21651.
Abstract

BONAZ B
Anti-inflammatory effects of vagal nerve stimulation with a special attention to intestinal barrier dysfunction.
Neurogastroenterol Motil. 2022 Sep 12:e14456. doi: 10.1111/nmo.14456.
Abstract

REJ A, Avery A, Aziz I, Black CJ, et al
Diet and irritable bowel syndrome: an update from a UK consensus meeting.
BMC Med. 2022;20:287.
Abstract

WANG K, Liu H, Liu J, Han L, et al
Factors related to irritable bowel syndrome and differences among subtypes: A cross-sectional study in the UK Biobank.
Front Pharmacol. 2022;13:905564.
Abstract

LIANG SB, Cao HJ, Kong LY, Wei JL, et al
Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials.
Front Pharmacol. 2022;13:904657.
Abstract

LU Q, Tan D, Luo J, Ye Y, et al
Potential of natural products in the treatment of irritable bowel syndrome.
Phytomedicine. 2022;106:154419.
Abstract

MENGZHU S, Yujie Z, Yafang S, Jing G, et al
Electroacupuncture at Tianshu (ST25) and Zusanli (ST36) alleviates stress-induced irritable bowel syndrome in mice by modulating gut microbiota and corticotropin-releasing factor.
J Tradit Chin Med. 2022;42:732-740.
Abstract

BUREYCHAK T, Faresjo A, Sjodahl J, Norlin AK, et al
Symptoms and health experience in irritable bowel syndrome with focus on men.
Neurogastroenterol Motil. 2022 Sep 8:e14430. doi: 10.1111/nmo.14430.
Abstract

ACHAREKAR MV, Guerrero Saldivia SE, Unnikrishnan S, Chavarria YY, et al
A Systematic Review on the Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in Gastrointestinal Motility Disorders: More Control, Less Risk.
Cureus. 2022;14:e27691.
Abstract

HOPMANN P, Tan E, Lo D
Multiseptate gallbladder presenting with biliary colic.
J Surg Case Rep. 2022;2022:rjac417.
Abstract

LONIEWSKI I, Skonieczna-Zydecka K, Solek-Pastuszka J, Marlicz W, et al
Probiotics in the Management of Mental and Gastrointestinal Post-COVID Symptomes.
J Clin Med. 2022;11.
Abstract

RADOS K, Cukelj Mustac N, Varga K, Drakula S, et al
Development of High-Fibre and Low-FODMAP Crackers.
Foods. 2022;11.
Abstract

WANG S, Lu J, Yu M, Wang X, et al
"I'm listening, did it make any difference to your negative emotions?" Evidence from hyperscanning.
Neurosci Lett. 2022;788:136865.
Abstract

ILYAS F
Successful low-dose corticosteroid treatment of aggressive pyoderma gangrenosum with irritable bowel syndrome: a case report.
Acta Dermatovenerol Alp Pannonica Adriat. 2022;31:111-114.
Abstract

ZEESHAN MH, Vakkalagadda NP, Sree GS, Anne KK, et al
Irritable bowel syndrome in adults: Prevalence and risk factors.
Ann Med Surg (Lond). 2022;81:104408.
Abstract

ELBADAWI M, Ammar RM, Rabini S, Klauck SM, et al
Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management.
Pharmaceuticals (Basel). 2022;15.
Abstract

MAZZAWI T, Hausken T, Refsnes PF, Hatlebakk JG, et al
The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study.
Microorganisms. 2022;10.
Abstract

SKROBISZ K, Piotrowicz G, Rudnik A, Naumczyk P, et al
Evaluation of Subcortical Structure Volumes in Patients with Non-Specific Digestive Diseases.
Diagnostics (Basel). 2022;12.
Abstract

HUDSON KE, Grau JW
Ionic Plasticity: Common Mechanistic Underpinnings of Pathology in Spinal Cord Injury and the Brain.
Cells. 2022;11.
Abstract

LIU A, Gao W, Zhu Y, Hou X, et al
Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome.
Toxins (Basel). 2022;14.
Abstract

SHRESTHA B, Patel D, Shah H, Hanna KS, et al
The Role of Gut-Microbiota in the Pathophysiology and Therapy of Irritable Bowel Syndrome: A Systematic Review.
Cureus. 2022;14:e28064.
Abstract

AILANI J, Kaiser EA, Mathew PG, McAllister P, et al
Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative Review.
Neurology. 2022 Sep 20. pii: WNL.0000000000201332.
Abstract

STONE AL, Epstein I, Bruehl S, Garber J, et al
Twenty-year outcomes of a pediatric chronic abdominal pain cohort: Early adulthood health status and offspring physical and behavioral health.
J Pain. 2022 Sep 17. pii: S1526-5900(22)00405.
Abstract

HE Z, Liu Y, Liu JJ, Shu GF, et al
PLR and IL-8 were Potential Markers in Differential Diagnosis and Disease Activity in Ulcerative Colitis Patients.
Clin Lab. 2022;68.
Abstract

STORR M

MMW Fortschr Med. 2022;164:26-27.
Abstract

FRITZ N, Berens S, Dong Y, Martinez C, et al
The serotonin receptor 3E variant is a risk factor for female IBS-D.
J Mol Med (Berl). 2022 Sep 19. pii: 10.1007/s00109-022-02244.
Abstract

RUIZ-MALAGON AJ, Rodriguez-Sanchez MJ, Rodriguez-Sojo MJ, Vezza T, et al
Intestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats.
Front Pharmacol. 2022;13:967644.
Abstract

SATO YZ, Hock RA, Garcia RL, Dihowm F, et al
Burkitt's Lymphoma of the Colon: A Case Report and Review of the Texas Cancer Registry.
Cureus. 2022;14:e27964.
Abstract

ALKHAYAL A, Alasmari FA, Alomeyr BK, Abumelha S, et al
Chronic pelvic pain syndrome symptoms significantly affect medical students' well-being.
Urol Ann. 2022;14:259-264.
Abstract

LIN ZL, Lu JB, Chen QY, Cui JQ, et al
[Clinical effectiveness of fecal microbiota transplantation combined with nutritional support and psychological intervention in patients with "Tetralogy of Tongji"].
Zhonghua Wei Chang Wai Ke Za Zhi. 2022;25:784-791.
Abstract

LIU MJ, Yang JY, Yan ZH, Hu S, et al
Recent findings in Akkermansia muciniphila-regulated metabolism and its role in intestinal diseases.
Clin Nutr. 2022;41:2333-2344.
Abstract

ASKARI H, Shojaei-Zarghani S, Raeis-Abdollahi E, Jahromi HK, et al
The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art.
Mini Rev Med Chem. 2022 Sep 14. pii: MRMC-EPUB-126304.
Abstract

ZENG HY, Bai T, Li SE, Zhang L, et al
Exploration of "Zhang" in functional gastrointestinal disorders: A cross-cultural challenge in Chinese clinical setting.
J Dig Dis. 2022;23:388-395.
Abstract

ABDELGHAFAR YA, AbdelQadir YH, Motawea KR, Nasr SA, et al
Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta-analysis of randomized control trials.
Health Sci Rep. 2022;5:e814.
Abstract

HOU Y, Zhao Y, Jiang H, Wang K, et al
Maintenance of Intestinal Homeostasis in Diarrhea-Predominant Irritable Bowel Syndrome by Electroacupuncture Through Submucosal Enteric Glial Cell-Derived S-Nitrosoglutathione.
Front Physiol. 2022;13:917579.
Abstract

TANG HY, Chen XQ, Wang H, Chu HR, et al
Acupuncture relieves the visceral pain of diarrhea-predominant irritable bowel syndrome rats by regulating P2X4 expression.
Am J Transl Res. 2022;14:5563-5573.
Abstract

BADAWY M, Johnson G, Jain M, Kendi AT, et al
Intracranial neuroendocrine tumour simulating meningioma for several years: an overview of diagnosis and treatment.
BJR Case Rep. 2022;8:20210222.
Abstract

FORMICA S, Rizzo G, Martino G, Lucifora C, et al
Relationship Between Sensitivity to Disgust and Irritable Bowel Syndrome: A Study on Healthy Individuals.
Clin Neuropsychiatry. 2022;19:230-235.
Abstract

TORNKVIST NT, Tornblom H
European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendations.
United European Gastroenterol J. 2022;10:615-616.
Abstract

GUGNOWSKA K, Novembre G, Kohler N, Villringer A, et al
Endogenous sources of interbrain synchrony in duetting pianists.
Cereb Cortex. 2022;32:4110-4127.
Abstract

ATUH NI, Anong DN, Jerome FC, Oriero E, et al
High genetic complexity but low relatedness in Plasmodium falciparum infections from Western Savannah Highlands and coastal equatorial Lowlands of Cameroon.
Pathog Glob Health. 2022;116:428-437.
Abstract

GROEGER D, Murphy EF, Tan HTT, Larsen IS, et al
Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combination.
Neurogastroenterol Motil. 2022 Sep 30:e14477. doi: 10.1111/nmo.14477.
Abstract

GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
Willingness to pay for medications among patients with Rome IV irritable Bowel syndrome.
Neurogastroenterol Motil. 2022 Sep 30:e14483. doi: 10.1111/nmo.14483.
Abstract

KIM N, Kim J, Yang BR, Hahm BJ, et al
Associations of unspecified pain, idiopathic pain and COVID-19 in South Korea: a nationwide cohort study.
Korean J Pain. 2022;35:458-467.
Abstract

BYALE A, Lennon RJ, Byale S, Breen-Lyles M, et al
High-dimensional clustering of 4000 Irritable Bowel Syndrome Patients reveals Seven Distinct Disease Subsets.
Clin Gastroenterol Hepatol. 2022 Sep 26. pii: S1542-3565(22)00917.
Abstract

ARAI T, Inoue Y
Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist.
ERJ Open Res. 2022;8.
Abstract

MENG Y, Feng Y, Hang L, Zhou Y, et al
No synergistic effect of fecal microbiota transplantation and shugan decoction in water avoidance stress-induced IBS-D rat model.
Front Microbiol. 2022;13:995567.
Abstract

HOJO M, Nagahara A
Current perspectives on irritable bowel syndrome: a narrative review.
J Int Med Res. 2022;50:3000605221126370.
Abstract

WU J, Wang C, Lv L
Diagnostic yield of colonoscopy for organic disease in irritable bowel syndrome and its risk factors: A meta-analysis.
Neurogastroenterol Motil. 2022 Sep 27:e14481. doi: 10.1111/nmo.14481.
Abstract

BRIERLEY SM, Greenwood-Van Meerveld B, Sarnelli G, Sharkey KA, et al
Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.
Nat Rev Gastroenterol Hepatol. 2022 Sep 27. pii: 10.1038/s41575-022-00682.
Abstract

LI HY, Chen Y, Hu ZY, Chen W, et al
[Meta analysis of acupuncture and moxibustion for anxiety and depression in irritable bowel syndrome].
Zhen Ci Yan Jiu. 2022;47:821-9.
Abstract

COSTANTINO A, Pessarelli T, Vecchiato M, Vecchi M, et al
A practical guide to the proper prescription of physical activity in patients with irritable bowel syndrome.
Dig Liver Dis. 2022 Sep 21. pii: S1590-8658(22)00663.
Abstract

DEMIRBAS A, Elmas OF, Eker H, Demirbas GU, et al
The relationship between hidradenitis suppurativa and irritable bowel syndrome: a cross-sectional study.
Turk J Med Sci. 2022;52:97-104.
Abstract

DONG X, Yang Y, Luo S, Deng X, et al
Upregulation of P2X3 receptors in primary afferent pathways involves in colon-to-bladder cross-sensitization in rats.
Front Physiol. 2022;13:920044.
Abstract

WU PN, Xiong S, Zhong P, Yang WQ, et al
Global trends in research on irritable bowel syndrome and the brain-gut axis: Bibliometrics and visualization analysis.
Front Pharmacol. 2022;13:956204.
Abstract

IKEDA Y, Taniguchi K, Sawamura H, Tsuji A, et al
Promising role of D-amino acids in irritable bowel syndrome.
World J Gastroenterol. 2022;28:4471-4474.
Abstract

NISHIDA A, Nishino K, Ohno M, Sakai K, et al
Update on gut microbiota in gastrointestinal diseases.
World J Clin Cases. 2022;10:7653-7664.
Abstract

JIANG S, Song CY, Feng MX, Lu YQ, et al
Adult patients with allied disorders of Hirschsprung's disease in emergency department: An 11-year retrospective study.
World J Gastrointest Surg. 2022;14:656-669.
Abstract

MALLARET G, Lashermes A, Meleine M, Boudieu L, et al
Involvement of toll-like receptor 5 in mouse model of colonic hypersensitivity induced by neonatal maternal separation.
World J Gastroenterol. 2022;28:3903-3916.
Abstract

QUAGLIO AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, et al
Gut microbiota, inflammatory bowel disease and colorectal cancer.
World J Gastroenterol. 2022;28:4053-4060.
Abstract

FANG XC, Fan WJ, Drossman DD, Han SM, et al
Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
World J Gastroenterol. 2022;28:4861-4874.
Abstract

POMENTI S, Devinsky J, Jodorkovsky D
Diet for Functional Gastrointestinal Disorders/Disorders of Gut-Brain Interaction.
Med Clin North Am. 2022;106:899-912.
Abstract

M H S, P E H, C F, S B, et al
Economic living standard and abdominal pain mediate the association between functional gastrointestinal disorders and depression or anxiety.
Neurogastroenterol Motil. 2022 Sep 25:e14465. doi: 10.1111/nmo.14465.
Abstract

BARBA E, Burri E, Quiroga S, Accarino A, et al
Visible abdominal distension in functional gut disorders: Objective evaluation.
Neurogastroenterol Motil. 2022 Sep 25:e14466. doi: 10.1111/nmo.14466.
Abstract

MURATORE A, Shah ED, Chan WW
Cost-Benefit Analysis of Hydrogen Breath Test-Directed Rifaximin for Treatment of Diarrhea-Predominant Irritable Bowel Syndrome.
Clin Gastroenterol Hepatol. 2022 Sep 21. pii: S1542-3565(22)00907.
Abstract

SVENSSON A, Roth B, Kronvall L, Ohlsson B, et al
TSH receptor antibodies (TRAb) - A potential new biomarker for endometriosis.
Eur J Obstet Gynecol Reprod Biol. 2022;278:115-121.
Abstract

WENDT L, Brandt J, Ushakov DS, Bodmer BS, et al
Evidence for Viral mRNA Export from Ebola Virus Inclusion Bodies by the Nuclear RNA Export Factor NXF1.
J Virol. 2022;96:e0090022.
Abstract

RAY K
Bacterial histamine and abdominal pain in IBS.
Nat Rev Gastroenterol Hepatol. 2022;19:623.
Abstract

NARAYANA V, McMeans AR, Levy RL, Shulman RJ, et al
Children with functional abdominal pain disorders successfully decrease FODMAP food intake on a low FODMAP diet with modest improvements in nutritional intake and diet quality.
Neurogastroenterol Motil. 2022;34:e14392.
Abstract

GOLLIFER RM, Taylor SA, Menys A, Zarate-Lopez N, et al
Magnetic resonance imaging assessed enteric motility and luminal content analysis in patients with severe bloating and visible distension.
Neurogastroenterol Motil. 2022;34:e14381.
Abstract

ATAY O, David J, Mehta A
A Hypothetical Case Example Illustrating the Importance of a Multidisciplinary Approach to Treating Chronic/Functional Abdominal Pain in Pediatric Patients.
Pediatr Clin North Am. 2022;69:917-927.
Abstract

OKAFOR PN, Dahlen A, Youssef M, Olayode A, et al
Environmental Pollutants are Associated with Irritable Bowel Syndrome in a Commercially Insured Cohort of California Residents.
Clin Gastroenterol Hepatol. 2022 Sep 30. pii: S1542-3565(22)00923.
Abstract

WANG Y, Cui W, Yang C, Wei H, et al
Comparison of Geqingpi and Sihuaqingpi based on ultra high performance liquid chromatography-tandem mass spectrometry combined with multivariate statistics, network pharmacology analysis, and molecular docking.
J Sep Sci. 2022 Oct 6. doi: 10.1002/jssc.202200564.
Abstract

HABIB N, Buzzaccarini G, Centini G, Moawad GN, et al
Impact of lifestyle and diet on endometriosis: a fresh look to a busy corner.
Prz Menopauzalny. 2022;21:124-132.
Abstract

BOURSEAU S, Bastens B, Leclercq P
Umbilical spider's web.
Acta Gastroenterol Belg. 2022;85:542.
Abstract

NOVLJAN U, Pintar T
Small Intestinal Bacterial Overgrowth in Patients with Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass.
Obes Surg. 2022 Oct 5. pii: 10.1007/s11695-022-06299.
Abstract

WANG F, Zhao T, Wang W, Dai Q, et al
Meta-analysis of the efficacy of probiotics to treat diarrhea.
Medicine (Baltimore). 2022;101:e30880.
Abstract

ZHANG M, Zheng Y, Li X, Wu H, et al
Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2/PERK-eIF2alpha-ATF4 signaling pathway.
Phytomedicine. 2022;107:154350.
Abstract

YUAN Y, Wu H, Pan H
Comparative analysis of the fecal microbiome and metabolomics of healthy versus captive South China tigers with mild-diarrhea.
Can J Microbiol. 2022 Oct 4. doi: 10.1139/cjm-2022-0115.
Abstract

HUANG HL, Zhu JQ, Yang LS, Wu Q, et al
Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea.
Oxid Med Cell Longev. 2022;2022:5121496.
Abstract

SHARAWI S, Graffeo V, Goebel LJ
Sclerosing Mesenteritis: A Rare Cause of Abdominal Pain.
Cureus. 2022;14:e28573.
Abstract

SATO T, Honda S, Tominaga Y, Miyakoshi Y, et al
A probiotic blend improves defecation, mental health, and productivity in healthy Japanese volunteers under stressful situations.
Heliyon. 2022;8:e10614.
Abstract

LARAUCHE M, Erchegyi J, Miller C, Sim MS, et al
Peripheral CRF-R1/CRF-R2 antagonist, astressin C, induces a long-lasting blockade of acute stress-related visceral pain in male and female rats.
Peptides. 2022;157:170881.
Abstract

YI SL, Huang ZT, Liao L, Lu YL, et al
The Effects of Patchouli Alcohol on Diarrhea-Predominant Irritable Bowel Syndrome are Correlated with Phenotypic Plasticity in Myenteric Neurons and the Targeted Regulation of Myosin Va.
Am J Chin Med. 2022 Oct 3:1-21. doi: 10.1142/S0192415X22500811.
Abstract

RAJ SR, Sheldon RS
Vasovagal syncope: Treat the patient, and not just the disease.
Auton Neurosci. 2022;243:103035.
Abstract

LOH-DOYLE JC, Stephens-Shields AJ, Rolston R, Newcomb C, et al
Predictors of Male Sexual Dysfunction in Urologic Chronic Pelvic Pain Syndrome (UCPPS), Other Chronic Pain Syndromes, and Healthy Controls in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.
J Sex Med. 2022 Sep 27. pii: S1743-6095(22)01774.
Abstract

LIU P, Zhang S, Ma J, Jin D, et al
Vimentin inhibits alpha-tubulin acetylation via enhancing alpha-TAT1 degradation to suppress the replication of human parainfluenza virus type 3.
PLoS Pathog. 2022;18:e1010856.
Abstract

CHENG X, Guo B, Hu Y
Distinct neural couplings to shared goal and action coordination in joint action: evidence based on fNIRS hyperscanning.
Soc Cogn Affect Neurosci. 2022;17:956-964.
Abstract

JIN S, Lu X, Xu C
COVID-19 induces gastrointestinal symptoms and affects patients' prognosis.
J Int Med Res. 2022;50:3000605221129543.
Abstract

RICCI C, Rizzello F, Valerii MC, Spisni E, et al
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial.
Nutrients. 2022;14.
Abstract

ABBOUD M, Haidar S, Mahboub N, Papandreou D, et al
Association between Serum Vitamin D and Irritable Bowel Syndrome Symptoms in a Sample of Adults.
Nutrients. 2022;14.
Abstract

BAYER SB, Heenan P, Frampton C, Wall CL, et al
Two Gold Kiwifruit Daily for Effective Treatment of Constipation in Adults-A Randomized Clinical Trial.
Nutrients. 2022;14.
Abstract

AUPETIT A, Grigioni S, Roman H, Coeffier M, et al
Association between Endometriosis, Irritable Bowel Syndrome and Eating Disorders: ENDONUT Pilot Study.
J Clin Med. 2022;11.
Abstract

WASEEM MR, Shin A, Siwiec R, James-Stevenson T, et al
ASSOCIATIONS OF FECAL SHORT CHAIN FATTY ACID WITH COLONIC TRANSIT, FECAL BILE ACIDS, AND FOOD INTAKE IN IRRITABLE BOWEL SYNDROME.
Clin Transl Gastroenterol. 2022 Oct 13. pii: 01720094-990000000-00102.
Abstract

PATEL SJ, Kaye A, Meyers SR, Ahlawat S, et al
Outcomes of Patients Who Developed Clostridioides difficile Infection During Hospitalization and Had a History of Comorbid Post-Traumatic Stress Disorder.
Cureus. 2022;14:e28810.
Abstract

TIAN YQ, Zhang SP, Zhang KL, Cao D, et al
Paeoniflorin Ameliorates Colonic Fibrosis in Rats with Postinfectious Irritable Bowel Syndrome by Inhibiting the Leptin/LepRb Pathway.
Evid Based Complement Alternat Med. 2022;2022:6010858.
Abstract

ZIA S, Saleem M, Asif M, Hussain K, et al
Diospyros malabarica (Desr.) Kostel fruits extract attenuated acute and chronic inflammation through modulation of the expression of pro- and anti-inflammatory biomarkers in rat models.
Inflammopharmacology. 2022 Oct 12. pii: 10.1007/s10787-022-01048.
Abstract

ALGERA JP, Colomier E, Melchior C, Hreinsson JP, et al
Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome.
Neurogastroenterol Motil. 2022 Oct 11:e14482. doi: 10.1111/nmo.14482.
Abstract

LACY BE, Cangemi DJ
Updates in functional dyspepsia and bloating.
Curr Opin Gastroenterol. 2022;38:613-619.
Abstract

SUGIYAMA Y, Mori Y, Nara M, Kotani Y, et al
Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production.
Gut Microbes. 2022;14:2128605.
Abstract

GIRON MC, Baj A, Giaroni C
Editorial: Neuroendocrine signalling pathways along the microbiota-gut-brain axis in functional gut disorders.
Front Endocrinol (Lausanne). 2022;13:996382.
Abstract

LI H, Zhang W, Ma F, Zhang X, et al
Abdominal Massage Improves the Symptoms of Irritable Bowel Syndrome by Regulating Mast Cells via the Trypase-PAR2-PKCepsilon Pathway in Rats.
Pain Res Manag. 2022;2022:8331439.
Abstract

BHATTACHARJEE G, Khambhati K, Gohil N, Singh P, et al
Gut microbiota in gastrointestinal diseases.
Prog Mol Biol Transl Sci. 2022;191:141-151.
Abstract

GARVEY SM, Mah E, Blonquist TM, Kaden VN, et al
The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial in healthy adults.
Gut Microbes. 2022;14:2122668.
Abstract

CAREY ET, Geller EJ, Rapkin A, Farb D, et al
Rationale and design of a multicenter randomized clinical trial of vestibulodynia: understanding pathophysiology and determining appropriate treatments (vestibulodynia: UPDATe).
Ann Med. 2022;54:2885-2897.
Abstract

OMES C, Tomasoni V, De Amici M, Testa G, et al
Calprotectin as a novel diagnostic approach to screen male infertility risk: A pilot study.
Immunobiology. 2022;227:152291.
Abstract

FAN W, Fang X, Hu C, Fei G, et al
Multiple rather than specific autoantibodies were identified in irritable bowel syndrome with HuProt proteome microarray.
Front Physiol. 2022;13:1010069.
Abstract

LALOUNI M, Bujacz A, Bonnert M, Jensen KB, et al
Parental responses and catastrophizing in online cognitive behavioral therapy for pediatric functional abdominal pain: A mediation analysis of a randomized controlled trial.
Front Pain Res (Lausanne). 2022;3:962037.
Abstract

CHEN KH, Zeng BY, Zeng BS, Sun CK, et al
The efficacy of exogenous melatonin supplement in ameliorating irritable bowel syndrome severity: A meta-analysis of randomized controlled trials.
J Formos Med Assoc. 2022 Oct 15. pii: S0929-6646(22)00385.
Abstract

CHEN Z, Liu Y, Wu X, Lin W, et al
Spinal circKcnk9 regulates chronic visceral hypersensitivity of irritable bowel syndrome.
J Pain. 2022 Oct 15. pii: S1526-5900(22)00433.
Abstract

BENTELE M, Stengel A
[Hypnotherapy for Irritable Bowel Syndrome].
Psychother Psychosom Med Psychol. 2022;72.
Abstract

NASRUN NE, Fujita K, Chieda K, Abiko Y, et al
Association between impaired healing after orthognathic surgery and irritable bowel syndrome: A case report and literature review.
Int J Surg Case Rep. 2022;100:107745.
Abstract

SHIN SY, Park S, Moon JM, Kim K, et al
Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial.
J Neurogastroenterol Motil. 2022;28:642-654.
Abstract

JOSEFSSON A, Tornblom H, Simren M
Type of Rectal Barostat Protocol Affects Classification of Hypersensitivity and Prediction of Symptom Severity in Irritable Bowel Syndrome.
J Neurogastroenterol Motil. 2022;28:630-641.
Abstract

KIM JH, Lee SW, Kwon Y, Ha EK, et al
Infantile Colic and the Subsequent Development of the Irritable Bowel Syndrome.
J Neurogastroenterol Motil. 2022;28:618-629.
Abstract

MIN YW, Rezaie A, Pimentel M
Bile Acid and Gut Microbiota in Irritable Bowel Syndrome.
J Neurogastroenterol Motil. 2022;28:549-561.
Abstract

JIANG W, Wu J, Zhu S, Xin L, et al
The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome.
J Neurogastroenterol Motil. 2022;28:540-548.
Abstract

LV L, Ruan G, Ping Y, Cheng Y, et al
Clinical study on sequential treatment of severe diarrhea irritable bowel syndrome with precision probiotic strains transplantation capsules, fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsul
Front Cell Infect Microbiol. 2022;12:1025889.
Abstract

KASAHARA S, Matsudaira K, Sato N, Niwa SI, et al
Attention-Deficit/hyperactivity disorder and centralized pain: A review of the case of John F. Kennedy.
Clin Case Rep. 2022;10:e6422.
Abstract

NOGUEIRA V, Chang CK, Lan CY, Pereira C, et al
Causative links between ER stress and oxidative damage in a yeast model of human N88S seipinopathy.
Free Radic Biol Med. 2022;192:165-181.
Abstract

FRISSORA CL, Rao SSC
Sucrose intolerance in adults with common functional gastrointestinal symptoms.
Proc (Bayl Univ Med Cent). 2022;35:790-793.
Abstract

GRANT RK, Brindle WM, Donnelly MC, McConville PM, et al
Gastrointestinal and liver disease in patients with schizophrenia: A narrative review.
World J Gastroenterol. 2022;28:5515-5529.
Abstract

FLORES-CALDERA I, Ramos-Echevarria PM, Oliveras-Torres JA, Santos-Pinero N, et al
Ibero-American Endometriosis Patient Phenome: Demographics, Obstetric-Gynecologic Traits, and Symptomatology.
Front Reprod Health. 2021;3:667345.
Abstract

MCNAMARA HC, Frawley HC, Donoghue JF, Readman E, et al
Peripheral, Central, and Cross Sensitization in Endometriosis-Associated Pain and Comorbid Pain Syndromes.
Front Reprod Health. 2021;3:729642.
Abstract

RASHID A
Yonder: Primary aldosteronism, artificial intelligence, irritable bowel syndrome, and financial toxicity.
Br J Gen Pract. 2022;72:534.
Abstract

RHYS-JONES D, Varney JE, Muir JG, Gibson PR, et al
Application of The FODMAP Diet in a Paediatric Setting.
Nutrients. 2022;14.
Abstract

DICKS LMT
How does Quorum Sensing of Intestinal Bacteria Affect Our Health and Mental Status?
Microorganisms. 2022;10.
Abstract

SMOLINSKA S, Winiarska E, Globinska A, Jutel M, et al
Histamine: A Mediator of Intestinal Disorders-A Review.
Metabolites. 2022;12.
Abstract

OKAWA Y
A Discussion of Whether Various Lifestyle Changes can Alleviate the Symptoms of Irritable Bowel Syndrome.
Healthcare (Basel). 2022;10.
Abstract

CASTIGLIONE V, Berodes M, Lukas P, Louis E, et al
New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method.
Diagnostics (Basel). 2022;12.
Abstract

MAKAROVA AA, Ruchkina IN, Parfenov AI, Indeykina LK, et al
[The role of visceral hypersensitivity in the pathogenesis of irritable bowel syndrome].
Ter Arkh. 2021;93:969-974.
Abstract

ANDREEV DN, Kucheryavyy YA
[Obesity as a risk factor for diseases of the digestive system].
Ter Arkh. 2021;93:954-962.
Abstract

ARDATSKAYA MD, Butorova LI, Kalashnikova MA, Nugaeva NR, et al
[Gastroenterological symptoms in COVID-19 patients with mild severity of the disease: opportunities to optimize antidiarrheal therapy].
Ter Arkh. 2021;93:923-931.
Abstract

ANDREEV DN, Maev IV
[Efficacy of trimebutine in the treatment of functional gastrointestinal disorders: an observational multicenter study].
Ter Arkh. 2021;93:897-903.
Abstract

RUCHKINA IN, Fadeeva NA
[The role of a combined probiotic in the treatment of lactase deficiency].
Ter Arkh. 2021;93:431-434.
Abstract

ANDREEV DN, Bordin DS, Vyuchnova ES, Lebedeva EG, et al
[Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III-IV Criteria].
Ter Arkh. 2022;94:1099-1108.
Abstract

AKHMEDOV VA
[Correction of intestinal microbial composition disturbances as a potential link in complex therapy of patients with COVID-19].
Ter Arkh. 2022;94:277-282.
Abstract

YAKOVENKO EP, Strokova TV, Ivanov AN, Iakovenko AV, et al
[The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study].
Ter Arkh. 2022;94:180-187.
Abstract

PARFENOV AI
[Food intolerances and the small intestine].
Ter Arkh. 2022;94:153-159.
Abstract

BERGER M, Guiraud L, Dumas A, Sagnat D, et al
Prenatal stress induces changes in PAR2- and M3-dependent regulation of colon primitive cells.
Am J Physiol Gastrointest Liver Physiol. 2022.
Abstract

CHOJNACKI C, Konrad P, Kaczka A, Medrek-Sochab M, et al
The role of serotonin in pathogenesis of unclassified irritable bowel syndrome.
Pol Merkur Lekarski. 2022;50:277-281.
Abstract

BRAYDEN DJ
Localised Delivery of Macromolecules to the Large Intestine: Translation to Clinical Trials.
BioDrugs. 2022 Oct 25. pii: 10.1007/s40259-022-00562.
Abstract

XIONG Y, Wei H, Chen C, Jiao L, et al
Coptisine attenuates postinfectious IBS via Nrf2dependent inhibition of the NLPR3 inflammasome.
Mol Med Rep. 2022;26.
Abstract

YOSHIOKA T, Ohashi M, Matsumoto K, Omata T, et al
Repeated psychological stress, chronic vicarious social defeat stress, evokes irritable bowel syndrome-like symptoms in mice.
Front Neurosci. 2022;16:993132.
Abstract

SHI YZ, Tao QF, Qin D, Chen M, et al
Acupuncture vs. antispasmodics in the treatment of irritable bowel syndrome: An adjusted indirect treatment comparison meta-analysis.
Front Physiol. 2022;13:1001978.
Abstract

YOU S, Ma Y, Yan B, Pei W, et al
The promotion mechanism of prebiotics for probiotics: A review.
Front Nutr. 2022;9:1000517.
Abstract

COSTANTINO A, Aversano GM, Lasagni G, Smania V, et al
Diagnostic management of patients reporting symptoms after wheat ingestion.
Front Nutr. 2022;9:1007007.
Abstract

HAMBLIN H, Gunaratne AW, Clancy A, Pilarinos D, et al
Pre-Antibiotic Treatment Followed by Prolonged Repeated Faecal Microbiota Transplantation Improves Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: An Observational Australian Clinical Experience.
Gastroenterol Res Pract. 2022;2022:6083896.
Abstract

YANAI K, Ishibashi K, Morishita Y
MicroRNAs in Irritable Bowel Syndrome: a Systematic Review.
Discov Med. 2022;34:7-18.
Abstract

GOLLA R, Vuyyuru S, Kante B, Kumar P, et al
Long-term gastrointestinal sequelae following COVID-19: A prospective follow-up cohort study.
Clin Gastroenterol Hepatol. 2022 Oct 20. pii: S1542-3565(22)01004.
Abstract

SANDERS AE, Weatherspoon ED, Ehrmann BM, Soma PS, et al
Circulating polyunsaturated fatty acids and pain intensity in five chronic pain conditions.
J Pain. 2022 Oct 20. pii: S1526-5900(22)00434.
Abstract

ISHIOH M, Nozu T, Miyagishi S, Igarashi S, et al
Activation of basal forebrain cholinergic neurons improves colonic hyperpermeability through the vagus nerve and adenosine A2B receptors in rats.
Biochem Pharmacol. 2022;206:115331.
Abstract

MOAZZAM SW, Mobeen A, Siddiqui MA
Efficacy of Jawarish Shahi a herbal formulation in irritable bowel syndrome: An open-labeled single-arm clinical trial.
J Tradit Complement Med. 2022;12:529-535.
Abstract

DORFMAN L, El-Chammas K, Mansi S, Kaul A, et al
Gastrocolonic Response.
Curr Gastroenterol Rep. 2022 Nov 3. pii: 10.1007/s11894-022-00849.
Abstract

SCHOVSBO SU, Mollehave LT, Petersen MW, Ahrendt Bjerregaard A, et al
Association between infections and functional somatic disorders: a cross-sectional population-based cohort study.
BMJ Open. 2022;12:e066037.
Abstract

JACTEL SN, Olson JM, Wolin KY, Brown J, et al
Efficacy of a Digital Personalized Elimination Diet for the Self-Management of Irritable Bowel Syndrome and Co-Morbid Irritable Bowel Syndrome and Inflammatory Bowel Disease.
Clin Transl Gastroenterol. 2022 Nov 1. pii: 01720094-990000000-00105.
Abstract

WANG T, van Dijk L, Rijnaarts I, Hermes GDA, et al
Methanogen Levels Are Significantly Associated with Fecal Microbiota Composition and Alpha Diversity in Healthy Adults and Irritable Bowel Syndrome Patients.
Microbiol Spectr. 2022 Nov 2:e0165322. doi: 10.1128/spectrum.01653.
Abstract

KARAKAN T, Gundogdu A, Alagozlu H, Ekmen N, et al
Artificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome.
Gut Microbes. 2022;14:2138672.
Abstract

KITSELAAR WM, van der Vaart R, Perschl J, Numans ME, et al
Predictors of Persistent Somatic Symptoms in the General Population: A systematic review of cohort studies.
Psychosom Med. 2022 Oct 17. pii: 00006842-990000000-00071.
Abstract

SALARIEH N, Emami Meibodi A, Alipour S, Azimirad M, et al
Characterization of the mucosal microbiota in patients with nodular lymphoid hyperplasia with concurrent irritable bowel syndrome compared to healthy controls.
Mol Biol Rep. 2022 Oct 31. pii: 10.1007/s11033-022-07974.
Abstract

ALZABIBI MA, Shibani M, Alsuliman T, Ismail H, et al
Fibromyalgia: epidemiology and risk factors, a population-based case-control study in Damascus, Syria.
BMC Rheumatol. 2022;6:62.
Abstract

EETEMADI A, Tagkopoulos I
Algorithmic lifestyle optimization.
J Am Med Inform Assoc. 2022 Oct 29. pii: 6780144. doi: 10.1093.
Abstract

DAS DAD, Ghosh DS, Palanisamy DC, Guha DN, et al
Efficacy of individualized homeopathic medicines in irritable bowel syndrome: A double-blind randomized, placebo-controlled trial.
Explore (NY). 2022 Oct 19. pii: S1550-8307(22)00169.
Abstract

HU Y, Zhu M, Liu Y, Wang Z, et al
Musical Meter Induces Interbrain Synchronization during Interpersonal Coordination.
eNeuro. 2022;9.
Abstract

GEBALLA-KOUKOULA A, Gerssen A, Blokland MH, Nielen MWF, et al
Immunoaffinity Plastic Blade Spray Mass Spectrometry for Rapid Confirmatory Analysis of Food Contaminants.
J Am Soc Mass Spectrom. 2022;33:2038-2045.
Abstract

TRIPATHI G, Park M, Hossain M, Im SB, et al
Fabrication and characterization of cellulose nano crystal and soya modified injectable brushite bone cement for enhanced bone regeneration.
Int J Biol Macromol. 2022;221:1536-1544.
Abstract

ZHANG Y, Zhang J, Duan L
The role of microbiota-mitochondria crosstalk in pathogenesis and therapy of intestinal diseases.
Pharmacol Res. 2022;186:106530.
Abstract

FUJII R, Awaga Y, Nozawa K, Matsushita M, et al
Regional brain activation during rectal distention and attenuation with alosetron in a nonhuman primate model of irritable bowel syndrome.
FASEB Bioadv. 2022;4:694-708.
Abstract

MATSUSHIMA S, Kuromizu J, Miyajima N, Beniya A, et al
Characteristics of Fecal Incontinence in Male Patients in Japan.
J Anus Rectum Colon. 2022;6:274-281.
Abstract

BHATTACHARJEE S, Siyad I, Maramattom BV
Chronic diarrhea - The poetic masquerade.
J Postgrad Med. 2022;68:239-242.
Abstract

MOBASHERI F, Shidfar F, Aminianfar A, Keshteli AH, et al
The association between dietary acid load and odds and severity of irritable bowel syndrome in adults.
Sci Rep. 2022;12:18943.
Abstract

MELCHIOR C, Wilpart K, Midenfjord I, Trindade IA, et al
Relationship Between Abuse History and Gastrointestinal and Extraintestinal Symptom Severity in Irritable Bowel Syndrome.
Psychosom Med. 2022;84:1021-1033.
Abstract

TKACH S, Dorofeyev A, Kuzenko I, Sulaieva O, et al
Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial.
Front Med (Lausanne). 2022;9:994911.
Abstract

GRASA L, Brzozowski T, Seelaender M
Editorial: Emerging talents in Frontiers in pharmacology: Gastrointestinal and hepatic pharmacology 2022.
Front Pharmacol. 2022;13:1055030.
Abstract

CHANG L
Dietary Concerns and Patient-Focused Care in Irritable Bowel Syndrome.
Gastroenterol Hepatol (N Y). 2022;18:351-353.
Abstract

TORRES-MARAVILLA E, Holowacz S, Delannoy J, Lenoir L, et al
Serpin-positive Bifidobacterium breve CNCM I-5644 improves intestinal permeability in two models of irritable bowel syndrome.
Sci Rep. 2022;12:19776.
Abstract

OH JE, Chey WD, Spiegel B
Abdominal Bloating in the US: Results of a Survey of 88,795 Americans Examining Prevalence and Healthcare Seeking.
Clin Gastroenterol Hepatol. 2022 Nov 4. pii: S1542-3565(22)01020.
Abstract

PILIPENKO VI, Isakov VA, Morozov SV, Vlasova AV, et al
[Efficacy of newly developed kombucha-based specialized food product for treatment of constipation-predominant irritable bowel syndrome].
Vopr Pitan. 2022;91:95-104.
Abstract

BOOTZ-MAOZ H, Pearl A, Melzer E, Malnick S, et al
Diet-induced modifications to human microbiome reshape colonic homeostasis in irritable bowel syndrome.
Cell Rep. 2022;41:111657.
Abstract

ALGERA JP, Demir D, Tornblom H, Nybacka S, et al
Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.
Clin Nutr. 2022;41:2792-2800.
Abstract

VAZQUEZ-FRIAS R, Consuelo-Sanchez A, Acosta-Rodriguez-Bueno CP, Blanco-Montero A, et al
Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.
Paediatr Drugs. 2022 Nov 16. pii: 10.1007/s40272-022-00536.
Abstract

NAKAMURA Y, Suzuki S, Murakami S, Nishimoto Y, et al
Integrated gut microbiome and metabolome analyses identified fecal biomarkers for bowel movement regulation by Bifidobacterium longum BB536 supplementation: A RCT.
Comput Struct Biotechnol J. 2022;20:5847-5858.
Abstract

VALENCIA C, Fatima H, Nwankwo I, Anam M, et al
A Correlation Between the Pathogenic Processes of Fibromyalgia and Irritable Bowel Syndrome in the Middle-Aged Population: A Systematic Review.
Cureus. 2022;14:e29923.
Abstract

LI DJ, Chen MH, Bai YM, Tsai SJ, et al
Parental post-traumatic stress disorder and increased risk of chronic pain conditions and major psychiatric disorders in their offspring.
Gen Hosp Psychiatry. 2022;79:152-157.
Abstract

CHAOJU X, Zhangyin S, Changchun JI, Jinsheng Y, et al
Efficacy and safety of blood pricking and cupping for treating nonspecific low back pain: a systematic review and Meta-analysis.
J Tradit Chin Med. 2022;42:869-876.
Abstract

HENNINGSEN P, Hausteiner-Wiehle C, Hauser W
Migraine in the context of chronic primary pain, chronic overlapping pain disorders, and functional somatic disorders: A narrative review.
Headache. 2022 Nov 14. doi: 10.1111/head.14419.
Abstract

SU Q, Liu Q, Lau RI, Zhang J, et al
Faecal microbiome-based machine learning for multi-class disease diagnosis.
Nat Commun. 2022;13:6818.
Abstract

LIN M, Hu G, Yu B
Dysregulated cystathionine-beta-synthase/hydrogen sulfide signaling promotes chronic stress-induced colonic hypermotility in rats.
Neurogastroenterol Motil. 2022 Nov 13:e14488. doi: 10.1111/nmo.14488.
Abstract

NAIK TD, Tubaki BR, Patankar DS
Efficacy of whole system ayurveda protocol in irritable bowel syndrome - A Randomized controlled clinical trial.
J Ayurveda Integr Med. 2022 Nov 9:100592. doi: 10.1016/j.jaim.2022.100592.
Abstract

CAPONIO GR, Celano G, Calabrese FM, Riezzo G, et al
Evaluation of the Effects of the Tritordeum-Based Diet Compared to the Low-FODMAPs Diet on the Fecal Metabolome of IBS-D Patients: A Preliminary Investigation.
Nutrients. 2022;14.
Abstract

WIECEK M, Panufnik P, Kaniewska M, Lewandowski K, et al
Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD.
Nutrients. 2022;14.
Abstract

GASIOROWSKA A, Romanowski M, Walecka-Kapica E, Kaczka A, et al
Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of a Randomized Double-Blind Placebo-Controlled Trial.
J Clin Med. 2022;11.
Abstract

BABOS CI, Leucuta DC, Dumitrascu DL
Meditation and Irritable Bowel Syndrome, a Systematic Review and Meta-Analysis.
J Clin Med. 2022;11.
Abstract

STORR M, Weigmann H, Landes S, Michel MC, et al
Self-Medication for the Treatment of Abdominal Cramps and Pain-A Real-Life Comparison of Three Frequently Used Preparations.
J Clin Med. 2022;11.
Abstract

YANG YY, Jun S
The Effects of Cognitive Behavioral Therapy for Insomnia among College Students with Irritable Bowel Syndrome: A Randomized Controlled Trial.
Int J Environ Res Public Health. 2022;19.
Abstract

VARGA L, Edvine EM, Hudak P, Anton I, et al
Balancing at the Borderline of a Breed: A Case Study of the Hungarian Short-Haired Vizsla Dog Breed, Definition of the Breed Profile Using Simple SNP-Based Methods.
Genes (Basel). 2022;13.
Abstract

GALMICHE M, Godefroy C, Achamrah N, Grigioni S, et al
Mental health and health behaviours among patients with eating disorders: a case-control study in France.
J Eat Disord. 2022;10:160.
Abstract

VAN DER POST LFM, Wierdsma AI, Peen J, van Boeijen CA, et al
[Differences in the prevalence of acute involuntary admissions between Apeldoorn, Rotterdam and Amsterdam].
Tijdschr Psychiatr. 2022;64:580-587.
Abstract

YU J, Guo L, Zhang SH, Zhu QY, et al
Transcriptomic analysis of intermuscular bone development in barbel steed (Hemibarbus labeo).
Comp Biochem Physiol Part D Genomics Proteomics. 2022;44:101030.
Abstract

SONGTANIN B, Peterson CJ, Molehin AJ, Nugent K, et al
Biofilms and Benign Colonic Diseases.
Int J Mol Sci. 2022;23:14259.
Abstract

ESAWY MM, Saleh Al-Sowayan N, Mobasher MA, Abd-Elhameed A, et al
H19 and TUG1 lncRNAs as Novel Biomarkers for Irritable Bowel Syndrome in Diabetic Patients.
Biomedicines. 2022;10:2978.
Abstract

NOBLE H, Hasan SS, Simpson V, Whorwell PJ, et al
Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice.
BMJ Open Gastroenterol. 2022;9:e001039.
Abstract

PESSARELLI T, Sorge A, Elli L, Costantino A, et al
The low-FODMAP diet and the gluten-free diet in the management of functional abdominal bloating and distension.
Front Nutr. 2022;9:1007716.
Abstract

FRIELING T, Gjini B, Melchior I, Euler P, et al
Endoscopic laser endomicroscopy and "leaky gut" in patients with functional gastrointestinal symptoms and food intolerance.
Z Gastroenterol. 2022 Nov 23. doi: 10.1055/a-1959-3200.
Abstract

WANG FY, Kang EY, Liu CH, Ng CY, et al
Diabetic Patients With Rosacea Increase the Risks of Diabetic Macular Edema, Dry Eye Disease, Glaucoma, and Cataract.
Asia Pac J Ophthalmol (Phila). 2022;11:505-513.
Abstract

FRITSCHE LG, Jin W, Admon AJ, Mukherjee B, et al
Characterizing and Predicting Post-Acute Sequelae of SARS CoV-2 infection (PASC) in a Large Academic Medical Center in the US.
medRxiv. 2022 Nov 17:2022.10.21.22281356. doi: 10.1101/2022.10.21.22281356.
Abstract

AZIZ AI, Nguyen LC, Oumeslakht L, Bensussan A, et al
Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
Cannabis Cannabinoid Res. 2022 Nov 22. doi: 10.1089/can.2022.0133.
Abstract

MALIK ZI, Umer MF, Ali KN, Kawish AB, et al
Functional Gastrointestinal Diseases and Dietary Practices among Pakistani Children-A Schools Based Cross-Sectional Study.
Diseases. 2022;10:103.
Abstract

LIU F, Shen Y, Li J, Bi L, et al
Characteristics of ginsenoside Rd-induced effects on rat intestinal contractility with irritable bowel syndrome.
Nat Prod Res. 2022 Nov 22:1-6. doi: 10.1080/14786419.2022.2146686.
Abstract

MAHMOUDI H, Hossainpour H
Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.
Saudi J Gastroenterol. 2022 Nov 14. doi: 10.4103.
Abstract

SINGH N, Singh V, Rai SN, Mishra V, et al
Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes.
Biomed Pharmacother. 2022;156:113958.
Abstract

PINGALI H, Hunter SD
Exploring mechanisms of blood pressure regulation in response to device-guided and non-device-guided slow breathing: A mini review.
Auton Neurosci. 2022;244:103050.
Abstract

HE X, Ji P, Guo R, Ming X, et al
Regulation of the central amygdala on intestinal motility and behavior via the lateral hypothalamus in irritable bowel syndrome model mice.
Neurogastroenterol Motil. 2022 Nov 21:e14498. doi: 10.1111/nmo.14498.
Abstract

LIU J, Lv C, Wang W, Huang Y, et al
Slow, deep breathing intervention improved symptoms and altered rectal sensitivity in patients with constipation-predominant irritable bowel syndrome.
Front Neurosci. 2022;16:1034547.
Abstract

SHIN C, Ali S, Hussain S, Trivedi I, et al
Epidemiology of irritable bowel syndrome in hospitalized patients with inflammatory bowel disease: Nationwide Inpatient Sample analysis from 2007-2016.
Ann Gastroenterol. 2022;35:603-608.
Abstract

ZHOU Y, Yang D, Gu W
Efficacy and Mechanism of Trimebutine Maleate Combined with Lactulose in the Treatment of Constipation-Predominant Irritable Bowel Syndrome in the Elderly.
Emerg Med Int. 2022;2022:6125120.
Abstract

LUO Y, Shah BJ, Keefer LA
Special Considerations for the Management of Disorders of Gut-Brain Interaction in Older Adults.
Curr Treat Options Gastroenterol. 2022.
Abstract

SAMUTHPONGTORN C, Kantagowit P, Pittayanon R, Patcharatrakul T, et al
Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials.
Front Med (Lausanne). 2022;9:1039284.
Abstract

SANEIE S, Aminianfar A, Shidfar F, Keshteli AH, et al
The association between dietary total antioxidant capacity and odds and severity of irritable bowel syndrome among Iranian adults: a cross-sectional study.
BMC Gastroenterol. 2022;22:472.
Abstract

BENDAVID E, Pfaller CK, Pan Y, Samuel CE, et al
Host 5'-3' Exoribonuclease XRN1 Acts as a Proviral Factor for Measles Virus Replication by Downregulating the dsRNA-Activated Kinase PKR.
J Virol. 2022;96:e0131922.
Abstract

BUSCAJONI L, Martinetz MC, Berkemeyer M, Brocard C, et al
Refolding in the modern biopharmaceutical industry.
Biotechnol Adv. 2022;61:108050.
Abstract

KERN D, Ljotsson B, Lonndahl L, Hedman-Lagerlof E, et al
Optimized User Experience, Efficiency, and Resource Use in Online Self-Management of Atopic Dermatitis.
JAMA Dermatol. 2022;158:1325-1327.
Abstract

LIU M, Zhong P
Modulating the Gut Microbiota as a Therapeutic Intervention for Alzheimer's Disease.
Indian J Microbiol. 2022;62:494-504.
Abstract

ZAZA S, Alverdy J
Pitfalls and Traps in the Surgical Evaluation of Patients with Irritable Bowel Syndrome (IBS).
J Gastrointest Surg. 2022 Dec 1. doi: 10.1007/s11605-022-05544.
Abstract

XIA X, Xie Y, Chen Q, Ding D, et al
Cocultivation of Chinese prescription and intestine microbiota: SJZD alleviated the major symptoms of IBS-D subjects by tuning neurotransmitter metabolism.
Front Endocrinol (Lausanne). 2022;13:1053103.
Abstract

CHEN W, Liao L, Huang Z, Lu Y, et al
Patchouli alcohol improved diarrhea-predominant irritable bowel syndrome by regulating excitatory neurotransmission in the myenteric plexus of rats.
Front Pharmacol. 2022;13:943119.
Abstract

DE JESUS CDF, de Assis Carvalho M, Machado NC
Impaired Health-Related Quality of Life in Brazilian Children with Chronic Abdominal Pain: A Cross-Sectional Study.
Pediatr Gastroenterol Hepatol Nutr. 2022;25:500-509.
Abstract

EL GENDY YGA, Abdel Wahed MA, Ragab MHH, Awad YMM, et al
Effects of a Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyol Diet on Symptoms of Functional Abdominal Pain in Pediatric Patients.
Pediatr Gastroenterol Hepatol Nutr. 2022;25:510-518.
Abstract

CHEN Q, Zhang Z, Bei S, Wang X, et al
Efficacy of oral fecal microbiota transplantation in recurrent bowel disease: A protocol for systematic review and meta-analysis.
Medicine (Baltimore). 2022;101:e31477.
Abstract

JAFARZADEH E, Shoeibi S, Bahramvand Y, Nasrollahi E, et al
Turmeric for Treatment of Irritable Bowel Syndrome: A Systematic Review of Population-Based Evidence.
Iran J Public Health. 2022;51:1223-1231.
Abstract

DEICA AV, Paduraru LF, Paduraru DN, Andronic O, et al
The SCN5A gene is a phenotype severity predictor in Brugada syndrome - a comprehensive literature review.
Med Princ Pract. 2022 Nov 29. doi: 10.1159/000528375.
Abstract

WAL A, Wal P, Verma N, Pandey SS, et al
Children And Adolescents With Irritable Bowel Syndrome: Treatment And Management.
Curr Pediatr Rev. 2022 Nov 28. doi: 10.2174/1573396319666221128094843.
Abstract

RAIMONDO D, Raffone A, Renzulli F, Sanna G, et al
Prevalence and Risk Factors of Central Sensitization in Women with Endometriosis.
J Minim Invasive Gynecol. 2022 Oct 29:S1553-4650(22)00963.
Abstract

VERNIA F, Tatti T, Necozione S, Capannolo A, et al
Is mastocytic colitis a specific clinical-pathological entity?
Eur J Histochem. 2022;66.
Abstract

SCHRODER L, Regnath F, Glasauer S, Hackenberg A, et al
Altered sensorimotor processing in irritable bowel syndrome: Evidence for a transdiagnostic pathomechanism in functional somatic disorders.
Front Neurosci. 2022;16:1029126.
Abstract

XU W, Zhang Z, Lu Y, Li M, et al
Traditional Chinese medicine Tongxie Yaofang treating irritable bowel syndrome with diarrhea and type 2 diabetes mellitus in rats with liver-depression and spleen-deficiency: A preliminary study.
Front Nutr. 2022;9:968930.
Abstract

LIU J, Ren H, Yuan F, Shao M, et al
The effects of Saccharomyces boulardii on rat colonic hypermotility induced by repeated water avoidance stress and the potential mechanism.
PeerJ. 2022;10:e14390.
Abstract

CHEN J, Xu XW, Kang JX, Zhao BC, et al
Metasilicate-based alkaline mineral water confers diarrhea resistance in maternally separated piglets via the microbiota-gut interaction.
Pharmacol Res. 2022 Nov 24:106580. doi: 10.1016/j.phrs.2022.106580.
Abstract

GU X, Chen ZH, Zhang SC
Fecal microbiota transplantation in childhood: past, present, and future.
World J Pediatr. 2022 Dec 9. doi: 10.1007/s12519-022-00655.
Abstract

YANG YC, Zhou ZX, Xue T, Feng YH, et al
[Effect of electroacupuncture on visceral sensitivity and colonic NGF, TrkA, TRPV1 expression in IBS-D rats].
Zhongguo Zhen Jiu. 2022;42:1395-402.
Abstract

HANG L, Wang E, Feng Y, Zhou Y, et al
Metagenomics and metabolomics analysis to investigate the effect of Shugan decoction on intestinal microbiota in irritable bowel syndrome rats.
Front Microbiol. 2022;13:1024822.
Abstract

HARAIKAWA M, Shibuya T, Kurosawa T, Ito K, et al
Differential diagnosis of ulcerative colitis with increased diarrhea; collagenous colitis or irritable bowel syndrome? A case report.
J Int Med Res. 2022;50:3000605221140686.
Abstract

LU GY, Xing XY, Wang JY, Wang Y, et al
[Research progress of Shenling Baizhu San and predictive analysis on its quality markers].
Zhongguo Zhong Yao Za Zhi. 2022;47:5171-5181.
Abstract

MAKAROVA AA, Diukova GM, Ruchkina IN, Romashkina NV, et al
[Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome].
Ter Arkh. 2022;94.
Abstract

LIU J, Tang W, Hou L, Wang J, et al
Alteration of gut microbiota in migraine patients with irritable bowel syndrome in a Chinese Han population.
Front Neurol. 2022;13:899056.
Abstract

LIU Y, Chen Z, Lin W, Zhou Y, et al
Role of hippocampal circKcnk9 in visceral hypersensitivity and anxiety comorbidity of irritable bowel syndrome.
Front Cell Neurosci. 2022;16:1010107.
Abstract

GENTILE M, De Luca V, Patalano R, Laudisio D, et al
Innovative approaches to service integration addressing the unmet needs of irritable bowel syndrome patients and new approaches for the needs of IBS patients.
Front Med (Lausanne). 2022;9:998838.
Abstract

JUGANAVAR A, Joshi KS
Chronic Pelvic Pain: A Comprehensive Review.
Cureus. 2022;14:e30691.
Abstract

E S, J T
Post-Covid-19 Gastro-Intestinal Disturbances.
Rev Recent Clin Trials. 2022 Dec 1. doi: 10.2174/1574887118666221201104833.
Abstract

TALOYAN M, Alinaghizadeh H, Wettermark B, Jan Hasselstrom JH, et al
Physical-mental multimorbidity in a large primary health care population in Stockholm County, Sweden.
Asian J Psychiatr. 2022;79:103354.
Abstract

LIN W, Liu Y, Zhou Y, Lin M, et al
Methyltransferase-like 3 modulates visceral hypersensitivity through regulating the nuclear export of circKcnk9 in YTHDC1-dependent manner.
Mol Pain. 2022;18:17448069221144540.
Abstract

WAN C, Kong X, Liao Y, Chen Q, et al
Bibliometric analysis of the 100 most-cited papers about the role of gut microbiota in irritable bowel syndrome from 2000 to 2021.
Clin Exp Med. 2022 Dec 15. doi: 10.1007/s10238-022-00971.
Abstract

LINSALATA M, Prospero L, Riezzo G, Orlando A, et al
Somatization is associated with altered serum levels of vitamin D, serotonin, and brain-derived neurotrophic factor in patients with predominant diarrhea irritable bowel syndrome.
Neurogastroenterol Motil. 2022 Dec 15:e14512. doi: 10.1111/nmo.14512.
Abstract

GROSS M, Beckenbauer UE, Bruder L, Zehrer A, et al
[Diverticular disease: treatment and management by general practitioners in Germany - high importance of probiotics in primary care].
MMW Fortschr Med. 2022;164.
Abstract

MITRA S, Hussain MS, Rahman R, Salam MA, et al
A survey on the incidence of common musculoskeletal side effects among the patients taking long-term anti-ulcerant therapies in Bangladesh.
Toxicol Rep. 2022;9:1796-1805.
Abstract

LI M, Zhu J, Liu X, Dong Z, et al
Chaihu-Guizhi-Ganjiang Decoction is more efficacious in treating irritable bowel syndrome than Dicetel according to metabolomics analysis.
Chin Med. 2022;17:139.
Abstract

BARBARA G, Cremon C, Bellini M, Corsetti M, et al
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO),
Dig Liver Dis. 2022 Dec 11:S1590-8658(22)00814-3. doi: 10.1016/j.dld.2022.
Abstract

LIMBRI LF, Wilson TG, Oliver MR
Prevalence of irritable bowel syndrome and functional abdominal pain disorders in children with inflammatory bowel disease in remission.
JGH Open. 2022;6:818-823.
Abstract

KAMP KJ, Morgan H, Yoo L, Munson SA, et al
Symptom management needs of patients with irritable bowel syndrome and concurrent anxiety and/or depression: A qualitative study.
J Adv Nurs. 2022 Dec 13. doi: 10.1111/jan.15532.
Abstract

YIN X, Li S, Ouyang M, Ou R, et al
Acupoint application therapy for diarrhea-predominant irritable bowel syndrome: a protocol for systematic review and network meta-analysis.
Ann Palliat Med. 2022 Dec 6:apm-22-725. doi: 10.21037.
Abstract

OBERHOFER E
[Not Available].
MMW Fortschr Med. 2022;164.
Abstract

BONETTO S, Boano V, Valenzi E, Saracco GM, et al
Non-pharmacological strategies to treat irritable bowel syndrome: 2022 update.
Minerva Gastroenterol (Torino). 2022;68:475-481.
Abstract

ZHANG L, Yu C, Chen B, Chao Y, et al
Modulation of colonic function in irritable bowel syndrome rats by electroacupuncture at ST25 and the neurobiological links between ST25 and the colon.
Front Neurosci. 2022;16:930489.
Abstract

ZHUANG Z, Huang C, Zhang Y, Lv B, et al
Effects of Massa Medicata Fermentata on the intestinal pathogenic flagella bacteria and visceral hypersensitivity in rats with irritable bowel syndrome.
Front Physiol. 2022;13:1039804.
Abstract

WIEGERS C, Veerman MA, Brummer RJ, Larsen OFA, et al
Reviewing the state of the art of probiotics as clinical modalities for brain-gut-microbiota axis associated disorders.
Front Microbiol. 2022;13:1053958.
Abstract

BOINPALLY R, Weissman D
Single-dose Pharmacokinetics of Eluxadoline in Healthy Participants With Normal Renal Function and Participants With Renal Impairment.
Clin Pharmacol Drug Dev. 2022 Dec 11. doi: 10.1002/cpdd.1204.
Abstract

XIE N, Xie J, Wang Z, Shu Q, et al
The Role of Calcium, 25-Hydroxyvitamin D, and Parathyroid Hormone in Irritable Bowel Syndrome: A Bidirectional Two-Sample Mendelian Randomization Study.
Nutrients. 2022;14:5109.
Abstract

JUNG S, Kim KM, Youn SM, Kim KN, et al
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic in Patients with Functional Diarrhea and High Fecal Calprotectin Levels: A Pilot Study.
Nutrients. 2022;14:5017.
Abstract

CHOJNACKI C, Medrek-Socha M, Blonska A, Zajdel R, et al
A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites.
Int J Mol Sci. 2022;23:15314.
Abstract

FILIPPONE A, Ardizzone A, Bova V, Lanza M, et al
A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome.
J Clin Med. 2022;11:7073.
Abstract

TOMITA T, Fukui H, Morishita D, Mori S, et al
Efficacy of Serotonin Type 3 Receptor Antagonist Ramosetron on Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-Like Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
J Clin Med. 2022;11:6882.
Abstract

GRASA L
Molecular Mechanisms of Chronic Intestinal Diseases in Response to Microbiota.
Cells. 2022;11:3722.
Abstract

ZHAI L, Huang C, Ning Z, Zhang Y, et al
Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis.
Cell Host Microbe. 2022 Nov 29:S1931-3128(22)00562.
Abstract

HODSON DZ, Repetti GG, Hoesterey DT, Jeon Y, et al
A 77-Year-Old Woman With Capillary Hypoxia and Perioral Cyanosis.
Chest. 2022;162:e295-e299.
Abstract

SEQUEIRA C, Santos I, Lopes S, Teixeira C, et al
Isolated jejunal Crohn's disease: a challenging diagnosis.
Rev Esp Enferm Dig. 2022 Dec 23. doi: 10.17235/reed.2022.9423/2022.
Abstract

ZENG XL, Yang XD, Yang XL, Huang S, et al
[Etiology and clinical classification of constipation].
Zhonghua Wei Chang Wai Ke Za Zhi. 2022;25:1120-1125.
Abstract

DE CAMP NV, Bergeler J
Correlations between EEG and intestinal electrical stimulation.
Transl Neurosci. 2022;13:440-452.
Abstract

ALTENBERND F, Schwarz L, Lipowicz B, Vissiennon C, et al
Myrrh and Chamomile Flower Extract Inhibit Mediator Release from IgE-stimulated Mast-Cell-Like RBL-2H3 Cells.
Plants (Basel). 2022;11:3422.
Abstract

ROCZNIAK W, Szymlak A, Mazur B, Chobot A, et al
Nutritional Status and Selected Adipokines in Children with Irritable Bowel Syndrome.
Nutrients. 2022;14:5282.
Abstract

THOMAS-DUPONT P, Velazquez-Soto H, Izaguirre-Hernandez IY, Amieva-Balmori M, et al
Obesity Contributes to Inflammation in Patients with IBS via Complement Component 3 and C-Reactive Protein.
Nutrients. 2022;14:5227.
Abstract

SANZ MORALES P, Wijeyesekera A, Robertson MD, Jackson PPJ, et al
The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome.
Microorganisms. 2022;10:2338.
Abstract

ABUSAGEAH F, Hakami A, Zogel B, Zaalah S, et al
A Cross-Sectional Study about Knowledge, Attitude, and Practices among Primary Health Care Physicians in Jazan Province, Saudi Arabia, Regarding Rome IV Criteria for Diagnosis of Irritable Bowel Syndrome.
Medicina (Kaunas). 2022;58:1811.
Abstract

AIT ABDELLAH S, Scanzi J, Gal C, Martin M, et al
Lactobacillus gasseri LA806 Supplementation in Patients with Irritable Bowel Syndrome: A Multicenter Study.
J Clin Med. 2022;11:7446.
Abstract

ADEWUYI EO, O'Brien EK, Porter T, Laws SM, et al
Relationship of Cognition and Alzheimer's Disease with Gastrointestinal Tract Disorders: A Large-Scale Genetic Overlap and Mendelian Randomisation Analysis.
Int J Mol Sci. 2022;23:16199.
Abstract

BANDLA A, Melancon E, Taylor CR, Davidson AE, et al
A New Transgenic Tool to Study the Ret Signaling Pathway in the Enteric Nervous System.
Int J Mol Sci. 2022;23:15667.
Abstract

HOLST LM, Iribarren C, Sapnara M, Savolainen O, et al
Fecal Luminal Factors from Patients with Gastrointestinal Diseases Alter Gene Expression Profiles in Caco-2 Cells and Colonoids.
Int J Mol Sci. 2022;23:15505.
Abstract

LU KT, Ho YC, Chang CL, Lan KC, et al
Evaluation of Bodily Pain Associated with Polycystic Ovary Syndrome: A Review of Health-Related Quality of Life and Potential Risk Factors.
Biomedicines. 2022;10:3197.
Abstract

WENG RX, Wei YX, Li YC, Xu X, et al
Folic acid attenuates chronic visceral pain by reducing Clostridiales abundance and hydrogen sulfide production.
Mol Pain. 2022 Dec 22:17448069221149834. doi: 10.1177/17448069221149834.
Abstract

ALHARBI MH, Alhazmi AH, Ujaimi MH, Alsarei M, et al
The Prevalence of Irritable Bowel Syndrome and Its Relation to Psychiatric Disorders Among Citizens of Makkah Region, Saudi Arabia.
Cureus. 2022;14:e32705.
Abstract

SARNOFF RP, Bhatt RR, Osadchiy V, Dong T, et al
A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits.
Neuropharmacology. 2022 Dec 17:109381. doi: 10.1016/j.neuropharm.2022.109381.
Abstract

MANSUETO P, Seidita A, Soresi M, Giuliano A, et al
Anemia in non-celiac wheat sensitivity: Prevalence and associated clinical and laboratory features.
Dig Liver Dis. 2022 Dec 17:S1590-8658(22)00820-9. doi: 10.1016/j.dld.2022.
Abstract

SCIBERRAS N, Pisani A, Vella V, Zahra Bianco E, et al
An Updated Comparative Study on the Impact of COVID-19 Infection and Vaccination in Patients with Inflammatory Bowel Disease and Irritable Bowel Syndrome.
J Gastrointestin Liver Dis. 2022;31:424-428.
Abstract

KRIDIN K, Ludwig RJ
Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome- A large-scale global study.
J Am Acad Dermatol. 2022 Dec 15:S0190-9622(22)03304.
Abstract

YUAN H, Ahmed WL, Liu M, Tu S, et al
Contribution of pain to subsequent cognitive decline or dementia: A systematic review and meta-analysis of cohort studies.
Int J Nurs Stud. 2022;138:104409.
Abstract

BUTT I, Kasmin F, Pouri S, Torkashvand F, et al
Quality by Design in Downstream Process Development of Romiplostim.
Iran Biomed J. 2022;26:416-27.
Abstract

HASLBERGER M, Schorr SG, Strech D, Haven T, et al
Preclinical efficacy in investigator's brochures: Stakeholders' views on measures to improve completeness and robustness.
Br J Clin Pharmacol. 2023;89:340-350.
Abstract

FOX M
Editorial: meal-induced symptoms in irritable bowel syndrome-"all in the mind"?
Aliment Pharmacol Ther. 2022;55:880-881.
Abstract

QUIGLEY EMM
Editorial: risky business. What do sufferers' perceptions of risk from interventions for irritable bowel syndrome really mean?
Aliment Pharmacol Ther. 2022;55:1218-1219.
Abstract

LOVDAHL J, Tornblom H, Ringstrom G, Palsson OS, et al
Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome.
Aliment Pharmacol Ther. 2022 May 3. doi: 10.1111/apt.16934.
Abstract

GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom.
Aliment Pharmacol Ther. 2022 May 1. doi: 10.1111/apt.16939.
Abstract

GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition. Authors' reply.
Aliment Pharmacol Ther. 2022;55:1590-1591.
Abstract

BERINSTEIN JA, Fendrick AM
Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition.
Aliment Pharmacol Ther. 2022;55:1588-1589.
Abstract

COFFIN PB, Duboc H
Diagnostic and therapeutic approach to persistent abdominal pain beyond irritable bowel syndrome.
Aliment Pharmacol Ther. 2022 Jun 2. doi: 10.1111/apt.17064.
Abstract

LOVDAHL J, Tornblom H, Ringstrom G, Palsson OS, et al
Editorial: group-based hypnotherapy as good as individually delivered hypnotherapy for symptoms of irritable bowel syndrome-authors' reply.
Aliment Pharmacol Ther. 2022;56:160-161.
Abstract

MIKOCKA-WALUS A, Lores T
Editorial: group-based hypnotherapy as good as individually delivered hypnotherapy for symptoms of irritable bowel syndrome.
Aliment Pharmacol Ther. 2022;56:158-159.
Abstract

BIESIEKIERSKI JR, Wu J, Van Oudenhove L
Letter: gut-brain axis dysfunction underlies symptom generation in irritable bowel syndrome-a plea for rational interpretation of irrational doses of FODMAPs. Authors' reply.
Aliment Pharmacol Ther. 2022;56:368-369.
Abstract

HALMOS EP, Gibson PR
Letter: gut-brain axis dysfunction underlies symptom generation in irritable bowel syndrome-a plea for rational interpretation of irrational doses of FODMAPs.
Aliment Pharmacol Ther. 2022;56:366-367.
Abstract

GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
Impact of Rome IV Irritable Bowel Syndrome on Work and Activities of Daily Living.
Aliment Pharmacol Ther. 2022 Jul 6. doi: 10.1111/apt.17132.
Abstract

BIESIEKIERSKI JR, Manning LP, Murray HB, Vlaeyen JWS, et al
Review article: Exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome.
Aliment Pharmacol Ther. 2022 Jul 1. doi: 10.1111/apt.17111.
Abstract

INGROSSO MR, Ianiro G, Nee J, Lembo AJ, et al
Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.
Aliment Pharmacol Ther. 2022 Aug 9. doi: 10.1111/apt.17179.
Abstract

CASTRO TEJERA V, Ohman L, Aabakken L, Fellstrom B, et al
Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-Effects on gastrointestinal symptoms and rectal biomarkers of immune activity.
Aliment Pharmacol Ther. 2022 Aug 8. doi: 10.1111/apt.17182.
Abstract

GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply.
Aliment Pharmacol Ther. 2022;56:894-895.
Abstract

SHAH ED, Wechsler EV
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome.
Aliment Pharmacol Ther. 2022;56:892-893.
Abstract

FAIRBRASS KM, Hamlin PJ, Gracie DJ, Ford AC, et al
Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 6 years of longitudinal follow-up.
Aliment Pharmacol Ther. 2022 Aug 22. doi: 10.1111/apt.17193.
Abstract

GU Y, Xiang Y
Letter: efficacy of peppermint oil in irritable bowel syndrome.
Aliment Pharmacol Ther. 2022;56:1215-1216.
Abstract

INGROSSO MR, Ianiro G, Nee J, Lembo AJ, et al
Letter: efficacy of peppermint oil in irritable bowel syndrome-authors' reply.
Aliment Pharmacol Ther. 2022;56:1217-1218.
Abstract

ALGERA JP, Magnusson MK, Ohman L, Storsrud S, et al
Randomised controlled trial: effects of gluten-free diet on symptoms and the gut microenvironment in irritable bowel syndrome.
Aliment Pharmacol Ther. 2022 Sep 29. doi: 10.1111/apt.17239.
Abstract

SHIN A
Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease.
Aliment Pharmacol Ther. 2022;56:1300-1301.
Abstract

FAIRBRASS KM, Hamlin PJ, Gracie DJ, Ford AC, et al
Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease-authors' reply.
Aliment Pharmacol Ther. 2022;56:1302-1303.
Abstract

QUIGLEY EMM
Editorial: 5-aminosalicylic acid fails to impact on irritable bowel syndrome-wrong population, intervention, target or hypothesis?
Aliment Pharmacol Ther. 2022;56:1497-1498.
Abstract

LEMBO A, Kuo B, Boinpally R, Li E, et al
Randomised clinical trial: effects of MD-7246 on irritable bowel syndrome with diarrhoea.
Aliment Pharmacol Ther. 2022 Nov 2. doi: 10.1111/apt.17274.
Abstract

QUIGLEY EMM, Markinson L, Stevenson A, Treasure FP, et al
Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome.
Aliment Pharmacol Ther. 2022 Nov 11. doi: 10.1111/apt.17310.
Abstract

FITZPATRICK JA, Halmos EP
Editorial: gluten-free but not pain-free in IBS.
Aliment Pharmacol Ther. 2022;56.
Abstract

ALGERA JP, Magnusson MK, Ohman L, Storsrud S, et al
Editorial: gluten-free but not pain-free in IBS-authors' reply.
Aliment Pharmacol Ther. 2022;56.
Abstract

GOODOORY VC, Guthrie EA, Ng CE, Black CJ, et al
Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome.
Aliment Pharmacol Ther. 2022 Dec 21. doi: 10.1111/apt.17356.
Abstract

CURTIS S, Curtis M
Tenapanor (Ibsrela) for the Treatment of Irritable Bowel Syndrome With Constipation.
Am Fam Physician. 2022;105:656-658.
Abstract

EBELL MH
British Society of Gastroenterology Guidelines for the Management of Irritable Bowel Syndrome.
Am Fam Physician. 2022;105:Online.
Abstract

PIMENTEL M, Mathur R, Wang J, Chang C, et al
A Smartphone Application Using Artificial Intelligence Is Superior to Subject Self-Reporting When Assessing Stool Form.
Am J Gastroenterol. 2022 Mar 14. pii: 00000434-990000000-00275.
Abstract

BRENNER DM, Harris LA, Chang CH, Waldman SA, et al
Real-World Treatment Strategies to Improve Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
Am J Gastroenterol. 2022;117.
Abstract

KASSEBAUM-LADEWSKI A, Poppers DM, Brenner DM
Effective Communication Strategies and Tools for Improving Treatment Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
Am J Gastroenterol. 2022;117.
Abstract

SAYUK GS, Waldman SA, Brenner DM
Mechanisms of Action of Current Pharmacologic Options for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
Am J Gastroenterol. 2022;117.
Abstract

HARRIS LA, Chang CH
Burden of Constipation: Looking Beyond Bowel Movements.
Am J Gastroenterol. 2022;117.
Abstract

BRENNER DM
Best Practices for the Management of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation: A Roundtable Discussion and Review.
Am J Gastroenterol. 2022;117.
Abstract

ZHANG X, Xiao X, Yang JL
Shall we reduce endoscopy in patients with irritable bowel syndrome?
Am J Gastroenterol. 2022 Apr 15. pii: 00000434-990000000-00342.
Abstract

SINGH P, Tuck C, Gibson PR, Chey WD, et al
The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation.
Am J Gastroenterol. 2022 Apr 8. pii: 00000434-990000000-00347.
Abstract

TAKAKURA W, Pimentel M, Rao S, Villanueva-Millan MJ, et al
A Single Fasting Exhaled Methane Level Correlates With Fecal Methanogen Load, Clinical Symptoms and Accurately Detects Intestinal Methanogen Overgrowth.
Am J Gastroenterol. 2022;117:470-477.
Abstract

VAN DEN HOUTE K, Bercik P, Simren M, Tack J, et al
Mechanisms underlying food-triggered symptoms in disorders of gut-brain interactions.
Am J Gastroenterol. 2022 May 4. pii: 00000434-990000000-00357.
Abstract

DULANEY DT
Continuing Medical Education Questions: May 2022.
Am J Gastroenterol. 2022;117:720.
Abstract

LACY BE, Cangemi DJ
A Pragmatic Approach to the Evaluation and Treatment of Abdominal Bloating.
Am J Gastroenterol. 2022;117:701-705.
Abstract

TACK J, Tornblom H, Tan V, Carbone F, et al
Evidence-Based and Emerging Dietary Approaches to Upper Disorders of Gut-Brain Interaction.
Am J Gastroenterol. 2022;117:965-972.
Abstract

VOLLEBREGT PF, Wiklendt L, Burgell RE, Chaichanavichkij P, et al
Abnormal Perception of Urge to Defecate: An Important Pathophysiological Mechanism in Women With Chronic Constipation.
Am J Gastroenterol. 2022;117:1125-1136.
Abstract

HUANG Z, Lin Z, Lin C, Chu H, et al
Transcutaneous Electrical Acustimulation Improves Irritable Bowel Syndrome with Constipation by Accelerating Colon Transit and Reducing Rectal Sensation via Autonomic Mechanisms.
Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00418.
Abstract

NORDIN E, Hellstrom PM, Brunius C, Landberg R, et al
Modest conformity between self-reporting of Bristol stool form and fecal consistency measured by stool water content in irritable bowel syndrome, a FODMAP and gluten trial.
Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00449.
Abstract

VILLANUEVA-MILLAN MJ, Leite G, Wang J, Morales W, et al
Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes.
Am J Gastroenterol. 2022 Sep 6. pii: 00000434-990000000-00500.
Abstract

BRENNER DM, Lacy BE, Ford AC, Bartolini W, et al
Linaclotide Reduced Response Time for Irritable Bowel Syndrome with Constipation Symptoms: Analysis of Four Randomized Controlled Trials.
Am J Gastroenterol. 2022 Oct 12. pii: 00000434-990000000-00551.
Abstract

D'SILVA A, Marshall DA, Vallance JK, Nasser Y, et al
Meditation and Yoga for Irritable Bowel Syndrome: A Randomized Clinical Trial.
Am J Gastroenterol. 2022 Nov 25. doi: 10.14309/ajg.0000000000002052.
Abstract

SPIEGEL B
Gravity and the Gut: A Hypothesis of Irritable Bowel Syndrome.
Am J Gastroenterol. 2022;117:1933-1947.
Abstract

GEARRY R, Fukudo S, Barbara G, Kuhn-Sherlock B, et al
Consumption of two green kiwifruit daily improves constipation and abdominal comfort - results of an international multicentre randomised controlled trial.
Am J Gastroenterol. 2022 Dec 20. doi: 10.14309/ajg.0000000000002124.
Abstract

OLIVER D, Talley NJ
In drug-refractory IBS, group CBT with interoceptive exposure improved symptoms and QoL at 13 wk.
Ann Intern Med. 2022 Aug 2. doi: 10.7326/J22-0054.
Abstract

COX JF 3RD
In IBS, a smartphone application for self-managing a FODMAP-lowering diet vs. otilonium bromide reduced symptoms at 8 wk.
Ann Intern Med. 2022;175:JC91.
Abstract

CALVET X
Recommendations for pharmacologic management of IBS with constipation.
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0086.
Abstract

CALVET X
Recommendations for pharmacologic management of IBS with diarrhea.
Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0087.
Abstract

RADZIWON CD, Quigley BM, Vargovich AM, Krasner SS, et al
Do I really have to do my homework? The role of homework compliance in cognitive behavioral therapy for irritable bowel syndrome.
Behav Res Ther. 2022;152:104063.
Abstract

LACKNER JM, Gudleski GD, Radziwon CD, Krasner SS, et al
Cognitive flexibility improves in cognitive behavioral therapy for irritable bowel syndrome but not nonspecific education/support.
Behav Res Ther. 2022;154:104033.
Abstract

JAMES K, Patel M, Goldsmith K, Moss-Morris R, et al
Transdiagnostic therapy for persistent physical symptoms: A mediation analysis of the PRINCE secondary trial.
Behav Res Ther. 2022;159:104224.
Abstract

LUKIC S, Mijac D, Filipovic B, Sokic-Milutinovic A, et al
Chronic Abdominal Pain: Gastroenterologist Approach.
Dig Dis. 2022;40:181-186.
Abstract

HUNGIN AP
Chronic Constipation in Adults: The Primary Care Approach.
Dig Dis. 2022;40:142-146.
Abstract

NAKOV R, Velikova T, Dimitrova-Yurukova D, Snegarova V, et al
Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Bulgaria: an internet-based survey.
Dig Dis. 2022 Aug 16. pii: 000526355. doi: 10.1159/000526355.
Abstract

AIT ABDELLAH S, Gal C, Laterza L, Velenza V, et al
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study.
Dig Dis. 2022 Aug 25. pii: 000526712. doi: 10.1159/000526712.
Abstract

MADISCH A, Frieling T, Zimmermann A, Hollenz M, et al
Menthacarin, a proprietary peppermint oil and caraway oil combination, improves multiple complaints in patients with functional gastrointestinal disorders - a systematic review and meta-analysis.
Dig Dis. 2022 Dec 9. doi: 10.1159/000528553.
Abstract

BRAY NA, Koloski NA, Jones MP, Do A, et al
Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study.
Dig Dis Sci. 2022 Apr 1. pii: 10.1007/s10620-022-07464.
Abstract

GANJI L, Shirazi MH, Ebrahimi-Daryani N, Eslami P, et al
Carriage of CdtB Encoding Campylobacter spp., Salmonella enterica, and Yersinia entercolitica in Patients with Gastroenteritis and Irritable Bowel Syndrome.
Dig Dis Sci. 2022 Mar 31. pii: 10.1007/s10620-022-07468.
Abstract

BRAVO-VAZQUEZ LA, Medina-Rios I, Marquez-Gallardo LD, Reyes-Munoz J, et al
Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review.
Dig Dis Sci. 2022 May 4. pii: 10.1007/s10620-022-07516.
Abstract

YAO C, Li Y, Luo L, Xie F, et al
Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China.
Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07500.
Abstract

WANG T, Rijnaarts I, Hermes GDA, de Roos NM, et al
Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome.
Dig Dis Sci. 2022 May 27. pii: 10.1007/s10620-022-07543.
Abstract

OLMOS JI, Piskorz MM, Litwin N, Schaab S, et al
Exocrine Pancreatic Insufficiency is Undiagnosed in Some Patients with Diarrhea-Predominant Irritable Bowel Syndrome Using the Rome IV Criteria.
Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07568.
Abstract

LEE AA, McNabb-Baltar J
Undiagnosed Exocrine Pancreatic Insufficiency in Diarrhea-Predominant Irritable Bowel Syndrome.
Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07574.
Abstract

SHAH ED
Delta Variant: Expanding the Indication for Eluxadoline to Bile Acid Diarrhea.
Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-022-07386.
Abstract

HOU Y, Dong L, Lu X, Shi H, et al
Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome.
Dig Dis Sci. 2022 Jul 25. pii: 10.1007/s10620-022-07588.
Abstract

OH CJ, Rezaie A
Small Is Big: Why the Analysis of the Fecal Microbiome Provides Little Important Information on IBS Severity.
Dig Dis Sci. 2022;67:4974-4975.
Abstract

PIOVEZANI RAMOS G, Camilleri M
Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea.
Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07700.
Abstract

HASSANIN TM, Fouad Y, Mohamed FE, Abdel-Hafeez EH, et al
Colonic mucosal eosinophilia and immunohistochemical expression of COX-2 and NF-kB in patients with irritable bowel syndrome.
Eur J Gastroenterol Hepatol. 2022 Mar 10. pii: 00042737-900000000-97082.
Abstract

HURYCH J, Vodolanova L, Vejmelka J, Drevinek P, et al
Freezing of faeces dramatically decreases the viability of Blastocystis sp. and Dientamoeba fragilis.
Eur J Gastroenterol Hepatol. 2022;34:242-243.
Abstract

CHENG F, Fan Z, Lin C, Zhu Y, et al
Effect of altered gut microbiota on visceral hypersensitivity of postinfectious irritable bowel syndrome mice.
Eur J Gastroenterol Hepatol. 2022 Sep 12. pii: 00042737-990000000-00069.
Abstract

SIYAL M, Abbas Z, Ashraf J, Ali Qadeer M, et al
Incidence and predisposing factors for de novo post-COVID-19 irritable bowel syndrome.
Eur J Gastroenterol Hepatol. 2023;35:59-63.
Abstract

JAGIELSKI CH, Harer KN
Working with Trauma in the Gastroenterology Setting.
Gastroenterol Clin North Am. 2022;51:867-883.
Abstract

SALWEN-DEREMER JK, Sun M
Management of Sleep and Fatigue in Gastrointestinal Patients.
Gastroenterol Clin North Am. 2022;51:829-847.
Abstract

BEDELL A, Friedlander A
Management of Sexual Dysfunction in Gastrointestinal Disorders.
Gastroenterol Clin North Am. 2022;51:815-828.
Abstract

BURTON MURRAY H, Ljotsson B
Future of Brain-Gut Behavior Therapies: Mediators and Moderators.
Gastroenterol Clin North Am. 2022;51:723-739.
Abstract

KINSINGER SW
Practical Approaches to Working with a Gastrointestinal Psychologist.
Gastroenterol Clin North Am. 2022;51:711-721.
Abstract

CHEN LJ, Kamp K, Fang A, Heitkemper MM, et al
Delivery Methods of Cognitive Behavior Therapy for Patients With Irritable Bowel Syndrome.
Gastroenterol Nurs. 2022 May 6. pii: 00001610-990000000-00002.
Abstract

CHEY WD, Hashash JG, Manning L, Chang L, et al
AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review.
Gastroenterology. 2022 Mar 22. pii: S0016-5085(21)04084.
Abstract

BUSHYHEAD D, Quigley EMM
Small Intestinal Bacterial Overgrowth, Pathophysiology and its implications for Definition and Management.
Gastroenterology. 2022 Apr 7. pii: S0016-5085(22)00357.
Abstract

AHUJA A
Minority Patients With Irritable Bowel Syndrome Receive More Gastroenterology-Related Procedures Than White Counterparts: Nuances in Disparities Research.
Gastroenterology. 2022;162:1354-1355.
Abstract

LEMBO A, Sultan S, Chang L, Heidelbaugh JJ, et al
AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea.
Gastroenterology. 2022;163:137-151.
Abstract

CHANG L, Sultan S, Lembo A, Verne GN, et al
AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.
Gastroenterology. 2022;163:118-136.
Abstract

ZIA JK, Lenhart A, Yang PL, Heitkemper MM, et al
Risk Factors for Abdominal Pain Disorders of Gut Brain Interaction in Adults and Children: A Systematic Review.
Gastroenterology. 2022 Jun 15. pii: S0016-5085(22)00646.
Abstract

EL-SALHY M, Winkel R, Casen C, Hausken T, et al
Efficacy of fecal microbiota transplantation for patients with irritable bowel syndrome at three years after transplantation.
Gastroenterology. 2022 Jun 13. pii: S0016-5085(22)00625.
Abstract

GRABAUSKAS G, Gao J, Wu X, Zhou SY, et al
Gut Microbiota Alter Visceral Pain Sensation and Inflammation via Modulation of Synthesis of Resolvin D1 in Colonic Tuft Cells.
Gastroenterology. 2022 Aug 4. pii: S0016-5085(22)00829.
Abstract

KESZTHELYI D
Histamine-producing bacteria: the missing link in irritable bowel syndrome?
Gastroenterology. 2022 Sep 8. pii: S0016-5085(22)01038.
Abstract

CAMILLERI M, Dilmaghani S
Treatment of Irritable Bowel Syndrome Using Fecal Microbiota Transplantation: A Step Forward?
Gastroenterology. 2022;163:815-817.
Abstract

CARBONE F, Van den Houte K, Besard L, Tack C, et al
Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute.
Gut. 2022 Apr 28. pii: gutjnl-2021-325821. doi: 10.1136/gutjnl-2021-325821.
Abstract

CAMILLERI M, Carlson P, BouSaba J, McKinzie S, et al
Comparison of biochemical, microbial and mucosal mRNA expression in bile acid diarrhoea and irritable bowel syndrome with diarrhoea.
Gut. 2022 May 17. pii: gutjnl-2022-327471. doi: 10.1136/gutjnl-2022-327471.
Abstract

REJ A, Sanders DS, Aziz I
Further research needed to determine first-line therapy for IBS in primary care.
Gut. 2022 Jun 22. pii: gutjnl-2022-328047. doi: 10.1136/gutjnl-2022-328047.
Abstract

HOWELL CA, Kemppinen A, Allgar V, Dodd M, et al
Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D).
Gut. 2022 Jun 27. pii: gutjnl-2022-327293. doi: 10.1136/gutjnl-2022-327293.
Abstract

CAMILLERI M
Fifty-point IBS-SSS responders but persistence of moderate severity IBS in over 40% of those on diet.
Gut. 2022 Jul 26. pii: gutjnl-2022-328211. doi: 10.1136/gutjnl-2022-328211.
Abstract

BALSIGER LM, Van den Houte K, Zheng T, Toth J, et al
Genetic analyses of treatment response in primary care IBS, a pilot study.
Gut. 2022 Sep 23. pii: gutjnl-2022-328430. doi: 10.1136/gutjnl-2022-328430.
Abstract

JALANKA J, Gunn D, Singh G, Krishnasamy S, et al
Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery.
Gut. 2022 Sep 28. pii: gutjnl-2021-326828. doi: 10.1136/gutjnl-2021-326828.
Abstract

TACK J, Van den Houte K, Carbone F
Role of the DOMINO diet application for managing IBS in primary care and beyond.
Gut. 2022 Oct 13. pii: gutjnl-2022-328315. doi: 10.1136/gutjnl-2022-328315.
Abstract

PETITFILS C, Maurel S, Payros G, Hueber A, et al
Identification of bacterial lipopeptides as key players in IBS.
Gut. 2022 Oct 14. pii: gutjnl-2022-328084. doi: 10.1136/gutjnl-2022-328084.
Abstract

CAMILLERI M, Boeckxstaens G
Irritable bowel syndrome: treatment based on pathophysiology and biomarkers.
Gut. 2022 Oct 28. pii: gutjnl-2022-328515. doi: 10.1136/gutjnl-2022-328515.
Abstract

GORKA AM, Nauta F, Bijlsma MW, Taselaar P, et al
Current treatment practice of functional abdominal pain disorders in children: A multicenter survey.
Indian J Gastroenterol. 2022 Sep 3. pii: 10.1007/s12664-022-01253.
Abstract

GHOSHAL UC, Sachdeva S, Ghoshal U, Misra A, et al
Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association.
Indian J Gastroenterol. 2022 Oct 10. pii: 10.1007/s12664-022-01292.
Abstract

YAMAMOTO Y, Furukawa S, Watanabe J, Kato A, et al
Association between body mass index and irritable bowel syndrome in the young Japanese population: a cross-sectional study.
Int J Colorectal Dis. 2022 Oct 20. pii: 10.1007/s00384-022-04267.
Abstract

WANG Y, Chen N, Niu F, Li Y, et al
Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs.
Int J Colorectal Dis. 2022 Oct 17. pii: 10.1007/s00384-022-04261.
Abstract

GIULIO M, Gaia S, Andrea C, Giacomo C, et al
Recurrent diverticulitis after elective surgery.
Int J Colorectal Dis. 2022;37:2149-2155.
Abstract

FRANCO L, Jones-Pauley M, Tamimi O, Neshatian L, et al
Irritable Bowel Syndrome Symptoms in Nonalcoholic Fatty Liver Disease Patients Are an Indicator of Depression and Anxiety.
J Clin Gastroenterol. 2022 Oct 10. pii: 00004836-990000000-00068.
Abstract

ASHRAF MU, Akhouri D, Bhardwaj D, Siddiqui B, et al
A Study to Evaluate the Effectiveness of "Mindfulness-Based Stress Reduction Therapy(MBSRT)" in Reducing Symptom Severity and Improving Quality of Life in Patients Suffering From Irritable Bowel Syndrome.
J Clin Gastroenterol. 2022 Nov 15. pii: 00004836-990000000-00097.
Abstract

TANAKA Y, Yamashita R, Kawashima J, Mori H, et al
Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation.
J Gastroenterol. 2022 Jul 30. pii: 10.1007/s00535-022-01888.
Abstract

ROTH B, Larsson E, Ohlsson B
Poor intake of vitamins and minerals among patients with irritable bowel syndrome is associated with symptoms.
J Gastroenterol Hepatol. 2022 Mar 18. doi: 10.1111/jgh.15830.
Abstract

CHONG RIH, Yaow CYL, Loh CYL, Teoh SE, et al
Vitamin D Supplementation for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
J Gastroenterol Hepatol. 2022 Apr 8. doi: 10.1111/jgh.15852.
Abstract

FAN K, Eslick GD, Nair PM, Burns GL, et al
HUMAN INTESTINAL SPIROCHETOSIS, IRRITABLE BOWEL SYNDROME AND COLONIC POLYPS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
J Gastroenterol Hepatol. 2022 Apr 6. doi: 10.1111/jgh.15851.
Abstract

ABUELAZM M, Abdelazeem B
Vitamin D Supplementation for Irritable Bowel Syndrome: Concerns About the Meta-Analysis.
J Gastroenterol Hepatol. 2022 May 5. doi: 10.1111/jgh.15883.
Abstract

UNO Y
Paradigm shift in FODMAP theory.
J Gastroenterol Hepatol. 2022;37:954.
Abstract

BEK S, Teo YN, Tan XH, Fan KH, et al
Association between Irritable Bowel Syndrome and Micronutrients: A Systematic Review.
J Gastroenterol Hepatol. 2022 May 17. doi: 10.1111/jgh.15891.
Abstract

ZHANG Y, Fu F, Zhang L, Zhang W, et al
Telomere is Shortened in Patients with Irritable Bowel Syndrome in the Chinese Population.
J Gastroenterol Hepatol. 2022 Jun 15. doi: 10.1111/jgh.15912.
Abstract

LI X, Ren K, Hong X, Guo S, et al
Ameliorating Effects of Electroacupuncture on the Low-grade Intestinal Inflammation in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome.
J Gastroenterol Hepatol. 2022 Aug 12. doi: 10.1111/jgh.15981.
Abstract

GWEE KA, Lee YY, Suzuki H, Ghoshal UC, et al
Asia-Pacific Guidelines for Managing Functional Dyspepsia Overlapping with Other Gastrointestinal Symptoms.
J Gastroenterol Hepatol. 2022 Nov 1. doi: 10.1111/jgh.16046.
Abstract

YANPING W, Gao X, Cheng Y, Liu M, et al
The Interaction between Obesity and Visceral Hypersensitivity.
J Gastroenterol Hepatol. 2022 Dec 7. doi: 10.1111/jgh.16083.
Abstract

STRISCIUGLIO C, Cenni S, Serra MR, Dolce P, et al
Functional Gastrointestinal Disorders in Mediterranean Countries According to Rome IV Criteria.
J Pediatr Gastroenterol Nutr. 2022;74:361-367.
Abstract

KAMPHORST K, Vlieger AM, Oosterloo BC, Garssen J, et al
Neonatal Antibiotics and Food Allergy are Associated with FGIDs at 4-6 years of age.
J Pediatr Gastroenterol Nutr. 2022 Feb 24. pii: 00005176-900000000-95409.
Abstract

THOMASSEN RA, Luque V, Assa A, Borrelli O, et al
An ESPGHAN Position Paper on the Use of Low-FODMAP Diet in Pediatric Gastroenterology.
J Pediatr Gastroenterol Nutr. 2022 Jun 16. pii: 00005176-990000000-00092.
Abstract

REXWINKEL R, Bovendeert JFM, Rutten JMTM, Frankenhuis C, et al
Long-Term Follow-up of Individual Therapist Delivered and Standardized Hypnotherapy Recordings in Pediatric Irritable Bowel Syndrome or Functional Abdominal Pain.
J Pediatr Gastroenterol Nutr. 2022;75:24-29.
Abstract

RIZVI SA, Oriala C, Thomas J, Li S, et al
Identifying Mast Cells in Gastrointestinal Biopsies in Pediatric Irritable Bowel Patients.
J Pediatr Gastroenterol Nutr. 2022 Aug 17. pii: 00005176-990000000-00147.
Abstract

MENON J, Thapa BR, Kumari R, Kadyada SP, et al
EFFICACY OF ORAL PSYLLIUM IN PEDIATRIC IRRITABLE BOWEL SYNDROME : A DOUBLE BLIND RANDOMISED CONTROL TRIAL.
J Pediatr Gastroenterol Nutr. 2022 Sep 22. pii: 00005176-990000000-00183.
Abstract

TRINDADE IA, Melchior C, Tornblom H, Simren M, et al
Quality of life in irritable bowel syndrome: Exploring mediating factors through structural equation modelling.
J Psychosom Res. 2022;159:110809.
Abstract

MAROTI D, Lumley MA, Schubiner H, Lilliengren P, et al
Internet-based emotional awareness and expression therapy for somatic symptom disorder: A randomized controlled trial.
J Psychosom Res. 2022;163:111068.
Abstract

SLOMSKI A
Durable IBS Response From Fecal Microbiota Transplant.
JAMA. 2022;328:322.
Abstract

TOUNY AA, Kenny E, Mansson M, Webb DL, et al
Pain relief and pain intensity response to GLP-1 receptor agonist ROSE-010 in irritable bowel syndrome; clinical study cross-analysis with respect to patient characteristics.
Scand J Gastroenterol. 2022 Mar 2:1-9. doi: 10.1080/00365521.2022.2041084.
Abstract

WALLEN H, Ljotsson B, Svanborg C, Rydh S, et al
Exposure based cognitive behavioral group therapy for IBS at a gastroenterological clinic - a clinical effectiveness study.
Scand J Gastroenterol. 2022 Mar 9:1-8. doi: 10.1080/00365521.2022.2047220.
Abstract

EL-SALHY M, Mazzawi T, Hausken T, Hatlebakk JG, et al
The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
Scand J Gastroenterol. 2022 Apr 29:1-10. doi: 10.1080/00365521.2022.2064725.
Abstract

HEDSTROM A, Kvarnstrom M, Lindberg G, Alsabeah S, et al
High prevalence of gastrointestinal symptoms in patients with primary Sjogren's syndrome cannot be attributed to pancreatic exocrine insufficiency.
Scand J Gastroenterol. 2022 Apr 24:1-7. doi: 10.1080/00365521.2022.2065888.
Abstract

YAN X, Wang J, Bai Y
Potentials of circSOBP in the diagnosis and prognosis of gastric cancer.
Scand J Gastroenterol. 2022 Aug 20:1-5. doi: 10.1080/00365521.2022.2088246.
Abstract

HONG G, Li Y, Yang M, Li G, et al
Baseline gut microbial profiles are associated with the efficacy of Bacillus subtilis and Enterococcus faecium in IBS-D.
Scand J Gastroenterol. 2022 Oct 25:1-10. doi: 10.1080/00365521.2022.2136013.
Abstract

PAGAN-BUSIGO JE, Lopez-Carrasquillo J, Appleyard CB, Torres-Reveron A, et al
Beyond depression and anxiety; a systematic review about the role of corticotropin-releasing hormone antagonists in diseases of the pelvic and abdominal organs.
PLoS One. 2022;17:e0264909.
Abstract

IVASHKIN VT, Kudryavtseva AV, Krasnov GS, Poluektov YM, et al
Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial.
PLoS One. 2022;17:e0263880.
Abstract

OZAKA S, Sonoda A, Ariki S, Minata M, et al
Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
PLoS One. 2022;17:e0269698.
Abstract

ABID S, Rehman H, Awan S, Artani A, et al
Epidemiology of functional gastrointestinal disorders using ROME III adult questionnaire, a population based cross sectional study in Karachi-Pakistan.
PLoS One. 2022;17:e0268403.
Abstract

LIU J, Peng R, Tan Q, Li B, et al
Proteomic analysis of rat colonic mucosa following acupuncture treatment for irritable bowel syndrome with diarrhea.
PLoS One. 2022;17:e0273853.
Abstract

GROZIC A, Coker K, Dussik CM, Sabir MS, et al
Identification of putative transcriptomic biomarkers in irritable bowel syndrome (IBS): Differential gene expression and regulation of TPH1 and SERT by vitamin D.
PLoS One. 2022;17:e0275683.
Abstract

HINSE M, Thronicke A, Berghofer A, Matthes H, et al
New multimodal intervention to reduce irritable bowel syndrome (IBS) severity symptoms-Pilot study with a 12 month follow-up.
PLoS One. 2022;17:e0277880.
Abstract

NAKATA R, Tanaka F, Sugawara N, Kojima Y, et al
Analysis of autonomic function during natural defecation in patients with irritable bowel syndrome using real-time recording with a wearable device.
PLoS One. 2022;17:e0278922.
Abstract

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge.

;